Applications of Model-Based Lung Mechanics in the Intensive Care Unit by Sundaresan, Ashwath
Applications of Model-Based Lung
Mechanics in the Intensive Care
Unit
Ashwath Sundaresan
A thesis presented for the degree of
Doctor of Philosophy
in
Mechanical Engineering
at the
University of Canterbury,
Christchurch, New Zealand.
13 May 2010
ii
iii
Acknowledgements
To Professor Geoff Chase. Thank you for being a solid supervisor and constantly pushing
me to improve my work.
To Dr Geoff Shaw. Cheers for always making time for me. Could not have done this
project without your inputs.
To the ICU staff. Thanks for putting up with me and assisting me in my trials. Somehow I
always got in your way, and yet you guys were always patient!
To Dr Chris Hann. Thank you for your technical and mathematical advice during my
research.
To the Bioeng suite. Cheers for the good times and laughs. Loved the goss, loved the jokes
and appreciate the accumulation of random knowledge I now have thanks to you guys!
To Messer’s Fleury and Jackson. PG for life! Enjoyed living with you guys and also
appreciated the support from you guys during the first two years of our postgrad.
To my Dad (Sundar). Thank you for all your wisdom and guidance. You have been an
awesome role model to me and appreciate all the advice you have imparted on me.
To my Mum (Narayani), Mythrayee & Frances. Thank you heaps for your love and
support. Also, thank you for putting up with me when I was difficult. Love you lots.
iv
vTable of Contents
ACKNOWLEDGEMENTS ................................................................................................. III
TABLE OF CONTENTS ....................................................................................................... V
LIST OF FIGURES...............................................................................................................IX
LIST OF TABLES............................................................................................................... XV
NOMENCLATURE ........................................................................................................XVIII
ABSTRACT ........................................................................................................................XXI
CHAPTER 1 - INTRODUCTION ......................................................................................... 2
1.1 Mechanical Ventilation .................................................................................................................................. 2
1.2 Lung Physiology ............................................................................................................................................. 5
1.3 ARDS............................................................................................................................................................... 8
1.4 Ventilation & ARDS Treatment ................................................................................................................... 9
1.5 The Quest For Gold...................................................................................................................................... 10
1.5.1 Tidal Volume.......................................................................................................................................... 10
1.5.2 PEEP....................................................................................................................................................... 12
1.6 Problem Summary ....................................................................................................................................... 14
1.7 Preface........................................................................................................................................................... 15
CHAPTER 2 - LUNG MECHANICS AND MODELS...................................................... 17
2.1 Lung Mechanics ........................................................................................................................................... 17
2.1.1 Recruitment & De-Recruitment.............................................................................................................. 18
2.1.2 Pressure Distributions............................................................................................................................. 19
2.2 Clinical Selection Of PEEP.......................................................................................................................... 20
2.2.1 Computed Tomography.......................................................................................................................... 21
2.2.2 Pressure Volume Curves ........................................................................................................................ 23
2.3 Model-Based Approaches ............................................................................................................................ 26
2.3.1 Lumped Parameter Models..................................................................................................................... 27
Gas Exchange Models ................................................................................................................................ 27
Recruitment Models ................................................................................................................................... 29
2.4 Summary....................................................................................................................................................... 30
CHAPTER 3 - RECRUITMENT MODEL......................................................................... 31
3.1 Model Summary ........................................................................................................................................... 31
3.1.1 Threshold Pressures................................................................................................................................ 32
3.1.2 Unit Compliance..................................................................................................................................... 33
3.1.3 Model Simulation ................................................................................................................................... 34
3.2 Parameter Identification.............................................................................................................................. 35
3.3 Preliminary Model Validation .................................................................................................................... 37
3.4 Model Prediction .......................................................................................................................................... 43
3.5 Model Limitations ........................................................................................................................................ 48
3.6 Summary....................................................................................................................................................... 50
CHAPTER 4 - MODEL-BASED DFRC.............................................................................. 52
4.1 Model Introduction ...................................................................................................................................... 52
4.2 Model Summary ........................................................................................................................................... 54
vi
4.3 Analysis & Statistics..................................................................................................................................... 60
4.4 Preliminary Model Validation..................................................................................................................... 61
4.4.1 FRC Prediction ....................................................................................................................................... 65
4.5 Model Discussion .......................................................................................................................................... 67
4.6 Model Limitations ........................................................................................................................................ 69
4.7 Summary ....................................................................................................................................................... 71
CHAPTER 5 - STUDY DESIGN..........................................................................................72
5.1 Trial Objectives ............................................................................................................................................ 72
5.1.1 Recruitment Model ................................................................................................................................. 72
5.1.2 Dynamic FRC (dFRC) Model ................................................................................................................ 73
5.2 Protocol Development .................................................................................................................................. 74
5.2.1 Recruitment Manoeuvres........................................................................................................................ 74
5.2.2 CT Scans................................................................................................................................................. 75
FRC Measurement ...................................................................................................................................... 76
Alveolar Recruitment.................................................................................................................................. 76
5.2.3 EthiCal Considerations ........................................................................................................................... 77
The Science Of Radiation ........................................................................................................................... 78
Impact On Study Design............................................................................................................................. 80
5.3 Methodology & Protocols ............................................................................................................................ 80
5.3.1 Patient Selection Criteria ........................................................................................................................ 80
Inclusion Criteria ........................................................................................................................................ 80
Exclusion Criteria ....................................................................................................................................... 81
5.3.2 Trial Setup .............................................................................................................................................. 81
5.3.3 Study Protocols....................................................................................................................................... 83
Protocol 1 – Recruitment Manoeuvre Only ................................................................................................ 83
Protocol 2 – Recruitment Manoeuvre with CT Scan .................................................................................. 84
5.4 Summary ....................................................................................................................................................... 85
CHAPTER 6 - RECRUITMENT MODEL VALIDATION ..............................................86
6.1 Metrics........................................................................................................................................................... 86
6.1.1 Metrics for PEEP Decision Support ....................................................................................................... 86
TOP............................................................................................................................................................. 86
TCP............................................................................................................................................................. 87
Net Recruitment.......................................................................................................................................... 89
Choice of Metric ......................................................................................................................................... 90
6.1.2 Disease State Metrics.............................................................................................................................. 91
Mean – Time Metric ................................................................................................................................... 91
Compliance – Time Metric ......................................................................................................................... 92
TOP Gradient Metric .................................................................................................................................. 93
TCP Gradient Metric .................................................................................................................................. 93
6.1.3 Metric Summary ..................................................................................................................................... 94
6.2 Clinical Results ............................................................................................................................................. 94
6.2.1 Model-Based Optimal PEEP .................................................................................................................. 95
6.2.2 Monitoring Disease Evolution ................................................................................................................ 98
Patient 5 ...................................................................................................................................................... 99
Patient 6 ...................................................................................................................................................... 99
6.3 Discussions & Limitations ......................................................................................................................... 101
6.3.1 PEEP Selection ..................................................................................................................................... 101
6.3.2 Compliance Changes ............................................................................................................................ 103
6.3.3 SD & Compliance................................................................................................................................. 104
6.3.4 Mechanical Failure ............................................................................................................................... 107
6.3.5 Effect of Inspiratory Resistance............................................................................................................ 108
6.3.6 Airway Obstructions............................................................................................................................. 109
6.3.7 H1N1 .................................................................................................................................................... 111
6.4 Summary ..................................................................................................................................................... 112
CHAPTER 7 - DFRC ESTIMATION VALIDATION.....................................................113
7.1 Clinical Results ........................................................................................................................................... 113
vii
7.2 Discussion & Limitations........................................................................................................................... 120
7.2.1 Compliance Changes ............................................................................................................................ 120
7.2.2 Combined Dataset ................................................................................................................................ 121
7.2.3 dFRC & Recruitment Models............................................................................................................... 122
7.3 Summary..................................................................................................................................................... 124
CHAPTER 8 - CARDIAC OUTPUT ESTIMATION...................................................... 126
8.1 Introduction................................................................................................................................................ 126
8.2 Diffusion Model .......................................................................................................................................... 128
8.3 Combined Model Development ................................................................................................................. 131
8.3.1 Diffusion Model Parameters................................................................................................................. 131
8.3.2 Estimating Shunt Changes Due To PEEP – Linking the two Models .................................................. 134
8.4 Model Validation & Analysis .................................................................................................................... 137
8.4.1 Proof of Concept .................................................................................................................................. 137
8.4.2 Optimisation of PEEP & Patient Care .................................................................................................. 139
8.4.3 Robustness Testing............................................................................................................................... 142
8.4.4 Sensitivity to Lung Mechanics ............................................................................................................. 144
8.5 Model Limitations & Discussions ............................................................................................................. 146
8.6 Summary..................................................................................................................................................... 147
CHAPTER 9 - CONCLUSIONS ........................................................................................ 148
9.1 Overview ..................................................................................................................................................... 148
9.2 Specific Outcomes & Implications ............................................................................................................ 148
CHAPTER 10 - FUTURE WORK..................................................................................... 152
10.1 Clinical Pathway....................................................................................................................................... 152
10.1.1 CT Scanning ....................................................................................................................................... 152
10.1.2 N × N Trials........................................................................................................................................ 152
10.1.3 Non-Interventional Trials ................................................................................................................... 153
10.1.4 Cardiac Output Monitoring ................................................................................................................ 153
10.1.5 Variation in Ventilation Mode............................................................................................................ 153
10.1.6 Spontaneously Breathing Patients ...................................................................................................... 154
10.1.7 Dataset Size ........................................................................................................................................ 154
10.2 Modelling Pathway................................................................................................................................... 155
10.2.1 ARDS Distribution Modelling............................................................................................................ 155
10.2.2 Incremental Stress Strain Approach ................................................................................................... 156
10.2.3 COPD ................................................................................................................................................. 156
10.2.4 Automation......................................................................................................................................... 157
APPENDIX A – FRC SENSITIVITY PLOTS.................................................................. 159
APPENDIX B – MODEL FITTING ERRORS ................................................................ 164
APPENDIX C – RECRUITMENT MODEL RESULTS................................................. 168
APPENDIX D – MEASURED DFRC PLOTS.................................................................. 181
REFERENCES .................................................................................................................... 187
viii
ix
List of Figures
Figure 1.1 – Pressure Volume curve showing dFRC, Vt, PEEP and PIP.................................. 3
Figure 1.2 - Diaphragmatic movement during inspiration and expiration [Sebel et al., 1985] . 5
Figure 1.3 - Trachea and airway bifurcation into bronchial branch [Sebel et al., 1985] ........... 6
Figure 1.4 - Alveolar sac surrounded by capillaries. Difference in partial pressure of the
gas causes gas exchange to occur [Sebel et al., 1985]....................................................... 7
Figure 2.1 - Static Pressure Volume Curve showing LIP and UIP ......................................... 24
Figure 3.1 - Lung modelled as a collection of units, evenly divided into compartments of
different superimposed pressure [Sundaresan et al., 2009]. ............................................ 31
Figure 3.2 - Unit compliance curve using the Venegas equation ............................................ 33
Figure 3.3 - A schematic of the model solution process. It shows each step of the process
for calculating one compartment volume. The total lung volume of a given pressure is
the sum of all the compartment volumes modelled. ........................................................ 34
Figure 3.4 - An example of the model fit. The plot shows the modelled inflation, modelled
deflation and the data for inflation and deflation. The model fits the entire lung
capacity ............................................................................................................................ 39
Figure 3.5 - PV loop showing the transient behaviour during inflation and deflation ............ 41
Figure 3.6(A) & (B) - Dataset 1 & 2. Dotted line shows the clinical data and solid line
shows the model fitted to the clinical data [Bersten, 1998]. The model fit is for PEEP
= 5 cmH2O, as shown. ..................................................................................................... 41
Figure 3.7 - A fitted mean shift for prediction for Dataset 1. PEEP = 7 and 12 cmH2O were
used to predict PV data at PEEP = 5 cmH2O. The linear lines for mean shifts (solid
lines) are identified from the 2 given datasets (solid dots). The * shows the true mean
for PEEP = 5 cmH2O. ...................................................................................................... 45
Figure 3.8 - A prediction result for PEEP = 5 cmH2O of Dataset 1. The PV data was
predicted by fitting 2 known PEEP levels (solid lines). The dots show the predicted
data and the dashed lines show original data................................................................... 45
Figure 3.9 - Predicted mean shift for PEEP of 5 cmH2O for Dataset 5................................... 46
Figure 4.1 - Schematic of lung showing the limitation of an absolute FRC measurement as
used in gas washin/washout methods .............................................................................. 53
Figure 4.2 - Schematic showing the difference between FRC and Dynamic FRC ................. 54
xFigure 4.3 - Effect of different lung and chest wall elastance. An equal total elastance may
arise from different combinations of lung and chest wall elastance [Gattinoni et al.,
2004], where (a) is typical of ARDS patient and (b) healthier patient. Thus, α is higher
in (a) .................................................................................................................................56
Figure 4.4 - PV curve showing two PEEP levels and the corresponding dFRC level relative
to FRC ..............................................................................................................................58
Figure 4.5 - Flow Chart showing the process of dFRC estimation ..........................................60
Figure 4.6 - Plot of Clinical dFRC vs Predicted dFRC for all patients with a PEEP of 5
cmH2O..............................................................................................................................62
Figure 4.7 - Plot of Clinical dFRC vs Predicted dFRC for all patients for all PEEP values ...63
Figure 4.8 - Bland Altman plot of predicted dFRC and measured dFRC. Solid red line is
the mean difference and dashed lines represent the 90% confidence interval .................63
Figure 4.9 - Plot of median beta vs PEEP taken across all data points....................................64
Figure 4.10 - FRC as a function of varying α for Patient 1. Thick dotted line indicates
estimated FRC when mean ELspec is used. (A) Normal distribution range - Thin lines
show the +/- 1 and 2 SD from mean as reported by Chiumello et al [Chiumello et al.,
2008]. (B) Lognormal distribution range - Thin dotted lines show the +/- 2 SD using
lognormal distribution ......................................................................................................66
Figure 4.11 - Measured and estimated dFRC for Patient 6. Although the percentage error is
high, the estimated dFRC can still pick up the trend due to PEEP application ...............70
Figure 4.12 - Estimate of the static PV curve for patient 1 using points of zero flow.............70
Figure 5.1 - Risk of Cancer vs Radiation Dose for LNT (blue) and Radiation Hormesis
model (red). Radiation hormesis shows beneficial impact of low dose radiation ...........79
Figure 6.1 - Combinations of TOP and TCP mean shift..........................................................88
Figure 6.2 - Static PV curve during inflation and deflation. Hysteresis is shown, with the
volume at inflation, Vinf, much lower than volume during deflation, Vdef, for a given
pressure, Pcrit.....................................................................................................................89
Figure 6.3 - Net recruitment as a function of pressure. Pcrit indicates pressure where net
recruitment is maximised. At pressures below Pcrit, the rate of de-recruitment
increases, while pressures above Pcrit, the rate of recruitment decreases. ........................90
Figure 6.4 - Change in TOP as a function of time. Metric provides information with a
change in lung condition and stiffness, and also provides information to the overall
disease state ......................................................................................................................92
xi
Figure 6.5 – Model standard deviation as a function of time. ................................................. 93
Figure 6.6 - Schematic highlighting concept of Auto-PEEP. Figure (A) shows the presence
of a collapsed airway, with recruited alveoli causing a level of auto-PEEP. Figure (B)
shows the collapsed airway opening up when additional PEEP is applied ..................... 95
Figure 6.7 - PV curves for Patient 1 at PEEP below auto-PEEP. Auto-PEEP was equal to 7
cmH2O ............................................................................................................................. 95
Figure 6.8 - Main plot shows TOP and TCP as a function of PEEP for Patient 1. Bottom
left plot is the model fit. Bottom right indicates net recruitment .................................... 97
Figure 6.9 – (A) Average TOP and SD over time for Patient 5 and (B) TOP and TCP
gradient over time ............................................................................................................ 99
Figure 6.10 - (A) Average TOP and SD over time for Patient 6 and (B) TOP and TCP
gradient over time .......................................................................................................... 100
Figure 6.11 - (A) TOP and TCP vs PEEP for Patient 5, Trial 2. (B) Net recruitment for
Patient 5, Trial 2 indicating sub-optimal ventilation beyond 20 cmH2O. ..................... 102
Figure 6.12 - (A) PV curves for a dataset from Bersten et al showing similar linear
compliance. (B) PV curves from clinical data. Similar compliance is exhibited in the
linear portion, but compliance significantly varies at low and high PEEP. .................. 104
Figure 6.13 - SD vs linear compliance for all patients .......................................................... 105
Figure 6.14 - Static PV curve for Patient 1 and Patient 8. Red solid lines show the linear
compliance for both patients. SD is identical for both patients, but TLC is different,
causing linear compliance to vary. ................................................................................ 106
Figure 6.15 - SD vs normalised linear compliance for all patients ....................................... 106
Figure 6.16 - (A) TOP and TCP vs PEEP for Patient 2. (B) Net recruitment for Patient 2
indicating sub-optimal ventilation beyond 15 cmH2O. ................................................. 107
Figure 6.17 - PV curve takes on a narrower shape when corrected for resistive pressure .... 108
Figure 6.18 - TOP and TCP magnitude change when model is fitted to PV loops with
resistive pressure removed for Patient 5, Trial 1 ........................................................... 109
Figure 6.19 - Raw Flow vs Time and Pressure vs Time for Patient 4 ................................... 110
Figure 6.20 - Schematic highlighting the decreasing pressure phenomena........................... 111
Figure 7.1 - PEEP vs dFRC for Patient 1. Red thicker solid line indicates the linear portion
of the static PV curve..................................................................................................... 114
Figure 7.2 - Plot of Measured vs Predicted dFRC for all datasets. Red crosses indicate data
points from Group 1 and blue dots indicate data points from Group 2. Dashed line is
xii
regression line for Group 1, dotted line for Group 2 and solid line for combined data
set. ..................................................................................................................................117
Figure 7.3 - Bland Altman plot of predicted dFRC and measured dFRC for clinical
patients. Solid red line is the mean difference and dashed lines represent the 90%
confidence interval .........................................................................................................117
Figure 7.4 - PEEP vs dFRC for (A) Patient 4, (B) Patient 5, Trial 1, (C) Patient 5, Trial 2
and (D) Patient 9. Plots show very low compliance at low PEEP highlighting a
limitation to the dFRC estimation model across wide PEEP ranges. However, this
variation in compliance occurs at PEEP outside clinically reasonable range ................118
Figure 7.5 - Bland Altman plot of predicted dFRC and measured dFRC for clinical patients
without Patients 4, 5 and 9. Solid red line is the mean difference and dashed lines
represent the 90% confidence interval ...........................................................................119
Figure 7.6 - Median β across combined dataset compared with the median β of Group 1....122
Figure 7.7 - PV curves for Patient 6, Trial 1. No measurements of dFRC were taken as
patient was not deflated to ZEEP ...................................................................................123
Figure 7.8 - PV curves for Patient 6, Trial 1. dFRC is estimated using the linear
compliance for Patient 6, Trial 1. ...................................................................................123
Figure 7.9 - Comparison of TOP and TCP when dFRC is estimated for Patient 6, Trial 1...124
Figure 8.1 - Diffusion Model reproduced from Rees & Andreassen et al [Rees et al., 2002,
Andreassen et al., 1996] .................................................................................................129
Figure 8.2 - Oxygen saturation curves changing as a function of FiO2 and various levels of
shunt ...............................................................................................................................132
Figure 8.3 - Oxygen saturation curves at various levels of diffusion resistance and shunt =
0......................................................................................................................................133
Figure 8.4 - Oxygen saturation curve varying as a function of cardiac output ......................133
Figure 8.5 - Model fitting using measured PV loops - Dataset 1 from Bersten [Bersten,
1998]. dFRC is measured and then all PV loops fitted to maximum theoretical TLC ..135
Figure 8.6 - Flow chart determining the process of estimating cardiac output at a higher
PEEP level......................................................................................................................136
Figure 8.7 - Best fit oxygen saturation curve assumed to occur at the first PEEP. Shunt =
17% and diffusion resistance = 36 kPa/L/min with CO = 5 L/min................................138
Figure 8.8 - Improved oxygenation as shown by the increase in oxygen saturation with the
application of PEEP .......................................................................................................139
xiii
Figure 8.9 - Decrease/ negligible effect on oxygenation due to PEEP indicating that there is
a tradeoffs between decreased shunt and decreased CO when PEEP is applied ........... 140
Figure 8.10 - Effect of drop in cardiac output on oxygenation ............................................. 141
Figure 8.11- Scatter plot of drop in CO for different initial estimates of CO relative to
median drop. (A) Drop from changing PEEP from 5 to 7 cmH2O, (B) drop from
changing PEEP from 7 to 12 cmH2O ............................................................................ 143
Figure 8.12 - Scatter plot of percentage drop in CO for different initial estimates of CO
relative to median percentage drop. (A) Drop from 5 to 7 cmH2O, (B) drop from 7 to
12 cmH2O ...................................................................................................................... 144
Figure 8.13 - Effect on the percentage drop in shunt from 5 to 7 cmH2O as the theoretical
lung capacity is varied by 10%...................................................................................... 145
Figure 8.14 - Effect on shunt at PEEP 7 cmH2O as the theoretical lung capacity is varied
by 10%........................................................................................................................... 145
xiv
xv
List of Tables
Table 3.1 - Characteristics of study patients from Bersten [Bersten, 1998]............................ 38
Table 3.2 - Summary of model errors...................................................................................... 42
Table 3.3 - Range of mean and SD across all datasets ............................................................ 43
Table 3.4 - Summary of PV prediction errors for two data sets .............................................. 47
Table 3.5 - Summary of PV prediction percentage errors for all datasets. The errors are
listed according to predicted PEEP levels ....................................................................... 47
Table 4.1 - Exact and Median Values of β for different PEEP for all patients ....................... 61
Table 4.2 - Percentage Error of actual dFRC and predicted dFRC for all patients at all
PEEP levels...................................................................................................................... 62
Table 4.3 - Median, IQR and 90% Confidence Interval of R2 correlation coefficient, mβ
and β at every level of PEEP ........................................................................................... 64
Table 4.4 - Estimated FRC for all patients when α = 0.7 and ELspec = 13.6 cmH2O, and the
number of standard deviations using a normal and log normal distribution. .................. 67
Table 4.5 - Linearity of static PV curve for each patient......................................................... 70
Table 5.1 - Study objectives and corresponding clinical trial required ................................... 74
Table 5.2 - Recruitment manoeuvre protocol .......................................................................... 83
Table 5.3 - PEEP level where CT scans are obtained depending on PEEPmax ........................ 84
Table 6.1 - Characteristics of trial patients .............................................................................. 96
Table 6.2 - Model fitting error for Patient 1 ............................................................................ 96
Table 6.3 - Summary of fitting errors for all patients.............................................................. 96
Table 6.4 – Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net
recruitment for Patient 1 .................................................................................................. 97
Table 6.5 – Summary of auto-PEEP and model-based PEEP selection metrics for all
patients............................................................................................................................. 98
Table 6.6 - Variation in compliance across all patients......................................................... 103
Table 6.7 - SD and linear compliance for each clinical patient. Compliance was normalised
to allow correction for varying TLC.............................................................................. 105
Table 7.1 - Median ß from initial validation using data from Group 1 [Bersten, 1998], as
per Chapter 4.................................................................................................................. 115
xvi
Table 7.2 -Percentage Error of actual dFRC and predicted dFRC for all patients in Group 2
at all PEEP levels using median ß from Table 7.1 .........................................................115
Table 7.3 - Median ß from all patients, comprising of data from Group 1 [Bersten, 1998]
and data from Group 2 ...................................................................................................116
Table 1.4 - Percentage Error of actual dFRC and predicted dFRC for all patients in Group
2 at all PEEP levels using median ß from Table 7.3 ......................................................116
Table 7.5 - Percentage error between predicted and measured dFRC across all data sets
using median ß. Absolute error in brackets....................................................................120
Table 8.1 - Measured, estimate and calculated parameters in the diffusion resistance model131
Table 8.2 - Diffusion model parameters from Andreassen et al [Andreassen et al., 1996] ...132
Table 8.3 - Measured PV data for Patient 1 from Bersten [Bersten, 1998] fitted with the
recruitment model ..........................................................................................................137
Table 8.4 - Measured values of varying FiO2 and SpO2 from Andreassen et al. These values
are assumed to occur at the initial PEEP level ...............................................................138
Table 8.5 - Modified shunt and cardiac output as a function of PEEP. * indicates measured
or known input values. + indicates estimated values .....................................................139
Table 8.6 - Optimum level of PEEP depending on rate of cardiac output change ................142
Table 8.7 - Initial estimate of CO at PEEP = 5 cmH2O (grey cells). Drop in CO and
percentage drop in CO shown for the different initial estimates....................................143
xvii
xviii
Nomenclature
Intensive Care Unit (ICU)
Mechanical Ventilation (MV)
Endotracheal (ET)
Ventilator Induced Lung Injury (VILI)
Acute Respiratory Distress Syndrome (ARDS)
Acute Lung Injury (ALI)
Positive End Expiratory Pressure (PEEP)
Centimetre of Water – Pressure Measurement (cmH2O)
Tidal Volume (Vt)
Peak Inspiratory Pressure (PIP)
Functional Residual Capacity (FRC)
Dynamic Functional Residual Capacity (dFRC)
Volume Controlled Ventilation (VCV)
Pressure Controlled Ventilation (PCV)
Carbon Dioxide (CO2)
Pressure Volume (PV)
Lower Inflection Point (LIP)
Upper Inflection Point (UIP)
Zero End Expiratory Pressure (ZEEP)
Computed Tomography (CT)
Threshold Opening Pressure (TOP)
Threshold Closing Pressure (TCP)
Hounsfield unit (HU)
Static Pressure Volume (SPV)
Finite Element (FE)
Chronic Obstructive Pulmonary Disease (COPD)
Standard Deviation (SD)
Transpulmonary Pressure (PL)
Specific Lung Elastance (ELspec)
Plateau Airway Pressure (Paw)
Lung Elastance (EL)
Chest Wall Elastance (ECW)
Ratio of lung elastance to total respiratory elastance (α)
Normal Mean (µ’)
xix
Normal SD (σ’)
Lognormal Mean (µ)
Lognormal SD (σ)
Total Lung Capacity (TLC)
PEEP Stress (β)
Millisieverts (mSv)
International Commission on Radiological Protection (ICRP)
Linear No Threshold Model (LNT)
Medical Radiation Technologists (MRT)
Partial Pressure of Arterial Oxygen (PaO2)
Fraction of Inspired Oxygen (FiO2)
Fraction of Expired Oxygen (FEO2)
Synchronised Intermittent Mandatory Ventilation (SIMV)
Rocuronium Bromide (ROC)
Interquartile Range (IQR)
Cardiac Output (CO)
Oxygen Saturation (SaO2)
Oxygen Consumption (VO2)
Diffusion Resistance (R)
Pulmonary Shunt (fs)
Oxygen Dissociation Curve (ODC)
Proof of Concept (POC)
xx
xxi
Abstract
Mechanical ventilation (MV) therapy has been utilised in the intensive care unit (ICU) for
50 years to treat patients with respiratory illness by supporting the work of breathing,
providing oxygen and removing carbon dioxide. MV therapy is utilised by 30-50% of ICU
patients, and is a major driver of increased length of stay, increased cost and increased
mortality. For patients suffering from acute respiratory distress syndrome (ARDS), the
optimal MV settings are highly debated. ARDS patients suffer from a lack of recruited
alveoli, and the application of positive end expiratory pressure (PEEP) is often used to
maintain recruitment to maximise gas exchange and minimise lung damage. However,
determining what level of PEEP is best for the patient is difficult. In particular, it involves
a complex trade off between patient safety and ventilation efficacy.
Currently, no clinical protocols exist to determine a patient-specific “best” PEEP. Model-
based approaches provide an alternative patient-specific method to help clinical diagnosis
and therapy selection. In particular, model-based methods can utilise a mix of both
engineering and medical principles to create patient-specific models. The models are used
for optimising ventilation settings and providing greater physiological insight into lung
status than is currently available.
Two model-based approaches are presented here. First, a quasi-static, minimal model of
lung mechanics is presented based solely on fundamental lung physiology and mechanics.
Secondly, a model of dynamic functional residual capacity (dFRC) is developed and
presented based on model-based status of lung stress and strain. These models are
validated with retrospective clinical data to evaluate the potential of such model-based
approaches. Finally, the models are further validated with real time clinical data over a
broader spectrum of pressure-volume ranges than prior studies to evaluate the clinical
viability of model-based approaches to optimise MV therapy.
When validated with real-time clinical trials data, the outputs of the recruitment model
provide a range of optimal patient-specific values of PEEP based on different clinically
and physiologically derived criteria. The recruitment model is also shown to have the
ability to track the disease state of ARDS over time. The dFRC model introduces the PEEP
stress parameter, β, which represents a unique population constant. The dFRC model
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suggests that clinically reasonable estimates of dFRC can be achieved by using this novel
value of β, rather than the current, potentially hazardous, methods of deflating the lung to
atmospheric pressure.
Finally, a third model, combining the principles of recruitment and gas exchange is
introduced. The combined model has the ability to estimate cardiac output (CO) changes
with respect to PEEP changes during MV therapy. In addition, the model relates the
coupled areas of circulation and pulmonary management, as well as linking these MV
decision support models to oxygenation based clinical endpoints. A proof of concept is
shown for this model by combining two different retrospective datasets and highlighting its
ability to capture clinically expected drops in CO as PEEP increases. The model allows
valuable cardiovascular circulation data to be predicted and also provides an alternative
method and clinical end point by which PEEP could be optimised. The model requires
further clinical validation before clinical use, but shows significant promise.
The models developed and tested in this research enable rapid parameter identification
from minimal, readily available clinical data, and thus provide a novel way of guiding
therapy. The models can potentially provide clinicians with information to select an
optimal patient-specific level of PEEP using only standard ventilation data, such as
pressure-volume curves. In addition, the development of a dFRC stress model provides a
unique population constant, β. Overall, the modelling approaches developed and validated
in this research provide several novel methods of guiding therapy setting mechanical
ventilation parameters and tracking and assess a patient’s lung condition. This research
thus creates and provides novel validated methods for improving MV therapy with
minimal cost or added invasiveness.
1
2Chapter 1 - Introduction
The rapid development of technology has made many aspects of human life easier.
Innovations introduced in the past century have transformed the world and improved
human life. Medical technologies represent a small portion of the technology umbrella and
are used to diagnose, monitor or treat a wide range of conditions. Medical technologies are
used to improve the quality of care by providing earlier diagnosis, less invasive treatment
options and reduction in hospital times.
Although medical technologies can incorporate pharmaceuticals, procedures, and
organisational systems, an important category is medical devices. The purpose of medical
devices can range from diagnosis to treatment of disease conditions. The range of medical
devices available can be seen in a typical Intensive Care Unit (ICU), with patients being
monitored and managed through invasive catheters, ventilators and infusion pumps. The
technologies used in the ICU are used to deliver drug therapies, support circulation and
breathing, and provide several other specific treatments.
1.1 MECHANICAL VENTILATION
The most common treatment in the ICU is Mechanical Ventilation (MV) therapy, and is
used to aid patients who have respiratory failure.  MV aids patient breathing by delivering
bulk movement of air into and out of the lung, and thus supplements or replaces
spontaneous breathing. Through the application of additional pressure to the patient’s
airway, air is delivered invasively through an endotracheal (ET) tube or non-invasively
through a face mask. To prevent air from leaking, the ET tube is sealed with a pressure
cuff, to ensure the patient is accurately ventilated.
Patients who suffer from respiratory failure are treated with MV to improve gas exchange
and oxygenation. However, additional complications may arise if incorrect ventilation
settings are used. Ventilator Induced Lung Injury (VILI) can occur if patients are ventilated
with excessive pressures (barotrauma) or tidal volumes (volutrauma) [Dasta et al., 2005,
McLean et al., 2006]. This injury exacerbates the existing condition and increases a
3patient’s length of time under MV, resulting in increased length and cost of stay [Dasta et
al., 2005].
Ventilators offer a range of parameters to change. However, in practice, only a few
variables are considered of significant clinical relevance to patients. Positive End
Expiratory Pressure (PEEP) and Tidal Volume (Vt) are two key parameters that define a
state of MV. PEEP represents the pressure at the end of expiration to which the lung is
allowed to deflate and is greater than atmospheric pressure. MV status is also well
described by Vt, which represents the volume of air that enters the lung per breath. If PEEP
describes the minimum pressure which the lung experiences, the Peak Inspiratory Pressure
(PIP) describes the maximum pressure the lung experiences. Therefore, during ventilation,
the patient inspires a certain Vt of air from a pressure of PEEP up to a resulting PIP, as
shown on Figure 1.1, thus defining a typical breath in terms of pressure and volume.
Figure 1.1 – Pressure Volume curve showing dFRC, Vt, PEEP and PIP
Under normal breathing conditions, the pressure of the lung drops to atmospheric pressure
with the associated relaxed volume known as Functional Residual Capacity (FRC). When
MV is applied, the application of PEEP will produce extra recruitment or retain additional
lung volume at the end of expiration. Hence, there is an extra volume of gas to be
exchanged. This additional volume due to PEEP is known as Dynamic Functional Residual
Capacity (dFRC) and is caused due to alveolar distension or additional recruitment
maintained at the end of expiration above atmospheric pressure.
4Most commonly, two basic modes of ventilation exist: 1) Volume Controlled Ventilation
(VCV) and 2) Pressure Controlled Ventilation (PCV). Under PCV, the clinician directly
sets PEEP and PIP, with the patients compliance (volume change per pressure change)
determining the level of Vt. In contrast, if the clinician chooses VCV, then the PEEP and
Vt are set, with the PIP being the result. Thus, depending on the mode of ventilation, the
resulting PIP or Vt may be highly variable.
Ideally, MV should be applied for the least amount of time to prevent ventilator
dependence and other complications. Hence, the ability to choose optimal ventilator
settings and provide the best treatment is very important. Thus, the ideal MV therapy aims
to combine maximum recruitment and oxygenation, while minimising the risk of VILI. In
addition, it seeks to be as minimally invasive as possible (lower PEEP) without
compromising these goals. However, with the absence of any standardised protocol in MV
therapy or a readily available gold standard [Howman, 1999, Stather and Stewart, 2005], it
is often difficult to achieve this optimal balance in real time, especially as the patient
condition varies.
Numerous attempts to create standardised MV therapies have been trialled [Girard and
Bernard, 2007, Ware and Matthay, 2000]. In all the studies, the primary focus was to
control tidal volume [Brochard et al., 1998, Eichacker et al., 2002, Kallet et al., 2005, The
ARDS Network, 2000] and PEEP [Amato et al., 1998, Brower et al., 2004, Rouby et al.,
2002, Takeuchi et al., 2002]. In all the studies, no significant improvement in survival rates
was observed with the respective protocols, and there is still no standard method in which
to set ventilators.
The process of standardisation is difficult as the needs of the individual ICU patient can
vary significantly by patient condition and over time. Because the condition of the lung is
highly patient-specific and can also change with time, it means that a “one size fits all”
protocol may not work. As a consequence, the absence of patient-specific protocols
adoptive to these inter and intra-patient variability’s, mean that clinically chosen
ventilation settings are still highly dependent on the clinician’s experience and intuition
[Ferguson et al., 2005, Thompson et al., 2001].
51.2 LUNG PHYSIOLOGY
The human body requires a constant supply of oxygen to provide energy and sustenance.
When oxygen is delivered to the body, the by-product of respiration is carbon dioxide
(CO2). Thus, the function of the lungs is to provide oxygen to the body, while
simultaneously removing CO2 and other waste gas products. The oxygen is delivered to the
blood stream through lung alveoli via diffusion, while CO2 is similarly removed in
exchange.
The two primary objectives of the respiratory system are to provide bulk transport and
treatment of air and to provide maximum surface area to allow sufficient gas exchange.
However, before the lung can perform these functions, air must be drawn from the
atmosphere into the body. By itself, the lung does not draw in air during inspiration.
Rather, the process of inflation is determined by the movement of the diaphragm and the
intercostal muscles of the ribs. During inspiration, the diaphragm moves down and the
intercostal muscles move the ribs outwards and upwards, as shown in Figure 1.2. This
movement causes a sudden increase in volume and results in a negative pressure gradient
between the lung and the atmosphere. As a result, the air is drawn from the atmosphere
into the lungs and allows for the pressure gradient to equilibrate, thus forming the process
of inspiration.
Figure 1.2 - Diaphragmatic movement during inspiration and expiration [Sebel et al., 1985]
6In contrast, under normal breathing, the deflation process occurs due to the elastic recoil of
tissues. At the end of inspiration, but prior to expiration, the intercostal muscles and
diaphragm are under elastic deformation. When the pressure in the lung is at equilibrium
with the atmosphere, the elastic recoil causes the muscles to relax. This forces all the air
out of the lung and the lung resumes its original value. The outgoing air now contains the
waste products of respiration, such as CO2.
When inspired air enters the body, it enters through the nasal cavity or mouth, moves
through the larynx and then into the trachea. The role of the upper respiratory system is to
treat the incoming air by filtering, heating and humidifying the air. This filtering and
treatment process ensures that the more delicate surfaces of the airways are not damaged
and remain protected. Just above the heart, the trachea begins to bifurcate, with the airway
diameter eventually decreasing and forming the bronchi. The bronchi then branch off to
feed air to the respective sides of the lung. As the bronchi spread further into the lung, the
airway diameter continues to decrease at each bifurcation, becoming steadily smaller, as
shown in Figure 1.3. Eventually, the diameter ceases to decrease, while bifurcation
continues, thus increasing the total surface area of the lung. Up till now, the primary
function of these airways is to transport air and maintain humidity and temperature [Sebel
et al., 1985, Martini, 2006].
Figure 1.3 - Trachea and airway bifurcation into bronchial branch [Sebel et al., 1985]
7Eventually, the cartilage lining supporting the bronchial branch begins to be replaced by
alveoli, known as respiratory bronchioles. With each generation of airways, the number of
bronchioles continues to increase. This change in lung structure marks the transition of the
role of the lung from gas transport to gas exchange. The airway walls gradually become
dominated with alveoli, thus increasing the total surface area available for gas exchange.
As air continues to flow through the bronchial branch, it finally reaches the alveolar sac.
The alveolar sac differs from the alveolar duct, as it represents an end to the bronchial
branch and contains roughly half the total alveoli in the lung [Sebel et al., 1985].
The alveoli perform the second primary function of the lung, which is gas exchange. The
number of total alveoli significantly varies depending on the individual’s sex and the size
of the lung [Ochs et al., 2004]. However, the average human has about 600 million alveoli
with each approximately 200 µm in diameter [Seeley et al., 2003]. Each alveolus is
surrounded by capillaries, which carry red blood cells, shown in Figure 1.4. The capillaries
and the alveolus are separated by an epithelium of about 0.2 µm thick, which allows fast
gas transfer between them [Vander et al., 2001]. The gas exchange between the alveoli and
the capillaries occurs through diffusion, with oxygen moving from the alveoli to the
capillaries and CO2 moving in the opposite direction, as a result of a partial pressure
gradient.
Figure 1.4 - Alveolar sac surrounded by capillaries. Difference in partial pressure of the gas causes gas exchange
to occur [Sebel et al., 1985]
81.3 ARDS
Acute Respiratory Distress Syndrome (ARDS), is a severe form of Acute Lung Injury
(ALI), and is a condition where the lung is inflamed and filled with fluid. As a result, the
lung loses its ability to exchange gas effectively, resulting in oxygen deficient blood. In
addition, the inflammation in the alveoli results in less surfactant being produced, which
causes alveoli to collapse. This situation results in bronchioles and alveoli filling up with
fluid or collapsing, preventing them from filling with air. Thus, alveoli are lost to the
diseased state and the lung volume is decreased, resulting in the “baby lung” [Gattinoni
and Pesenti, 2005].
A formal definition of ARDS was first defined in 1967 [Ashbaugh et al., 1967]. The study
recognised that ARDS was a consequence of a wide variety of illness, which resulted in
common symptoms among patients. Hence, it is a syndrome, rather than a specific
infection or virus. Although the study highlighted the importance of positive pressure
ventilation, there are still no specific criteria in treating ARDS patients. This deficiency is
due to the fact that ARDS does not present any unique disease specific symptoms [Artigas
et al., 1998, Rouby et al., 2000].
The additional fluid in the alveoli has the overall effect of making the lung stiffer. A stiffer
lung requires a larger pressure gradient to inflate, which leads to an increase in the work of
breathing required by the patient. Thus, the ARDS lung is characterised by being stiffer
and smaller. It is thus, less effective at optimal gas exchange, requiring in these cases,
mechanical support.
When gas exchange has been limited or impaired, the vital organs do not obtain the
necessary oxygen, a condition known as hypoxemia. The onset of severe hypoxemia can
be fatal for these vital organs, which cannot function without oxygen. In addition, when
alveoli collapse, tidal ventilation from the collapsed region is transferred to other areas and
causes an increase in local pressure. This increase in local pressure can restrict blood flow
in the capillaries, a phenomenon known as shunt, and can make CO2 elimination more
difficult, further complicating the ventilation problem.
ARDS can be caused either directly or indirectly. Direct lung injury, such as smoke
inhalation, near drowning or direct physical injury, can lead to the onset of ARDS. In
9addition, ARDS can also be caused indirectly though sepsis, severe trauma to other body
parts, or an inflammatory response to surgery.
Prior to the implementation of ICU’s, patients with ARDS typically did not survive long
enough for detailed investigations [Girard and Bernard, 2007]. ARDS incidence rates have
been reported to range from 3 to 74 cases per 100,000 of total population per year from
various parts of the world [Bersten et al., 2002, Luhr et al., 2000, Phua et al., 2009,
Reynolds et al., 1998]. Mortality for those hospitalised in the ICU with moderate to severe
ARDS, ranges from 22 to 66% [Ferguson et al., 2005, Esteban et al., 2002, Suchyta et al.,
1997 , Zilberberg and Epstein, 1998]. With the advance of technology and increasingly
better equipped ICU’s, as well as the increased availability of positive pressure ventilators
and trained staff, patients now survive much longer and in greater numbers [Baudouin,
1998, Hudson and Steinberg, 1999]. However, improvements in mortality rates have
plateaued since 1994 with no further improvements in therapy [Phua et al., 2009].
1.4 VENTILATION & ARDS TREATMENT
Because no patient-specific or adaptive treatments exist for ARDS, the only option is for
clinicians to provide an environment that ensures the patient can recover by themselves
with time. Although clinical therapies such as anti-inflammatory and surfactant therapy
exist, these approaches have been shown so far to be ineffective [Ware and Matthay,
2000]. Because ARDS increases the work of breathing, patients can find it difficult to
spontaneously breathe, and most require additional support to assist them. MV therapy is
therefore used to assist the patient and help minimise the work of breathing.
In essence, the ventilator is a precision pump that delivers a fixed amount of air to the lung
through an ET tube or a face mask. The ventilator can either assist or replace the work of
breathing depending on the clinically assessed requirements of the patient. In addition, it
can be used to prevent alveolar collapse and/or prevent further alveolar damage, allowing
the lung a better chance of recovery.
PEEP is therefore one of the most important settings in MV therapy. When PEEP is
applied, the ventilator stops the airflow at a certain expiratory pressure. This restriction
prevents the lung from deflating to the low FRC’s that ARDS patients can exhibit. In
particular, this additional pressure is important for ARDS patients, because without it,
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ARDS affected alveoli are highly susceptible to collapsing due to fluid build up and
inflammation. When alveoli collapse, the pressure required to open them up is higher than
before. Thus, collapse increases the stiffness of the lung increasing damage to alveoli and
thus, effectively reducing the compliance. PEEP prevents or minimises this impairment,
maintaining the FRC at the end of expiration at a healthier level and thus preserving
recruitment.
Tidal volume is the second major parameter setting in MV therapy. It determines the
volume of air delivered to the lung per breath and is typically determined by the patient’s
condition. If tidal volume is set too high, it can over inflate the lung and cause VILI
[Carney et al., 2005, Dreyfuss and Saumon, 1998, Moloney and Griffiths, 2004, Pavone et
al., 2007, Ricard et al., 2003]. If tidal volume is too low, then this can result in inadequate
oxygenation and atelectasis [Hauber et al., 2010].
If the ventilator is operating under pressure controlled mode, the PEEP and PIP are set,
with the air flow the resulting parameter. In contrast, if volume controlled mode is used,
PEEP and tidal volume are set, with the pressure increasing as a result. In both cases, the
inspiration phase is actively controlled by the ventilator, which then typically allows
passive deflation to PEEP as controlled by the lung’s own elastic recoil and compliance.
1.5 THE QUEST FOR GOLD
The use of a gold standard method of ventilation is the ultimate clinical goal, but it is often
difficult to determine the optimal parameters. In normal conditions, Vt provides maximum
gas exchange for minimum breathing effort [Otis et al., 1950]. However, for the ARDS
lung, which is both stiffer and smaller in volume, normal amounts of Vt may be too high
and lead to over-inflation and induce further injury. Finally, there is no standard
measurement or assessment that defines an optimal state, which could be assessed or
targeted.
1.5.1 TIDAL VOLUME
The application of tidal volume also implies that there is a level of strain occurring or
being induced within the lung. Lung strain over the entire organ can be defined as the ratio
of Vt /FRC [Chiumello et al., 2008]. Thus, for patients with severe ARDS, who have lower
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FRC due to alveolar collapse, the lung stress and strain may be higher compared to
healthier patients who have more healthy alveoli units available. Therefore, having a larger
tidal volume, which results in a higher strain, may result in added risk of VILI for the
ARDS patient [Ricard et al., 2003].
Because the ARDS lung is described to be heterogeneously distributed [Rouby et al., 2002,
Gattinoni et al., 2001], some regions of lung are affected more than others. This strain
distribution is particularly important for ARDS patients where the damaged alveoli are
surrounded by healthy alveoli and local strains may vary. Thus, the use of low tidal volume
has been investigated as an optimisation parameter to provide safe, so called lung
protective, MV strategies.
Early interest in low tidal volume ventilation was spurred by Hickling and colleagues in an
observational study [Hickling, 1998]. Animal studies also showed that large tidal volumes
resulted in the development of ALI characteristics [Dreyfuss et al., 1985, Gajic et al.,
2004]. The results of animal trials provided researchers with the justification that low tidal
volumes would be beneficial to patients, and in the late 1990’s four controlled trials were
conducted to evaluate the effect of low versus high tidal volumes [Brochard et al., 1998,
Amato et al., 1998, Stewart et al., 1998, Brower et al., 1999].
Out of these four studies, only Amato et al showed a significant decrease in outcome
mortality using lower tidal volumes. The remaining three studies by [Brochard et al., 1998,
Stewart et al., 1998, Brower et al., 1999] showed minimal and statistically insignificant
differences in mortality between patients on low and high tidal volumes. However, a later
randomised trial [Parsons et al., 2005] showed that low Vt reduced the inflammatory
response, which are associated with mortality in ARDS and VILI.
To conclusively determine the effect of low tidal volume ventilation, a study was
conducted by the ARDS Network on 861 patients in 2000 [The ARDS Network, 2000].
This study showed that patients with lower tidal volumes (6.2 ± 0.8 ml/kg) had a higher
number of days free of mechanical ventilation and lower mortality rates than those with
higher tidal volumes (11.8 ± 0.8 ml/kg). The result of this study has significantly improved
ARDS therapy and provided a means of advancing patient management by choosing the
appropriate tidal volume. However, these results and conclusions have also been criticised
due to the impractically high tidal volume used (12 ml/kg, compared to normal practice of
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8-10 ml/kg) during the trials for comparison [Eichacker et al., 2002] and for ignoring some
negative aspects of low Vt [Kacmarek, 2005] , suggesting that the result was skewed.
However, with all these studies regarding the optimal tidal volume, the tidal volume was
fixed for a given patient during the course of the MV therapy. Therefore, this methodology
does not consider the lung strain, as strain is a function of lung size, time, and the patient-
specific state of ARDS as it evolves [Jia et al., 2008, Johnston et al., 2003, Manzano et al.,
2005]. Nor does it consider evolution of therapy as the condition evolves. Finally, it does
not consider or account for variability in the individual patient response to therapy. Thus,
to properly optimise the lung strain, an ideal tidal volume must regularly be re-evaluated
based on patient-specific condition and response with a goal of minimising lung strain
induced by Vt.
Although the debate of high vs low tidal volume continues, the use of low tidal volumes of
300 – 500 ml is becoming widely accepted and common place among ICU’s. However, the
second major setting, PEEP, is still widely debated. In particular, the level of PEEP
required, regardless of tidal volume, is not standardised at all and requires further
investigation.
1.5.2 PEEP
PEEP represents the pressure that the lung experiences during the end of expiration and is
also set by the clinician. The objective of applying PEEP is to increase the level of
oxygenation by increasing the number of recruited alveoli. This is achieved by lifting the
lung pressure at the end of expiration so that alveoli remain open. This retention also
reduces damage to alveoli due to repetitive opening and collapse during subsequent
breaths.
The application of PEEP throughout the respiratory cycle has been shown to greatly
improve oxygenation in patients with ARDS, as shown in early animal and human models
[Hickling, 1998]. As a result, the outcomes of these early studies have led to the
widespread use of PEEP in MV therapy. However, the appropriate level of PEEP over a
given cohort has never been properly established, despite a very large amount of research
in the area [Levy, 2002].
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PEEP comes with tradeoffs and risks to a heterogeneous, injured lung. Too much PEEP
risks injuring healthy lung units. In contrast, not enough PEEP results in continuous
recruitment and de-recruitment of ARDS affected alveoli, which is also harmful [Brochard
et al., 1998]. Thus, PEEP also has a risk of VILI, and an optimal value balances these risks.
Several trials have been conducted to evaluate the benefit of high PEEP in the treatment of
ARDS. Higher PEEP would, it was hypothesised, maintain recruitment of these units
preventing repetitive collapse. Amato et al showed that patients with high PEEP had
significantly lower mortality [Amato et al., 1998]. Villar et al showed similar results for
high PEEP [Villar et al., 2006]. However, others have shown that increased PEEP results
in increased systemic inflammatory response [Miranda et al., 2005, Ranieri et al., 1999].
The problem with these studies was that the lower mortality rate could either be attributed
to high PEEP or low tidal volume because of the trade-off between these two variables in
setting MV [Jonson and Uttman, 2007]. No study has controlled both variables to date, nor
accounted for their potential to vary patient-specifically, both in general and over time.
A study by the ARDS Network was conducted to determine the effect on mortality solely
attributed to PEEP [Brower et al., 2004], by using only low tidal volumes. The study used
low tidal volumes (6 ml/kg) and concluded that high PEEP increases oxygenation.
However, there was no significant difference in mortality rates or length of MV. Thus, the
result of this and other studies [Amato et al., 1998, Villar et al., 2006], provide no
conclusive evidence on a set level of PEEP to be used to optimise recruitment across
heterogeneous ICU cohorts.
Although higher PEEP can improve oxygenation, the risk of alveoli over-inflation is also
increased at high PEEP for healthy alveoli in particular [Ricard et al., 2003]. Thus, using
the highest PEEP possible is not the best solution for optimum ventilation therapy as it
may cause more harm than good and contribute to VILI. However, if the PEEP is too low,
then injury is induced by the repetitive opening and closing of alveoli units [Pavone et al.,
2007, Schiller et al., 2003]. Therefore, the predicament lies in choosing an optimal value of
PEEP by maximising recruitment and minimising additional damage to the lung and
understanding that it might change or evolve over the time course of the disease.
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1.6 PROBLEM SUMMARY
The major problem in MV lies in the lack of standard clinical protocols for treating
patients with ARDS. Because ARDS implies a heterogeneous distribution of healthy and
damaged alveoli, and can significantly change over time, a new patient-specific method of
choosing PEEP is required. Currently, the clinical methodology is to use a low tidal
volume and then to choose an appropriate PEEP based on the patient’s condition, as
assessed by the clinician. However, an optimal solution would be to choose initial
parameters that would then vary over clinically relevant timeframes to continually optimise
the therapy for each patient. This approach would thus account for heterogeneity of the
disease and variability in response by patients.
To achieve this goal, patient-specific models need to be developed that can incorporate the
various MV metrics. The specific objective of a model-based approach is to allow rapid
patient-specific parameter identification and thus enable ready optimisation of MV with
respect to the risk of VILI or lung injury and lung strain. This approach could thus
potentially reduce the length of MV by providing more optimised care. Patient-specific
model parameter identification and the resulting patient-specific models would, as a result,
also enable model-based methods of monitoring disease progress and response to therapy.
This goal can be achieved by a mixture of engineering and physiological principles, which
can be utilised to develop mathematical models that describe patient condition and allow
optimal MV metric selection. In particular, a model that captures patient-specific
recruitment and lung strain, relative to clinically available measurements, can provide
weight into otherwise un-measureable metrics of lung status. Thus, such a model would
capture what would otherwise be available only via computed tomography scans or other
invasive measurements. In simpler terms, it would convert clinical pressure volume
measurements into a physiological picture of patient-specific condition to aid clinical
decision making.
The first goal of this thesis is to introduce a model of lung mechanics that captures the
characteristics of the mechanically ventilated lung. The model, based on simplified
physiology and lung mechanics has the capability of identifying patient-specific response
to PEEP without invasive measurements. The model uses clinically obtainable pressure
volume (PV) curves and estimates the recruitability of the lung for a given patient. In
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addition, a second model is introduced, which looks at the changes in lung volume due to
PEEP depending on lung stress and strain and estimates how responsive the lung is to
pressure changes.
The second goal is to clinically validate these models, and, as a result, be able to determine
the optimal patient-specific PEEP level for each patient. The validation process will consist
of data acquisition, data processing and analysis, with the results being presented in a clear
and clinically interpretable way. The criteria for such a validation is that the model should
be readily adoptable without any costly pieces of added equipment and should be
measurable in real time.
1.7 PREFACE
Chapter 2 of this thesis presents the background and basic theory of lung mechanics that
the model will use. In addition, the chapter also introduces the concept of model-based
approaches to managing ventilation therapy, and discusses various model-based
approaches that have been developed. This discussion leads to the premise of this thesis;
the development and application of a model-based method to optimise PEEP selection in
the mechanically ventilated patient.
Chapters 3 and 4 introduce the models used in this thesis. Chapter 3 focuses on a model of
lung mechanics and recruitment, as well as some initial validation performed. Chapter 4
introduces a model to estimate dFRC using lung stress and strain as a proxy as well as an
initial validation.
Chapters 5, 6 and 7, analyse the results of full scale clinical trials used in this thesis. In
particular, Chapter 5 discusses how the study was designed, and the ethics application and
approval process. Chapter 6 presents the results of these trials and discusses the clinical
implications of the recruitment model, and Chapter 7 further validates the lung stress strain
model.
Chapter 8 introduces a third model, which begins to make a link between the pulmonary
system and the cardiovascular system. The model provides a proof of concept approach to
combine the theory of gas exchange and recruitment to evaluate changes in cardiac output.
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Chapter 9 and 10 present the conclusions derived from this research then focus on the work
that is needed to continue this research and look at what the future holds for ventilation
therapy.
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Chapter 2 - Lung Mechanics and Models
The heterogeneous nature of the ARDS lung makes patient treatment difficult, as each
patient can exhibit significant heterogeneity in the distribution of ARDS affected units and
in the response to changes in MV parameters. A given MV setting for one patient may not
produce the same effect for another similar patient. This heterogeneity implies that a more
patient-specific treatment methodology is required to better optimise patient care. In
particular, what is needed is an approach that can be clinically implemented in real time,
while simultaneously providing relevant information on the condition of the lung and how
to treat it.
The idea of using model-based approaches to solve this problem provides a new
methodological approach that combines engineering and medical principles. Model-based
approaches can provide clinicians with rapid diagnostic capabilities, while simultaneously
allowing a patient-specific treatment therapy to be delivered. In particular, model-based
therapies use mathematical principles to model a given patient’s physiological system, and
outputs clinically relevant parameters to guide diagnosis and therapy selection. This overall
model-based therapeutic method has been validated in other physiological systems related
to critical care [Chase et al., 2008, Hann et al., 2010].
This chapter introduces a modern theory of lung mechanics on which the models used in
this research is based. It then shows how ventilation settings can be selected based on
current and prior theories of lung mechanics. In addition, the chapter also looks at past and
present attempts to use model-based approaches in MV and how these prior works differ
from the model presented in this thesis.
2.1 LUNG MECHANICS
Traditionally, the expansion of the lung was thought to be due to the isotropic balloon-like
expansion of alveoli units. This expansion was often interpreted using a measured static or
dynamic PV curve based on the lower inflection point (LIP) and upper inflection point
(UIP). The LIP was thought to be a single point where massive, simultaneous recruitment
of alveoli occurred, which was then followed by balloon-like expansion of all these alveoli.
18
This process is analogous to a balloon, which requires an initially high pressure to
overcome elastic forces before it suddenly starts to expand. In contrast, the UIP
represented the point where alveoli begin to overstretch and in effect begin to plastically
deform, resulting in a sudden decrease in compliance.
However, this theory does not correspond well to clinical observations [Schiller et al.,
2003, Hickling, 2002]. Rather, it is the recruitment and de-recruitment phenomenon that is
now thought to contribute to the hysteresis observed in PV curves [Cheng et al., 1995].
Furthermore, research has observed that recruitment is continuous and occurs throughout
the inspiratory PV curve and especially between the LIP and UIP [Albaiceta et al., 2004,
Jonson et al., 1999, Maggiore et al., 2001, Mergoni et al., 2001].
These early ideas failed to hold because, for example, if the LIP was a point of massive
recruitment, and PEEP was set above the LIP, clinicians should then have observed
minimum hysteresis. In addition, both inflation and deflation PV curves should then
overlap. However, this behaviour does not occur [Bersten, 1998]. Furthermore, if LIP
indicated a point of massive recruitment, then further alveolar recruitment cannot occur at
pressures above LIP. However, clinical data has shown that as PEEP increases, volume can
increase for a given pressure [Hickling, 2002, Bersten, 1998], thus indicating that
significant additional recruitment occurs above LIP.
2.1.1 RECRUITMENT & DE-RECRUITMENT
Thus, the current school of thought suggests that recruitment and de-recruitment greatly
influence and define the shape of the PV curve. In particular, once  healthy alveoli have
been recruited, they undergo minimal isotropic expansion [Schiller et al., 2003]. This result
leads directly to the conclusion that balloon-like expansion is not the correct mechanism of
lung volume change.
When lung volumes at a given pressure are compared under zero end expiratory pressure
(ZEEP) and PEEP conditions, there is an increase in volume as PEEP is increased [Jonson
and Svantesson, 1999]. This increase is evident even when PEEP is set above the LIP and
indicates that significant recruitment still occurs above the LIP. This result was directly
confirmed, as above the LIP, studies have observed recruitment using computed
tomography (CT) scans [Albaiceta et al., 2004, Gattinoni et al., 2001].
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Other studies have looked at the energy required to recruit collapsed alveoli [Cheng et al.,
1995]. Cheng et al used excised rat lungs and progressively increased the end inspiratory
pressure, while simultaneously decreasing the end expiratory pressure. The study showed
that additional energy was required to recruit alveoli. However, once recruited, less energy
was required to keep them inflated. The study thus concluded that recruitment and de-
recruitment are strongly dependent on end expiratory pressure.
Studies have correlated the continuous alveoli recruitment along the inspiratory PV curve
limb with CT scans. Crotti et al [Crotti et al., 2001] proved that recruitment occurred
throughout the inflation limb continuously and correlated well with the traditional super
syringe PV curve. Hence, this study, and others [Pelosi et al., 2001], found no correlation
between recruitment and the PV curve inflection points.
At the alveolar level, in vivo microscopy studies have captured alveolar dynamics. These
studies have shown that once recruited, there is no significant increase in alveolar volume
for healthy and some ARDS affected alveoli [Schiller et al., 2003, Carney et al., 1999]. In
particular, the studies highlight that recruitment and de-recruitment, as opposed to balloon-
like expansion, are the primary causes of volume change. Because normal, healthy alveoli
are effectively open [Halter et al., 2003], recruitment is only observed with damaged
alveoli. Thus, recruitment and de-recruitment are much more relevant in MV therapy when
treating ARDS.
All of these studies examined recruitment at both the micro and macro levels and via
different approaches. All of them lead to the conclusion that recruitment and de-
recruitment occur continuously throughout the breathing cycle. In addition, once alveoli
are recruited, the unit volume does not change significantly. Thus, volume change seen in
the lungs during MV is not due to balloon-like expansion, but, predominantly, due to
recruitment and de-recruitment. Therefore, managing and optimising PV curves in
mechanically ventilated patients directly concerns the management of recruitment and de-
recruitment of lung units.
2.1.2 PRESSURE DISTRIBUTIONS
The pressure at which an alveoli will recruit is known as the Threshold Opening Pressure
(TOP). Similarly, it de-recruits at a Threshold Closing Pressure (TCP). Because
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recruitment and de-recruitment is a continuous process, the TOP and TCP can take on a
range of values over an entire ARDS lung. The shape of the distribution reflects the patient
condition with respect to ARDS or lung damage, and thus reflects physical characteristics
such as oedema, inflammation, ARDS and others.
The shapes of these pressure distributions have been studied extensively [Crotti et al.,
2001, Pelosi et al., 2001]. An experiment using dog models concluded that the TOP and
TCP were normally distributed and are affected by physical factors, such as superimposed
pressures [Pelosi et al., 2001]. Similarly, another study looked at the difference in TOP and
TCP distributions [Crotti et al., 2001]. This study also verified that TOP and TCP were
normally distributed. Further, it found that the TOP distribution was higher in pressure
than the TCP distribution, indicating more energy was required to recruit alveoli than to
retain them. Thus, it reflected the results of other studies previously discussed [Cheng et
al., 1995].
The TOP and TCP distributions can give an indication of the severity of the disease state
and patient condition. Because ARDS results in alveoli being inflamed, filled with fluid or
collapsed completely, the pressures required for recruitment are much higher as compared
to healthy patients. In addition, because ARDS is heterogeneously distributed in the lungs,
the distribution of TOP and TCP pressures is also much broader than in healthy lungs.
Thus, the severity of ARDS can be quantified by the shape of the pressure distributions and
their breadth in particular.
Because alveolar recruitment occurs continuously, the problem lies in determining what
level of PEEP produces the maximum level of recruitment while retraining the greatest
number of alveoli at the end of expiration. The recruitment and de-recruitment theory puts
to rest the concept of titrating PEEP based on the LIP and UIP. Hence, a new method of
selecting PEEP must be developed to capture and optimise patient-specific responses to
ventilation therapy.
2.2 CLINICAL SELECTION OF PEEP
Choosing an appropriate level of PEEP is dependent on the clinical objective of MV
therapy. Depending on the patient’s condition, the objective is a combination of
maximising recruitment and gas exchange, while minimising lung stress. If the goal was to
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only maximise gas exchange at a given moment, then a very high PEEP would be
appropriate. However, if lung stress and over-inflation are to be minimised, then a lower
PEEP is more appropriate. Thus, the problem is defined as achieving a balance between
these criteria with respect to the PEEP selected, and then optimising this trade-off as the
patient-specific disease state evolves.
Several studies have evaluated the relationship between PEEP and lung stress. One
primary conclusion is that the stress index is a good indicator on which to titrate PEEP
[Grasso et al., 2004, Grasso et al., 2007]. The stress index describes the shape of the
pressure time curve and describes how the rate of change of pressure reflects changes in
lung elastance. In these studies, PEEP titration was performed for each patient based on the
value of the stress index. The main objective was to minimise damage to alveoli and
mitigate the risk of VILI from excessive lung stress. However, the stress index is only used
when a constant flow waveform is used.
However, PEEP has also been selected focusing on the potential for lung recruitment
[Barbas et al., 2005, De Michele and Grasso, 2006, Gattinoni et al., 2006]. These studies
highlighted the effect on recruitment as a function of PEEP. A major conclusion of these
studies is that the amount of potentially recruitable lung is strongly linked with the patient-
specific volume recruitment response to PEEP [Gattinoni and Pesenti, 2005]. In particular,
if a patient was highly responsive to PEEP, then the patient is more likely to have
additional lung to recruit. Because of this strong correlation, clinicians try to choose PEEP
based on how much potentially recruitable lung is available. However, this approach may
not always be the most appropriate method, as it does not directly allow for minimising
lung hyperinflation. In addition, determining the amount potentially recruitable lung is not
practical in the ICU.
2.2.1 COMPUTED TOMOGRAPHY
The use of CT scans has provided researchers with a gold standard on measuring PEEP
induced lung recruitment with ARDS [Rouby et al., 2003, Gattinoni et al., 2001, Albaiceta
et al., 2004]. In these studies, a full lung spiral CT is obtained at both a fixed PEEP and at
ZEEP. Comparison and image processing thus directly define the volume of recruited lung.
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The CT scan method utilises the attenuation of individual pixels of the scan to determine if
the alveoli are recruited, de-recruited or overinflated. This status is evaluated by assigning
each pixel within the CT scan a Hounsfield unit (HU) attenuation value. The HU measures
the radiodensity of the concerned medium and describes the level of x-ray radiation that
passes through completely (ie – Air HU = -1000) or is completely absorbed (ie – Bone HU
= 400). To measure the level of recruitment, a recruited lung unit is assigned a range
between [900, -500] HU, a hyperinflated lung between [-1000, -900] HU, poorly aerated
lung is between [-500, -100] HU, and non recruited lung is between [-100, 100] HU
[Rouby et al., 2003]. Thus, a visual interpretation of the recruitment behaviour is presented
for a given PEEP level.
Because the CT method distinguishes between overinflated and recruited units, the method
also provides a tool to predict a more optimum PEEP to mitigate VILI or lung damage at
any given time. By choosing the PEEP where the level of overinflated, and thus potentially
damaged lung units is minimal compared to recruitment, clinicians can choose an
appropriate setting for individual patients that recruit lung and minimises over-inflation
damage and maximising the efficacy of the therapy. Hence, if clinically practicable, one
could define, at a given time in the patient’s stay and evolution, a relationship between
recruitment and over-inflation versus PEEP. This trade-off curve could then be optimised
as clinically desired.
However, CT methods have obvious clinical limitations that reduce the viability of this
method in regular, everyday clinical use. First, CT scanning requires the patient to be
transported from the ICU to a radiology unit, which has several attendant risks. In
particular, many MV patients are less effectively ventilated in the CT scanner due to the
extension tubing required to reach the mask, potentially skewing results. Second, the CT
scanner provides additional radiation doses that might otherwise be avoided in normal
care, which is generally avoided where possible [Brenner and Hall, 2007, Tubiana et al.,
2008]. Finally, CT scans are time consuming, costly and heavily dependent on other
clinical resources or demand for radiological service, potentially reducing access for
patients who urgently need scans.
Hence, although CT scans provide exact and valuable information, it is not clinically
practical or viable, and is thus limited to use as a research tool. In particular, it is not a
bedside tool by any means. This last point clearly illustrates the need to have a simpler
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approach to minimise clinical burden and cost that can be located with the ventilator at the
bedside.
2.2.2 PRESSURE VOLUME CURVES
The static pressure volume (SPV) curve provides a bedside method of obtaining an
appropriate PEEP level. The SPV curve is generally measured by three different methods
[Harris, 2005]:
 The super syringe technique,
 The constant flow method,
 The multiple occlusion method.
SPV curves measure the steady state lung volume above the FRC for a given PEEP and
pressure in patients with ARDS on MV [Lichtwarck-Aschoff et al., 2000, Lu and Rouby,
2000]. SPV curves are obtained at a rate slower than a breath so no hysteresis is observed
from ZEEP to maximum pressure. These curves can be obtained directly from some
ventilators [Harris, 2005] or from sensors on the mask or tracheal end of the ET tube. SPV
curves provide a diagnostic tool that has been extensively used in the treatment and
management of patients with ARDS [Albaiceta et al., 2003, Fernández et al., 1990,
Servillo et al., 2000], and directly avoids the issues associated with using CT.
A SPV curve resembles a sigmoidal curve with no hysteresis, and is distinctly unique for
each patient. The SPV is generally characterised by an UIP and LIP. Examining Figure 2.1,
it is clear that along the SPV curve, compliance (slope of the curve) varies significantly.
The physiological explanations of the UIP and LIP have been thoroughly studied [Jonson
and Svantesson, 1999, Albaiceta et al., 2003, Maggiore et al., 2003] as previously
discussed, which has led to better understanding of alveoli recruitment behaviour as a
function of PEEP.
Although the conventional theory of lung mechanics, using balloon-like expansion,
suggested that PEEP be set slightly above the LIP, this was not appropriate as recruitment
is a continuous process and occurs above the LIP. Using the SPV as a tool for PEEP
titration meant that clinicians selected PEEP, such that it was above the LIP, but below the
UIP to prevent over-inflation within the linear portion of the curve. Hence, the LIP & UIP
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were still used as markers for guiding therapy with SPV curves [Maggiore et al., 2003,
Mergoni et al., 2001, Pelosi et al., 2001].
Figure 2.1 - Static Pressure Volume Curve showing LIP and UIP
However, continued investigation into the use of these inflection points to determine or
optimise PEEP yielded two distinct problems. First, PEEP is applied primarily to prevent
de-recruitment, as much as, to allow recruitment [Maggiore et al., 2001, Lu et al., 2006].
Thus, using the LIP to determine a minimum PEEP may not yield the best method
[Hickling, 2002]. Second, although PEEP should be set between the LIP and UIP, the
linear portion of the curve offers a very large range of PEEP values. Hence, this approach
with SPV curves still does not offer one unique setting, even though it clearly characterises
these inflection points.
Thus, the use of inflection points as anything more than a guide has been generally
discredited [Hickling, 1998, Mergoni et al., 2001]. In particular, current understanding
views the ARDS lung as:
 Heterogeneous in lung units and types (normal or ARDS affected)
 Heterogeneous in the effect of ARDS on any given alveoli or lung unit
 Heterogeneous in response to PEEP, with respect to the pressure (above PEEP)
required to open or recruit the alveoli.
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However, equally importantly, no other methods or approach has risen to replace the use of
such SPV curve points.
One final problem with all these methods based on SPV curves is that the patient is
temporarily disconnected from the ventilator [Lu and Rouby, 2000]. Although it is possible
to measure SPV curves without disconnection, only certain ventilators have the functions
required to measure this curve directly [Macnaughton, 2006, Piacentini et al., 2009]. It also
takes a fixed amount of time (10 to 15 minutes) if done via a super syringe, which may not
be available for clinical staff and requires specialised training to implement. Because not
all hospitals will necessarily have these advanced ventilators, and the super syringe
approach can be time consuming, intensive and problematic, the SPV curve is not an ideal
method for regular monitoring of patient status and resulting PEEP selection.
Thus, the problem still lies in determining PEEP while addressing alveolar heterogeneity.
More generally, for any type of lung unit, a given pressure may not recruit a certain
alveoli, whereas at a higher PEEP it may be recruited at the same pressure [Hickling, 1998,
Mergoni et al., 2001].  As a result, the problem can thus be defined by noting:
 Recruitment and de-recruitment can occur at any pressure, regardless of PEEP, and
is continuous over the PV curve
 PEEP and pressure values that recruit some alveoli may equally overstretch normal
alveoli creating a trade-off between recruitment and over distension/ damage, as
noted earlier.
Therefore, the MV PEEP setting optimisation problem becomes one of needing to know or
estimate two primary values:
 Recruitment status of the MV lung at a given PEEP
 Potential recruitment or volume change expected from a change in PEEP, which
include changes in the volume of alveoli retained at the end of expiration, as well as
new alveoli retained during inspiration.
Because these values would preferably be known before making that change, it would be
therefore ideal to create patient-specific lung mechanics models that can capture and
predict these changes. In particular, the ability to safely and accurately estimate the
potential volume change in recruitment by changing PEEP before making the change could
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allow this setting to be best optimised with minimal risk. Finally, these values should be
available at the bedside and preferably with no interruption to the MV therapy, requiring
then to be identified from measurements that are already available at the bedside and
preferably automated.
2.3 MODEL-BASED APPROACHES
Because no ideal method exists to easily, effectively or accurately manage the problem of
PEEP selection, researchers have been motivated to seek alternative methods. The overall
goal is to determine the appropriate PEEP level in patients without the complications or
other issues associated with the SPV curve or CT scans. By doing this task, clinicians can
thus measure recruitment and de-recruitment in an optimal, patient-specific fashion.
To minimise clinical burden and cost, an optimal solution would introduce no significant
new hardware or systems nor require excessive cost, clinical time or effort. Thus, some
researchers have strived to develop mathematical models to help aid clinical decision
making. Models can be used to turn readily available data, such as PV curves, from strings
of data or plots, into a clear physiological picture required to enable clinicians to readily
monitor and guide therapy.
Models of lung mechanics can be categorised into finite element models or lumped
parameter models. Each type has distinct advantages and limitations. Finite element (FE)
models of pulmonary recruitment and/or gas flow offer significant understanding of the
underlying physiology and offer detailed resolution of complex systems [Burrowes et al.,
2005, Swan et al., 2008, Tawhai et al., 2004]. FE models also offer the advantage of
allowing a patient-specific solution as each model can represent a unique geometry for a
given patient. However, the main barrier for FE models as a clinical tool is the cost
associated with computational power and length of time to run a simulation. In addition, a
patient-specific geometry would require a CT scan with additional costs and risk. Finally,
identifying recruitment status with a model of such high resolution would be problematic
and computationally very expensive. Thus, although FE models are very well suited to
helping understand the underlying physiology, they are limited to being a research tool and
do not provide a suitable bedside method for modelling patient-specific lung mechanics.
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Although very simple models based on this approach would not necessarily be precluded,
they have not been tried to date.
2.3.1 LUMPED PARAMETER MODELS
In contrast, lumped parameter models offer a simple and relatively inexpensive method of
assessing lung mechanics and/or gas exchange, and thus for capturing essential dynamics.
Lumped parameter models do not necessarily require excessive computational power.
Hence, they can be utilised directly at the bedside in clinically realistic time frames.
A significant limitation of these types of models is the lack of physiological detail
compared, for example, with FE models. Lumped parameter models can be made to be
more physiologically complex, but the direct clinical benefit of the complex model must be
compared with the computational power and costs associated with this added complexity.
In contrast, such lumped parameter models represent the same external “view” the
clinician has, and are thus defined in terms of readily available measurements.
Lumped parameter models, used for MV or similar therapeutic situations, can be broadly
classed into gas exchange models and recruitment models. Both types of models can be
used to assist in ventilation support and are used to model the effects of PEEP. Gas
exchange models are used to study the effect on gas exchange in the airways and alveoli.
In use, gas exchange models tend to be based on the perspective that MV therapy is about
maximising gas exchange, matching the fundamental physiological and clinical goal of
providing MV support. In contrast, recruitment models take a more mechanical view and
are typically used to evaluate the effect on alveoli recruitment. Hence, these models take
on a perspective that recruitment drives gas exchange or is proportional to it, turning the
physiological and clinical problem into one of recruitment.
GAS EXCHANGE MODELS
Gas exchange models are used in conjunction with MV to determine how various
parameters affect the oxygenation status of the blood. Ranging through different
mathematical complexities, gas exchange models offer detailed descriptions of the
diffusion process of oxygen using principles of mass balance. Ben-Tal reviewed these
models extensively noting up to three different types of gas models [Ben-Tal, 2006].
Though not directly related to recruitment, the models respond to PEEP changes by
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evaluating the impact of diffusion and gas exchange based on changes in recruitment and
alveolar pressure status. Thus, they can give a broad indication of recruitment status. The
use of clinical gas exchange models has been developed, but they often provide different
model outputs for use in patients with different clinical goals and prognosis [Goode, 2003,
Kwok, 2003, Rees et al., 2002].
The ALPE model (preceded by the INVENT system [Rees et al., 1999]) uses clinical
measurements available in the ICU to help determine parameters, such as ventilation
perfusion mismatch and pulmonary shunt [Rees et al., 2002, Rees et al., 1999, Rees et al.,
2001]. Although the model uses clinical measurements from the ventilator, such as PEEP,
and inspiratory and expiratory ratios, it does not determine the effect of MV on
recruitment. In addition, the models were tested on patients with Chronic Obstructive
Pulmonary Disease (COPD) or cardiac injuries, where gas exchange in the primary goal.
Thus, it did not specifically target ARDS patients where recruitment is the primary clinical
goal. However, the ALPE system provides a quick and easy estimate of gas exchange
impairments, which could be used to optimise ventilation parameters.
Another method used to evaluate gas exchange parameters is the SOPAVENT model
[Kwok, 2003, Goode, 2003, Wang et al., 2010]. The SOPAVENT model uses the concept
of fuzzy logic to evaluate blood gas parameters and the estimation of pulmonary shunt
fractions. The original SOPAVENT model provided an invasive means to estimate steady
state blood gas predictions using ventilator inputs and was then further developed to
incorporate other parameters, such as pulmonary shunt [Kwok, 2003, Goode, 2003].
However, the original models required an invasive measurement of oxygen consumption
and cardiac output and also proved to be computationally expensive [Wang et al., 2010].
More recently, the SOPAVENT models have been further developed to provide a
continuous real-time non-invasive prediction of blood gas parameters, which has been
validated in the ICU setting [Wang et al., 2010].
Gas exchange models provide a useful clinical diagnostic to aid clinicians to set ventilation
parameters. By examining how successfully gas is exchanged in the lungs, the models
provide a tool for clinicians to then choose additional ventilation settings. However, these
models fail to address the mechanism of recruitment, which is common in patients with
damaged lungs. Thus, patients who have ARDS may experience improved gas exchange,
but may still have plenty of additional recruitment available, which, as noted earlier, is not
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ideal [Gattinoni and Pesenti, 2005]. Therefore, models of alveolar recruitment are also
required to help optimise ventilation, particularly in ARDS where recruitment is crucial
[Gattinoni et al., 2006].
RECRUITMENT MODELS
Mathematical models of lung mechanics have driven new areas of research in the hope of
being able to choose the most appropriate PEEP setting for patients. Although gas
exchange models provide a means of finding optimal gas exchange with respect to a given
PEEP, this approach may not result in increasing alveolar recruitment which is the end
objective when treating ARDS patients [Ranieri et al., 1991]. In addition, gas exchange
models do not indicate the potential for recruitment, which is currently the primary clinical
goal [Gattinoni et al., 2006], and gas exchange is thus presumed to proportionally follow
recruitment.
Models of lung mechanics have been developed with the aim of studying the recruitment
behaviour of alveoli. A mathematical model developed by Hickling aimed to simulate and
understand the shape of the PV curve in an ARDS lung [Hickling, 1998]. The model
confirmed that recruitment occurs above the LIP, and that the fundamental shape of the PV
curve changes with recruitment. Although this paper did not adequately predict the volume
change resulting from a change in PEEP, it provided information on the effect of the
recruitment behaviour on the static PV curve. Although Hickling’s model readily predicts
the static PV curve during a recruitment manoeuvre, it has only been used as a research
tool to date.
One of the earliest contributions to mathematically model the PV curve, and thus
recruitment in general, was the Venegas equation [Venegas et al., 1998] which modelled
the PV curve as a sigmoid function. This equation allows the SPV to be obtained based on
geometric properties of the curve, while still maintaining good physiological accuracy as
defined by its ability to capture vital capacity, maximal inspiratory volume, compliance at
different inflation pressures, inflection pressure, and upper and lower corner pressures, by
fitting the sigmoid equation parameters to measured data. The Venegas equation has
shown very tight correlation with clinical data and has been validated in its ability to match
or fit data in several studies [Gattinoni et al., 2005, Luecke et al., 2003, Harris et al., 2002].
However, its predictive value for guiding therapy has not been shown or tested.
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More recently, animal studies [Schiller et al., 2003, Bickenbach et al., 2010] using in vivo
microscopy showed that ARDS affected alveoli can be characterised into three distinct
groups, with each group exhibiting different compliance and recruitment behaviour.
Although, mathematical models that account for all unit types have been developed [Yuta,
2007, Yuta et al., 2004], these models contained too many parameters for unique
identification from measurements readily available at the bedside. Hence, they are not
uniquely identifiable with the limited data available and are very time consuming to model,
rendering them ineffectual for clinical use in guiding therapy.
Thus, there is strong motivation to develop a model-based approach to specifically
evaluate the patient-specific response to PEEP. In particular, the effect on recruitment, and
retention at end expiration due to PEEP, a very is important clinical parameter to evaluate
in a real-time basis. Most of the models described lack predictive power to guide therapy.
Although the models accurately capture lung mechanics, the predictive value for guiding
therapy have not been shown.
2.4 SUMMARY
The selection of optimal PEEP has been shown to be ineffective. Conventional methods
which examine the LIP and UIP provide a guide to select PEEP. However, the LIP and
UIP can take on a range of values and do not offer one unique setting. The introduction of
model-based approaches provides an alternative method for selecting PEEP.
Model-based approaches use readily available data to capture lung dynamics. Although
models can be classified as finite element models and lumped parameter models, only
lumped parameter models are clinically viable. The two main lumped parameter models
describe gas exchange and recruitment. Clinical models using gas exchange have been
developed, but in patients with ARDS, recruitment is the major concern.
Most current recruitment models lack the power to guide therapy, and have only been
created as research tools. Thus, there is strong motivation to create models that capture
recruitment which can be used in a clinical setting. The following chapters discuss models
that have been developed to select PEEP using lung mechanics and the clinical
implications of such models.
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Chapter 3 - Recruitment Model
This chapter introduces the lung recruitment model utilised in this study developed by
Yuta [Yuta, 2007]. The model components are described along with their physiological
relevance. In addition, a preliminary validation is shown [Sundaresan et al., 2009, Yuta,
2007] using clinical data obtained from Bersten [Bersten, 1998].
3.1 MODEL SUMMARY
The recruitment model is based on the work by Hickling [Hickling, 1998], which models
the lung as a collection of multiple lung units. A unit represents sets of distal airways and
attached alveoli. The lung is divided into several “horizontal” compartments to capture the
different levels of superimposed pressure. The compartment at the bottom experiences
higher superimposed pressure than the ones above due to the weight of the lung. Figure 3.1
shows the fundamental components of the modelled lung.
Figure 3.1 - Lung modelled as a collection of units, evenly divided into compartments of different superimposed
pressure [Sundaresan et al., 2009].
Any given lung unit has only two possible states at any given pressure: (1) recruited or (2)
de-recruited. The mechanism of volume change is based on the hypothesis that it is caused
predominantly by recruitment and de-recruitment of lung units, especially in ARDS
affected lung. In particular, it is based on the in vivo studies by Schiller et al [Schiller et
al., 2003] that showed that the recruitment and de-recruitment of alveoli occurred even in
healthy lungs and that once a unit was recruited, it did not change its size significantly.
This result suggested that recruitment and de-recruitment is the dominant cause of volume
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change, rather than isotropic “balloon like”, expansion of alveoli, as discussed in detail
with significant supporting studies in Chapter 2.
3.1.1 THRESHOLD PRESSURES
The recruitment and de-recruitment of the modelled lung units are controlled by the
distribution of Threshold Opening Pressure (TOP) and Threshold Closing Pressure (TCP),
respectively. TOP is the critical pressure at which a previously collapsed unit is recruited
during inspiration. Similarly, TCP is the critical pressure where a previously recruited unit
collapses during expiration.
The work by Crotti et al and Pelosi et al [Crotti et al., 2001, Pelosi et al., 2001] indicated
that pressure distributions were normally distributed. TOP and TCP distributions can
therefore be modelled by a normal density (Gaussian) function. The shape of each
distribution is defined by two unique variables: standard deviation (SD) and mean. The
total number of lung units in the model is distributed according to these variables within a
defined physiological pressure range, as well as across superimposed pressure
compartments.
The TOP is distributed broadly from minimum to maximum pressure and simulates the
continuous recruitment of lung units during inspiration. In contrast, the TCP distribution is
significantly narrower compared the TOP, and concentrated at lower pressure.
Physiologically, these distributions represent a continuous recruitment of lung units over a
range of pressure during inflation and a more sudden, or faster, de-recruitment at lower
pressure during deflation. This trend of consistent recruitment throughout inspiration and
the relatively fixed point of de-recruitment has been evidenced in several clinical studies
[Albaiceta et al., 2004, Jonson et al., 1999].
The shapes and the values of the distributions are also unique to the condition of the patient
and the state of disease. These parameters therefore change as the state of disease and the
condition of a given patient evolve. Thus, they can be used as a model-based marker to
describe the level of recruitment, and thus oxygenation, in the lung, and indicate changes
in patient condition over time.
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3.1.2 UNIT COMPLIANCE
Once a lung unit is opened, it assumes a volume defined by a unit compliance curve. The
shape and values of the curve are based on the work of Venegas [Venegas et al., 1998] and
is described by the equation:
= + 1 + ( )/ (3.1)
where the volume, V, is defined at each pressure increment, P, by a, a minimum volume
[ml], b, the maximum volume [ml], c, the midpoint [cmH2O] and d, the curvature [cmH2O]
as seen in Figure 3.2.
Figure 3.2 - Unit compliance curve using the Venegas equation
Equation (3.1) describes the volume at every pressure value. However, the model only uses
a range of specified pressures. Venegas et al used a similar equation to describe the entire
PV curve in this model based on a balloon-like expansion hypothesis. However, this model
uses Equation (3.1) to describe the individual unit compliance curve, which represents
visco-elastic effects of recruited alveoli and distal airways. It thus provides the model with
slightly more flexibility to match observed clinical behaviour. Hence, it is important to
note that this curve considers expansion only after recruitment, which is a limited, added
fractional expansion from the opened state.
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Thus, this model is based on the hypothesis that volume change is predominantly caused
by recruitment and de-recruitment, and that the size of alveoli does not change
significantly once recruited. Hence, this curve has relatively small effect on the total PV
curve. The shape and values for the curve can therefore be fixed during the fitting process,
significantly simplifying the analysis and reducing potentially redundant variables.
3.1.3 MODEL SIMULATION
As pressure changes during a breathing cycle, the model calculates the volume of the lung
using the threshold pressure distributions and unit compliance curve. At each pressure
increment, the model evaluates the number of recruited units in each compartment, using
appropriate superimposed pressures and threshold pressure distributions. The number of
recruited units is then multiplied by the appropriate unit volume according to the unit
compliance curve to produce a volume of the compartment. Total lung volume at a specific
pressure is the sum of all the compartment volumes. This solution process is shown
schematically in Figure 3.3.
Figure 3.3 - A schematic of the model solution process. It shows each step of the process for calculating one
compartment volume. The total lung volume of a given pressure is the sum of all the compartment volumes
modelled.
Given data from clinical PV loops, the process can be readily inverted to find the threshold
pressure distribution parameters. In other words, the model is uniquely and readily
identifiable. Equally importantly, the model is effectively quasi-static, which is a
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significant simplification over almost all models in the pulmonary mechanics modelling
[Ben-Tal, 2006].
3.2 PARAMETER IDENTIFICATION
Early recruitment models developed by Yuta were validated and fitted to clinical data
[Yuta, 2007, Yuta et al., 2004]. However, the models included four different types of lung
units, based directly on work by Schiller et al [Schiller et al., 2003]. Each different type of
unit thus required unique unit compliance and threshold pressure distributions. The model
therefore required as many as 42 patient specific parameters to be identified [Yuta et al.,
2004].
Most of those model parameters were impractical, if not impossible, to obtain clinically,
especially with the limited time, data, and resources in a typical ICU. Hence, it was
effectively not identifiable from available data. However, the model in [Yuta et al., 2004]
was much more physiologically representative. Thus, its relationship to the model
presented here is used to define this minimal model’s physiological relevance, and ability
to equally capture physiological data.
The model of [Yuta et al., 2004] was thus modified to create the model presented here,
requiring only 2 parameters per breathing limb to make it clinically applicable. Reducing
the number of unit types to just one and using the hypothesis that most of the volume
change is caused by recruitment and de-recruitment (e.g. [Carney et al., 1999, Hickling,
2002]), the unit compliance has a relatively smaller contribution to the overall PV curve
shape. As a result, the unit compliance curve defined in Equation (3.1) can be fixed at
generic population values.
The minimum and maximum threshold pressures are fixed at 0 and 60 cmH2O respectively,
to cover the range of typically used ventilation pressures. The total number of parameters
is thus reduced to just four:
 TOP distribution mean − Inspiratory limb of breathing curve
 TCP distribution mean − Expiratory limb of breathing curve
 TOP standard deviation − Inspiratory limb of breathing curve
 TCP standard deviation − Expiratory limb of breathing curve
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Therefore, there are effectively two parameters for describing each of the inflation and
deflation limbs. Other clinical MV related variables, such as PEEP, PIP, and tidal volume
are assumed known, as they are set by the clinician or can be obtained directly from
ventilator.
Hence, the changes made in reducing 42 parameters to four do not remove any significant
physiological representation. What is lost is the level of physiological detail in the number
and the types of ARDS affected and healthy lung units. However, these values were not
uniquely identifiable without as many as 20 unique PV curves, which was not clinically
practical.
In their place, there is now a single unit which takes on two states; recruited and de-
recruited. However, these two states can, at a given pressure, represent the level of ARDS
by the level of recruitment available at a given pressure. More specifically, as ARDS
progresses, there is less recruitment at a given pressure and PEEP, which is effectively
captured by the four (2 each) parameters describing TOP and TCP. Hence, alveoli-specific
TOP and TCP, summarised by the mean and SD distribution parameters, can effectively
capture this level of ARDS.
As a result, the parameter identification is greatly simplified and importantly, is unique,
given a reasonably discretized measured PV curve. The main requirement is a minimum of
2 complete PV loops to provide enough data to identify the two parameters for the inflation
(TOP distribution) and deflation (TCP distribution) limbs. A second requirement is that
these loops be obtained at clinically different PEEP values. TOP and TCP parameter
identification is readily done by iteratively modifying the threshold pressure distribution
variables to minimize the sum squared error between the model and clinical data for each
limb of the PV loops.
Since the inflation and deflation limbs are generated by different independent parameters,
each limb can be fitted separately. The PEEP value sets the minimum pressure for the
PEEP to PIP breathing cycle. The standard deviation of the TOP or TCP distribution
primarily controls the slope of the curve and the mean value primarily controls the location
along the pressure axis of the respective curves.
The TOP and TCP distribution parameters are effective for capturing both inter-patient and
intra-patient variability. Inter-patient variability is accounted for by the difference in
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distribution mean values between patients. Each patient may have a different TOP and
TCP mean for a given PEEP and the mean is also reflective of the overall level of lung
damage. In particular, suppose a patient had PV loops at 3 different PEEP values, then
each PEEP would have an associated, patient-specific TOP and TCP mean. However, for a
given PEEP, there will almost certainly be different distribution mean values across
different patients, indicating the condition-specific level of lung damage in a patient. Intra-
patient variability is similarly seen in the different mean values obtained for TOP and TCP
at different PEEP in a given patient, where these are obtained at different points in time.
These differences indicate the effect of PEEP on recruitment in the patient, as well as their
patient-specific evolution of disease state.
Finally, the SD is held constant across all PEEP levels during each trial. The SD represents
the compliance of the lungs, and is thus representative of the ARSD state. As SD changes,
the severity of the ARDS affected lung changes. More specifically, a lower SD represents a
more diseased lung state, while a higher SD indicates a more compliant lung. The SD is
held constant across all PEEP as it represents the underlying disease state which does not
change for a given trial. Rather, SD can vary over time as the patient condition deteriorates
or improves.
3.3 PRELIMINARY MODEL VALIDATION
A preliminary model validation was performed by fitting to clinical PV data at different
PEEP levels from 10 patients as reported by Bersten [Bersten, 1998] with two additional
patients not reported. The datasets were recorded from patients with various levels of lung
injuries, detailed in Table 3.1. Each dataset included recordings of at least 3 different PEEP
levels with the deflation to FRC. The data was sampled for 60 seconds at 100 Hz for each
PEEP level, with the last 15 to 20 seconds used for the dFRC measurement.
For this validation analysis, PV loops at different PEEP levels from the same patient were
fit to the model by shifting the distribution mean value while other parameters, including
the SD, remain fixed. This shift represented the effect of the dynamic mechanism of lung
units at different PEEP values. More specifically, once a collapsed lung unit is recruited, it
does not necessarily collapse again at the same pressure at which it was recruited. Instead,
it stays recruited at a lower pressure [Maggiore et al., 2001] as discussed in Chapter 2. This
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effect is especially significant in the ARDS lung because of the reduced number of
functional lung units and lower compliance of the overall lung. In particular, the benefit of
recruitment manoeuvres on ventilated patients is explicitly based on this dynamic
mechanism [Foti et al., 2000]. The same effect results from increasing the PEEP, while
keeping the tidal volume the same, causing higher PIP.
Table 3.1 - Characteristics of study patients from Bersten [Bersten, 1998]
Sex Age [years] Cause of lung injury
Male 74 Ruptured abdominal aortic aneurysm
Male 24 Lung contusion
Female 72 Legionnaire’s disease
Male 48 Pancreatitis
Female 68 Pulmonary embolus
Male 54 Aspiration
Male 73 Aspiration
Male 72 Pneumonia
Male 81 Aspiration
Male 47 Liver transplant
This behaviour results in a shift in threshold pressure distributions in the model. Therefore,
as PEEP is increased, the centre of the TOP distribution shifts to lower pressure, indicating
that more units are kept recruited during the breathing cycle. Hence, the application of
PEEP begins to recruit lung units that were collapsed at lower PEEP settings. Again, this
physiological dynamic has been observed in several clinical studies (e.g. [Halter et al.,
2003, McCann et al., 2001]).
Similarly, the TCP distribution mean shifts to higher pressures indicating unit instability at
relatively higher pressures for these newly recruited lung units. The higher PEEP recruits
more units in regions with higher superimposed pressure and injured units. These newly
recruited units are inherently unstable, and thus, are likely to be de-recruited at relatively
higher pressures. Hence, the higher PEEP increases the recruitment of previously collapsed
units at a given pressure, increasing the number of functional units. However, some of
those units are unstable and collapse at relatively higher pressure.
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The amount of the shift in both distributions is dependent on the individual patients’
condition and state of disease. More specifically, PEEP is modified to increase recruitment
and optimize oxygenation, as well as to prevent de-recruitment at the end of expiration.
Therefore, tracking the number of recruited units at a given pressure and PEEP over time is
a measure of recruitment that effectively tracks the state of ARDS or lung disease using the
level of recruitment. Hence, it can be used as a key parameter to describe the
characteristics of a patient specific lung, track the level of recruitment, and quantitatively
determine the impact of therapy.
The method for fitting the data is based on simulating the entire inspiratory capacity of the
lung. For a given recruitment status of the lung, Figure 3.4 shows an example of a typical
PV curve as obtained from either standard volume controlled ventilation (VCV) or
pressure controlled ventilation (PCV) [Bersten, 1998]. Also shown is the tidal volume,
PEEP and PIP.
Figure 3.4 - An example of the model fit. The plot shows the modelled inflation, modelled deflation and the data
for inflation and deflation. The model fits the entire lung capacity
The lower dotted curve represents the inflation curve which is dependent on the type of
ventilation used. The upper dashed curve represents the quasi-static PV curve, which is
ventilator independent and represents the steady state volume obtainable for each pressure
increment from 0 to 60 cmH2O when the patient expires. Again, note that the figure is only
valid for a specific recruitment status of the lung. In practice, the alveoli recruitment
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dynamics can change if different settings of PEEP are used for sufficiently long periods.
The result of this physiological effect would be a change in the curves of Figure 3.4, and a
shift in the mean of the corresponding TOP and TCP distributions over time at the same
constant PEEP level. The upper dashed curve also represents the limiting behaviour of the
deflation phase of the PV relationship for the given recruitment status, and in principle
could be obtained experimentally by a sequence of pressure holds from 0 to 60 cmH2O.
For example, in Figure 3.4, the limiting behaviour is constrained by the given PEEP value.
In other words, during the passive expiratory phase of VCV, the pressure drops very
quickly and stays close to PEEP, so that the volume must eventually settle onto the quasi-
static PV curve. Therefore, the last, almost vertical part of this deflation curve is
effectively equivalent to a pressure hold at PEEP. Another way of describing the upper
expiratory dashed curve is that it is the asymptotic behaviour of the deflation curve from
PIP to PEEP. Similarly, the lower dotted line represents the asymptotic behaviour of the
inflation period.
Hence, at the start of inflation and end of deflation there is a transient period where the PV
curve is seeking to settle on the global asymptotic curves shown in Figure 3.4. This period
represents real lung mechanics. However, it does not significantly reflect the volume
responsiveness described by dFRC and PIP, which are important clinical variables.
This transient behaviour is also evident in the PV data of Figure 3.5, where the sparse point
distributions indicate this rapid transition, resulting in a reduced amount of sampled data.
The use of a normal distribution to model TCP and TOP is hence justified as the data dense
steady state part of the curve resembles a normal cumulative distribution. Similarly, the
quasi-static asymptotic curve in Figure 3.4 corresponding to the deflation part of the PV
curve has also been shown to be close to a normal distribution [Venegas et al., 1998]. The
result of [Venegas et al., 1998] combined with the studies of [Crotti et al., 2001, Pelosi et
al., 2001] further justifies the use of a normal distribution to model TCP and TOP.
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Figure 3.5 - PV loop showing the transient behaviour during inflation and deflation
Figure 3.4 and Figure 3.5 thus motivate a fitting procedure that uses the last approximately
60% of the inflation curve and the densely sampled 70% (by volume) of the deflation
curve. These numbers were chosen empirically and are essentially arbitrary.
Figure 3.6(A) and Figure 3.6(B) show the model fit for two clinical PV data sets from
[Bersten, 1998].The dotted lines show the clinical data and the solid lines show the model
fit across the densely sampled non-transitional regions. The model was fitted to all the PV
loops shown. However, only one model fit per dataset is shown here for clarity.
Figure 3.6(A) & (B) - Dataset 1 & 2. Dotted line shows the clinical data and solid line shows the model fitted to the
clinical data [Bersten, 1998]. The model fit is for PEEP = 5 cmH2O, as shown.
A B
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The identification and fitting error was calculated using the percentage difference between
the model and the data in the inflation and deflation limb for each PV loop dataset. These
results are shown in Table 3.2. Overall, the loops in Figure 3.6 show minimal deviation
and indicate a good match to the measured data. Table 3.2 shows these results are
relatively tight. Also shown are the range of mean and standard deviation for both the
inflation and deflation limb across all patients and PEEP values in Table 3.3.
Table 3.2 - Summary of model errors
PEEP [cmH2O]
5 7 10
Dataset 1 Inflation 1.71% 0.48% 0.34%Deflation 12.33% 4.25% 0.92%
PEEP [cmH2O]
5 7 10
Dataset 2 Inflation 1.74% 0.53% 0.59%Deflation 3.99% 2.59% 2.36%
PEEP [cmH2O]
5 7 10 12
Dataset 3 Inflation 3.03% 0.79% 0.58% 0.63%Deflation 10.02% 7.49% 5.59% 3.09%
PEEP [cmH2O]
5 7 10 12
Dataset 4 Inflation 3.47% 1.24% 1.03% 0.48%Deflation 9.83% 2.48% 1.12% 0.75%
PEEP [cmH2O]
5 7 10 12
Dataset 5 Inflation 1.86% 0.58% 0.40% 0.33%Deflation 7.09% 2.87% 0.53% 0.24%
PEEP [cmH2O]
5 7 12
Dataset 6 Inflation 2.50% 1.16% 0.85%Deflation 5.15% 1.86% 1.02%
PEEP [cmH2O]
10 12 15
Dataset 7 Inflation 0.78% 0.47% 1.01%Deflation 1.19% 0.78% 0.82%
PEEP [cmH2O]
5 7 10 12
Dataset 8 Inflation 2.59% 0.54% 0.05% 0.54%Deflation 9.39% 4.04% 2.19% 1.07%
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Table 3.2 - Summary of model errors(Cont)
PEEP [cmH2O]
5 7 10
Dataset 9 Inflation 1.62% 1.24% 0.62%Deflation 10.59% 5.34% 2.48%
PEEP [cmH2O]
5 10 15
Dataset 10 Inflation 2.30% 3.60% 0.93%Deflation 8.05% 5.17% 1.57%
PEEP [cmH2O]
0 5 10
Dataset 11 Inflation 24.31% 2.88% 1.16%Deflation 51.86% 1.25% 0.28%
PEEP [cmH2O]
5 7 10
Dataset 12 Inflation 1.48% 2.52% 0.45%Deflation 3.85% 2.96% 2.11%
Table 3.3 - Range of mean and SD across all datasets
Range Median
Inflation Mean [7.79, 32.43] 19.99
Inflation SD [12, 25] 17.5
Deflation Mean [7.42, 15.83] 9.89
Deflation SD [5, 10] 7
3.4 MODEL PREDICTION
The main objective of this research is to develop a minimal model that is also clinically
useful in selecting a clinically appropriate PEEP value. One approach is to provide an
objective method of determining optimal ventilator settings or PEEP for an individual
patient. Another is to provide constant monitoring for a patient’s level of lung recruitment,
and thus the level of ARDS and the impact of therapy as patient condition evolves.
The data that the model requires can be directly obtained from the ventilator during normal
operation and clinical adjustment. All the analysis can be done at bedside and be
immediately applied. Furthermore, it does not require additional equipment or tests. Thus,
additional cost and risk to the patient are mitigated. The ventilator setting optimization
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procedure is done in 3 steps: (1) parameter identification, (2) simulation of a change in
PEEP, and (3) analysis.
Because the model can identify lung mechanics over an entire pressure range, it can be
used to predict the lung mechanics at different ventilator settings. Thus, the model allows
the clinicians to see the result before it is actually applied to the patient, and decide on
whether to apply the changes. The model also allows predictions about multiple results to
be made quickly. Quick turnaround eliminates the need for clinical trial and error
procedures. Hence, optimum PEEP and ventilator settings can be obtained via simulation if
the model predictions are accurate.
Therefore, for patients with data at 3 PEEP settings in this data set, 2 PEEP settings are
used to fit the model and the mean shift trend. The fitted model is then tested to predict the
results of the remaining PV loop. If 4 PEEP settings are available, then the model is fitted
with 3 loops. Any combination of 2 in 3 or 3 in 4 can be used to test the ability of the
model trend to accurately predict the remaining unused PEEP value and PV curve.
Specifically, if 2 PV loops are obtained at higher PEEP values, then the model can predict
a PV loop for a lower PEEP. Prediction of a lower PEEP is useful in the clinical setting as
it means that alveolar collapse can be avoided as a result of PEEP reduction. Similarly,
predicting higher PEEP level responses allows evaluation of the clinical impact in
recruitment of changing PEEP.
The model was able to predict the missing mean shift and PV curve for the PEEP level
with relatively small errors. The error metric chosen is the average relative percentage
error, computed over the densely sampled portions of the PV loops used in the
identification process. This approach avoids the transient period, as previously discussed
and shown in Figure 3.4 and Figure 3.5.
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Figure 3.7 - A fitted mean shift for prediction for Dataset 1. PEEP = 7 and 12 cmH2O were used to predict PV dataat PEEP = 5 cmH2O. The linear lines for mean shifts (solid lines) are identified from the 2 given datasets (soliddots). The * shows the true mean for PEEP = 5 cmH2O.
Figure 3.7 illustrates the fitted mean shift and actual mean for PEEP of 5 cmH2O in
Dataset 1. This prediction was done by fitting the data to PEEP of 7 and 12 cmH2O. The
true mean value is marked with an asterisk (*) with predicted mean shown on the solid
line. Figure 3.8 shows the resulting PV curve prediction, where the dashed lines are the
original clinical data for the predicted PV loop. Because the model was not fit in the highly
dynamic transition area, the prediction was also only made for the steady portion of the
curve, as illustrated by the dots in the figure.
Figure 3.8 - A prediction result for PEEP = 5 cmH2O of Dataset 1. The PV data was predicted by fitting 2 knownPEEP levels (solid lines). The dots show the predicted data and the dashed lines show original data.
Figure 3.9 illustrates the same prediction method for a PEEP of 5 cmH2O in the larger
Dataset 5. In contrast to Dataset 1, the slope of these patient specific mean shift values is
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lower, indicating a patient that is much less responsive to changes in PEEP. More
specifically, this patient experiences far less of an increase in recruited lung volume for a
given increase in PEEP, indicating less clinical effect in modifying therapy. Similar to the
results for Dataset 1, all the predicted PV curves show clinically insignificant levels of
error in their predictions based on mean shift.
Figure 3.9 - Predicted mean shift for PEEP of 5 cmH2O for Dataset 5
The results of this model show that as PEEP increases, the TOP distribution mean
decreases, while the TCP distribution mean increases. These shifts indicate the change in
recruitment and de-recruitment characteristics of lung units as PEEP is altered [Halter et
al., 2003, McCann et al., 2001, Sundaresan et al., 2009]. In the model fit, inflation SD for
Dataset 1 was calculated to be 18, while inflation SD for Dataset 5 was 14. This implies
that Patient 5 is more compliant and is evident by the steeper slope of the PV curve from
Figure 3.9 compared to Figure 3.8. Thus, the assumption of holding SD constant does not
affect the predictive capability of the model.
The overall average pressure point error for Dataset 1 was 14.31 ml (1.40%) and 60.35 ml
(6.36%), for inflation and deflation respectively. For Dataset 5, the average absolute error
was 24.85 ml (1.61%) and 42.70 ml (3.33%), for inflation and deflation respectively. Table
3.4 summarises the prediction errors for these 2 data sets for each predicted PEEP value.
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Table 3.4 - Summary of PV prediction errors for two data sets
PEEP [cmH2O]
5 7 10
Dataset 1
Inflation Error [ml] 16.13 9.98 16.83
Error [%] 2.23 0.89 1.10
Deflation Error [ml] 49.26 67.16 64.65
Error [%] 7.58 6.71 4.78
PEEP [cmH2O]
5 7 10 12
Dataset 5
Inflation Error [ml] 31.87 35.09 21.82 10.63
Error [%] 2.52 2.33 1.11 0.48
Deflation Error [ml] 35.60 112.82 13.33 9.06
Error [%] 3.32 8.89 0.72 0.40
Table 3.5 summarises the overall prediction for all 12 datasets. This table shows the
maximum and average percentage absolute error for inflation and deflation at each
predicted PEEP level. The inter-quartile range of errors is also shown to provide the range
of errors.
Table 3.5 - Summary of PV prediction percentage errors for all datasets. The errors are listed according to
predicted PEEP levels
PEEP
[cmH2O] Inflation Deflation
Avg IQR 90% CI Max Avg IQR 90% CI Max
5 7.46 2.29 - 7.74 1.89 - 24.16 29.32 10.02 5.13 - 11.46 2.64 - 23.60 33.77
7 4.60 1.29 - 7.41 0.88 - 13.39 15.40 11.06 6.71 - 14.91 5.12 - 21.45 24.43
10 5.41 1.11 - 5.41 0.71 - 18.24 29.32 9.72 3.63 - 9.90 1.25 - 28.89 43.85
12 3.90 0.75 - 2.55 0.47 - 12.96 16.34 3.61 0.91 - 4.94 0.48 - 8.18 9.26
15 3.47 2.65 - 4.28 1.99 - 4.95 5.10 7.37 5.73 - 9.00 4.41 - 10.31 10.64
The model requires a minimum of two PV loops at different PEEP settings to obtain all the
required parameters. However, more data will increase the accuracy of the parameters and
resulting simulation, particularly in presence of noise. The values of PEEP used do not
need to be predetermined or specified, but should be within a safe range determined by
medical staff for that specific patient and be reasonably different. Once a best fit is
achieved, the model records those parameter values for prediction and simulation.
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The model can simulate the lung for any combination of PEEP and tidal volume, including
the extreme values that may not be safe to test on an actual patient. Since the model is
based on a reduced number of parameters and simplified mechanics, the simulation can be
done in matter of minutes. This produces real-time feedback and a condition specific
result.
The volume shifts between different PEEP levels are captured by the shifting distribution
means. In general, the TOP mean decreased as PEEP increased, and the TCP mean
increased as PEEP increased. Physiologically, this behaviour indicates the varying nature
of TOP and TCP under this therapy.
Since the model identifies essential parameters representing lung recruitment, it can be
used to track patient recruitment and oxygenation, while the patient is on the ventilator.
Thus, when the patient’s condition improves or worsens, these parameters change
accordingly. By tracking the changes in parameter values over time, the condition of the
patient can also be tracked. This approach can be used to aid clinical decisions and
evaluate the effect of treatment.
3.5 MODEL LIMITATIONS
The model has some potential limitations that need to be addressed. First, the fitting
method requires data with deflation to FRC. This data is not typically obtained during
current protocols for ventilator treatment. However, this measurement can be obtained by
deflating the lung to atmospheric pressure and measuring dFRC. Once the airway is
opened to atmospheric pressure, the lung assumes FRC rapidly, and the entire measuring
process can be completed in a matter of seconds [Bersten, 1998]. This value might have to
be obtained once every 1–2 days.
This process requires intervention from the ICU staff and interruption of the patient’s
breathing pattern, both of which may be clinically unavailable or undesirable. Furthermore,
a typical ventilator is only designed to record data on tidal ventilation, so that recording the
deflation to FRC would require either a specialised ventilator or a separate data acquisition
system. In this case, clinical model validation will employ external sensor systems.
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Similarly, the mean shift trend and prediction of PV loops are primarily based on the
relative change of the PV loops with respect to the first PV loop. In other words, for PV
predictive purposes, the initial volume or FRC is essentially arbitrary and could be set to 0.
All that is required is the change in FRC (ΔFRC) after each PEEP intervention. This ΔFRC
can be easily obtained by a pressure hold at each required increasing PEEP. For example,
the change in volume occurring from increasing PEEP from 0 to 5 cmH2O in a pressure
hold manoeuvre is precisely ΔFRC. This process could even be integrated into the
ventilator to measure ΔFRC automatically [Rees et al., 2002].
The mechanics of the lung at the missing PEEP values are readily predicted by linearly
fitting the mean shift to identify the impact of this change. It also allows a simple method
for predicting the mean at a new PEEP level. However, some of the mean values obtained
are not perfectly fitted as the dots are not exactly on the predictive linear line for this
relatively extreme PEEP setting. This inaccuracy causes the relatively larger error of the
predicted PV curve. Importantly, this error is still within clinical expectations.
The prediction method shown utilizes just a single parameter TOP and TCP (mean shift) to
predict between different PEEP settings. Thus, it is simple and easy to use, and can predict
an important patient specific response to the change in primary therapy of PEEP.
The model does not directly account for other ventilator settings, such as ventilator mode,
flow pattern and maximum inspiratory flow. Since the modelling approach can capture any
changes in the TOP and TCP distributions from their impact on the measured PV curves,
any PV changes that occur from different ventilator settings are therefore implicitly
accounted for. Therefore, the model potentially provides the framework for correlating
different ventilator settings with respect to their effect on TOP and TCP distributions.
That all said, such drastic ventilator changes are not typically part of standard ventilator
therapy, which focuses more on gradual evolution of settings [Rouby et al., 2002]. In
addition, more detailed models could potentially manage such changes, but at a cost of
much greater data requirements to create clinically useful patient specific models. Hence, it
might be best noted that the model is limited to evolutionary prediction and changes typical
of critical care.
This model has the ability to fit and follow the trend of any data including those from a
ventilator. Thus, it can reproduce the shape and values of the particular PV curves. For
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example, if the model was used to identify the parameters for ventilator data, then the
model can predict the ventilator data at different settings. Similarly, if carina measurements
like those of Karason et al [Karason et al., 2000] are used, then the model can be used to
predict the PV curve at the carina for different settings. Thus, the model can be very
generally applied to any dataset that may be available.
It may also be possible to use this model to assess the true lung mechanics, if the ET tube
and proximal airway resistances were better known or estimated empirically at the bedside.
This approach would require a smarter, more automated ventilator and/or excessive clinical
time. However, such smarter ventilators are being developed [Rees et al., 2002], and may
appear in future.
The patient specific mean shift parameter identified by this model is a direct result of
analysing raw proximal PV data, which includes dynamic and resistive effects. Therefore,
the parameter identified may not directly represent true lung mechanics. However, because
the model is based on the fundamental mechanics, the slope of the mean shift and its
clinical relevance can be readily related to the true lung mechanics. One such method to
show this relation is to use the estimated carina measurement, which require measurements
of the air flow rates and fluid dynamics based estimates of intubation tube resistance, and
integrate this aspect in the model.
3.6 SUMMARY
The validation performed in this section is done with limited clinical data from the
literature. Although this data contained PV loops at different PEEP levels, the range of
PEEP used is still small. In a typical recruitment manoeuvre, patients may exhibit PEEP
levels at much higher ranges which may lie outside the linear portion of the static pressure
volume curve. Therefore, further validation using more extensive clinical data is required.
Such data would also enable more direct study of clinical application and patient outcomes.
More features may need to be included in the model to be fully clinically practical. Such
features could include automated data acquisition, parameter identification, airway
resistance estimates, and more efficient analysis. However, the overall goal of a clinically
useful minimally complex model has been proven in concept.
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In addition, the limitation of measuring dFRC at each PEEP provides another problem that
needs to be addressed. The process of measuring dFRC could be harmful to the patient, as
it requires a deflation to ZEEP. Although a change in dFRC can be easily measured,
absolute dFRC values need to be calculated for the recruitment model to be effective.
Chapter 4 introduces a model to estimate dFRC at various PEEP levels as an alternative to
the invasive measurement.
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Chapter 4 - Model-Based dFRC
The recruitment model detailed in Chapter 3 requires a deflation to FRC to measure the
level of dFRC at a given level of PEEP. This measurement when typically done is
invasive, and, in MV patients, can cause sudden de-recruitment which can prove harmful.
In addition, the recruitment model does not evaluate the effect that PEEP has on
pulmonary volume, in that it does not capture it. This chapter introduces a model-based
method to estimate the patient-specific dFRC as a function of PEEP using lung stress and
strain as a proxy for pressure and volume.
4.1 MODEL INTRODUCTION
The level of FRC represents the pulmonary gas volume at the end of expiration at
atmospheric pressure. One objective of MV is to maximise FRC, thus increasing the
amount of recruited alveoli. Hence, there is significant motivation to track and measure
FRC as the patient undergoes MV therapy and as their condition evolves.
Currently, there are few methods of measuring FRC at the bedside. Gas washin/washout
techniques are one type of method [Heinze et al., 2007], but are not readily available on
most ventilators. A further limitation of this type of measurement is that only an absolute
value of FRC is measured. Hence, no information on the potential for new recruited lung
volume is given, which is critical in setting PEEP to gain maximum recruitment with
minimum added injury.
Figure 4.1 shows a schematic of the lung. When FRC is measured using a washin/washout
technique, it cannot be determined how many potential recruitable units are available.
Therefore, as shown in the schematic, a lung with an FRC of 1.4 litres could be a result of
a lung with 1.4 litres of fully recruited healthy lung units or 1.0 litre of recruited lung plus
an additional amount of lung (0.4 L) that was recruited due to additional PEEP. In both
cases, one gets the total recruited lung volume, not the recruited volume as a function of
PEEP.
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Figure 4.1 - Schematic of lung showing the limitation of an absolute FRC measurement as used in gas
washin/washout methods
FRC can also be measured by using CT scans [Malbouisson et al., 2001]. Timed at the end
of expiration, the gas volume can be assessed at each slice and summed across all the slices
in the lung to calculate FRC. However, this type of measurement is unrealistic for regular
use or monitoring in the ICU, due to its invasiveness, radiation dose, difficulty and cost.
Although specialised ventilators may have FRC measurements and can re-estimate FRC
due to PEEP changes (GE ventilators [GE Healthcare, 2006]), most standard ventilators do
not measure FRC and do not give the appropriate information required for optimal
ventilator treatment. In addition, measuring FRC using standard ventilators requires
transportation of the patient (CT scanning). Due to the currently limited availability of
specialised ventilators, not all ICU’s are equipped with them. Thus, in these situations,
there is no practical bedside method that can be used to estimate recruitable lung. In
addition, most current methods need the aid of the clinician and cannot be automated.
Therefore, there is a motivation to be able to estimate the level of potential recruitment in
the lung to help clinicians optimise MV treatment without the availability of advanced
ventilators.
The ability to use standard ventilator data to estimate dFRC as a function of PEEP, which
includes recruited lung, would be a potential enhancement in ventilation management.
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Dynamic FRC is the level of additional lung volume that is achieved in the lung due to an
additional level of applied PEEP [Amir et al., 1995] and is shown schematically in Figure
4.2. Although dFRC cannot by itself estimate the potential of lung recruitment, used with
the recruitment model from Chapter 3 and gas measurements, it can provide the clinician
with useful information on lung recruitability.
Figure 4.2 - Schematic showing the difference between FRC and Dynamic FRC
Thus, the dFRC value represents an aspect of the clinical endpoint in ventilation
management, with the potential to be continuously tracked with changes in patient
condition. This chapter develops a tool to estimate the level of additional pulmonary
volume of collapsed alveolar units that can be recruited resulting from changes made to the
applied inspiratory and expiratory airway pressures during MV. The method is based on
identifying global parameters using a stress strain approach and estimating the level of
additional lung volume obtained due to PEEP. The potential for the model to be used in a
clinical setting is explored based on the measurements required.
4.2 MODEL SUMMARY
The stress strain model introduced here is based on the work of Chiumello et al [Chiumello
et al., 2008], which studied the relationship between global stress and strain during MV in
ARDS patients. They defined the clinical equivalent of stress as the transpulmonary
pressure (ΔPL), while the strain was defined as the ratio of change in volume (ΔV) to the
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volume at the relaxed state of the lung or FRC. They also defined the specific lung
elastance (ELspec) as the transpulmonary pressure at which FRC effectively doubles. The
relationship between stress and strain was defined [Chiumello et al., 2008]:
∆ ( ) = × ∆ ( ) (4.1)
where ΔV/FRC is the strain. The values of the specific lung elastance ELspec in Chiumello’s
study were reported as 13.4 ± 3.4 for surgical control subjects, 12.6 ± 3.0 for medical
control subjects, 14.4 ± 3.6 for ALI subgroup and 13.6 ± 4.1 cmH2O for the ARDS
subgroup. This indicates that ELspec does not vary significantly within different groups and
has a tight range of values.
The general relationship between the change in plateau airway pressure (ΔPaw), when the
airflow is zero and the corresponding transpulmonary pressure is also defined [Chiumello
et al., 2008]:
∆ ( ) = ∆ × (4.2)
= + (4.3)
where α represents the static lung elastance and represents the ratio of the lung elastance
(EL) to the combined elastance of the lung and chest wall (ECW).
It is critical to understand the importance of α in MV therapy. When a given airway
pressure is applied, part of the pressure is used to inflate the lungs. The remainder is used
to inflate the chest wall. The aim of MV is to ventilate patients, while simultaneously
trying to minimise the stresses exhibited in the lungs.
Figure 4.3 shows the effect of different elastance values for the lungs and chest wall.
Although in both cases, the total elastance is the same, Figure 4.3(A), typical of an ARDS
patient, would experience a higher lung stress than Figure 4.3(B) as the lung is stiffer due
to the higher elastance. Thus, α gives an indication of the severity of the ARDS affected
lung, and is seen in Figure 4.3 in the relative contributions of EL and ECW versus Equation
(4.3), where ARDS patients have higher α values.
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Figure 4.3 - Effect of different lung and chest wall elastance. An equal total elastance may arise from different
combinations of lung and chest wall elastance [Gattinoni et al., 2004], where (a) is typical of ARDS patient and (b)
healthier patient. Thus, α is higher in (a)
The values of α in [Chiumello et al., 2008] varied from 0.69 ± 0.15 for surgical control
subjects, 0.74 ± 0.16 for medical control subjects, 0.64 ± 0.15 for the ALI subgroup, and
0.71 ± 0.16 for the ARDS subgroup. As with strain, α remained relatively constant across
all patients with little deviation. Hence, a population value of α is possible.
The equation of motion describes the total airway pressure (∆ ) as a function of the
resistive and elastic components of the respiratory system, and is defined as:
∆ _ = × + × + (4.4)
where is the lung volume, is the respiratory elastance, is the airflow rate, is the
respiratory resistance, and is the offset pressure, which is a combination of applied
PEEP and intrinsic PEEP [Carvalho et al., 2007, Eberhard et al., 1992]. As resistance and
elastance increase, the equation shows the airway pressure increasing, as expected, to
overcome the respiratory resistance and the increased elastic recoil of the respiratory
system.
In the case of no flow, the resistive term in Equation (4.4) is zero. In this case, the airway
pressure is purely a function of the respiratory elastance and is known as the plateau
airway pressure, as shown in Equation (4.5).
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∆ = × + (4.5)
Typically, if the pressure is measured, it is done at the ventilator or near the mask. Hence,
all the PEEP data in this study represents plateau airway pressures, which are measured at
zero flow at end expiration. Because transpulmonary pressure is not typically measured at
the bedside, it is estimated using the PEEP. Thus, rather than using the transpulmonary
pressure ∆ , the airway pressure is used as an estimate based on the relationship in
Equation (4.2).
At the beginning of inspiration, when the airway pressure is equal to PEEP, there is a point
of zero flow, when the airflow reverses between expiration and inspiration. At this point in
time, the volume is measured as the dFRC. Because plateau airway pressure occurs during
zero flow, this justifies the use of PEEP and the corresponding dFRC as a substitute for
plateau airway pressure and lung volume. Thus, measured at this time, ∆ = PEEP and
= in Equation (4.1) and (4.2).
Combining Equations (4.1) and (4.2) yields a formula for FRC involving the two easily
measured quantities and ∆ = ∆ assumed here:
= ∆∆ × (4.6)
Equation (4.6) represents the FRC as a function of the specific lung elastance and the
volume responsiveness (compliance) of the patient. The data provided by Bersten [Bersten,
1998] did not include any FRC measurements. However, it did include the dFRC
measurements measured by the deflation to ZEEP. These values are graphically
represented in Figure 4.4, where FRC is shown as the baseline volume at ZEEP, and dFRC
is thus measured relative to an unknown FRC value.
Figure 4.4 shows the dFRC for a low and a high PEEP setting for a given patient. The
dFRC is composed of FRC and the additional volume due to PEEP. As PEEP increases
from PEEP1 to PEEP2, there is an increase in dFRC. In a recruitment manoeuvre,
additional PEEP is applied to re-inflate collapsed alveoli. Once the additional PEEP is
removed, some of the re-inflated alveoli remain open and hence dynamic FRC is increased
at the original PEEP value. Therefore, physiologically, the change in dFRC represents the
ΔFRC plus the change in alveolar recruitment due to PEEP.
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Figure 4.4 - PV curve showing two PEEP levels and the corresponding dFRC level relative to FRC
In this model, the FRC is not known. The effect on FRC from the recruitment manoeuvre
is also not known, and typically is quite intensive or difficult to measure in a typical
clinical situation. Hence, the aim of this model was to estimate the increase in dFRC due to
PEEP.
Thus, this model hypothesises that the dFRC follows similar mathematical form to
Equation (4.6). The given PEEP and dFRC in Figure 4.4, correspond to = and∆ = ∆ .
+ = ∆∆ × (1 + ) (4.7)
Therefore, the dynamic FRC takes the form:
= ∆∆ × × (4.8)
where x is a function of the PEEP level at which dFRC is estimated. Because and α
are relatively constant values [Chiumello et al., 2008], it suggests that these parameters can
be lumped into a single parameter β, but of unknown value. Therefore, an alternative
model for estimating dFRC is developed:
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= ∆∆ × (4.9)
where β is a function of the PEEP level, and is labelled as the PEEP stress parameter . It
must be noted, the assumption that α remain constant only holds for the linear portion of
the static PV curve when elastance does not change significantly. Re-arranging Equation
(4.6) to solve for ΔdFRC/ΔPEEP (patient compliance), and substituting into Equation
(4.9), we can solve for β:
= × (4.10)
Equation (4.10) shows β as a function of ELspec, α, dFRC and FRC. At a given point in
time, FRC remains constant. In addition, as discussed previously, ELspec and α are relatively
constant. Thus, at a given point in time, β is only a function of dFRC. Because dFRC is a
function of PEEP, this implies that β is a function of PEEP. Thus, the hypothesis used for
this model is that for a single value of PEEP, β can be assumed to be constant for all
patients.
With PEEP increasing, the dFRC also increases as more recruitment occurs, as seen in
Figure 4.4. Thus, β represents the potential for additional recruitment based the given level
of PEEP, and also accounts for the level of damage to the lung by taking into account the
elastances of the lung and chest wall via and .
In the clinical setting, the dFRC is a parameter that is not normally measured and it is this
variable that the model estimates. Because dFRC is a function of PEEP, and β is a function
of dFRC, it is possible to combine parameters further, such that β is a function of PEEP.
This further manipulation then provides a method to estimate dFRC using a known β and
PEEP.
Because FRC was not known for any patient in the clinical data available, β was
analytically solved based on Equation (4.9) using the measured dFRC value from the data.
Once β values were calculated for each patient at each PEEP value, a median β over all
patients was then evaluated for each PEEP level. This median value was then used as a
generic population β value for a given PEEP across the entire population. The dFRC was
then estimated using this median β value. The overall process is summarised in Figure 4.5.
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Figure 4.5 - Flow Chart showing the process of dFRC estimation
4.3 ANALYSIS & STATISTICS
The median and interquartile range non parametric statistics were chosen to be the
summary statistics to report. Because of the limited number of data points available (N =
39 PV loops to predict from), the distribution of errors was non-Gaussian. In such
situations it is better to present the median which is a true representation of the central
tendency and the 50th percentile [Micceri, 1989]. As the number of data points increases,
the mean value would tend to converge to the median value if the distribution was
Gaussian.
The dFRC values that were estimated using the median β value were compared with the
actual measured dFRC values to assess the estimate error over the method and the impact
of the assumed population constant value of β. A cross correlation test was performed as a
preliminary validation with the measured clinical dFRC. The data provided 40 different
dFRC measurements at various PEEP levels. Thus, 80% of the data (32 data points) were
randomly selected without replacement and the median β value found for each PEEP along
with the gradient of β vs PEEP, or mβ.
Using these calculated parameters (β, mβ) from only 80% of the data, the dFRC was then
estimated for the remaining 20% of the data. A linear regression was performed by
comparing the estimated dFRC with the measured dFRC for the tests sets comprising the
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remaining 20% of the data (8 data points). This process was then repeated 100,000 times
and summary statistics reported.
This repetition (100,000 iterations) ensures a wide and reasonably exhaustive coverage of
possible test (n = 8) and validation (n = 32) sets being examined. This approach eliminates
or reduces the potential that random chance or specific patient data sets skewed the results.
The overall analysis using test and validation sets serves to statistically validate the general
modelling and analysis approach presented.
4.4 PRELIMINARY MODEL VALIDATION
The model was validated using the 12 datasets obtained from Bersten [Bersten, 1998], with
the data acquisition process detailed in Chapter 3. Table 4.1 shows the analytical solution
of β for each PEEP level over all 12 patients. The median and IQR are shown. The dFRC
for each PEEP value was then estimated using the median value of β at that PEEP value,
over all patients.
Table 4.1 - Exact and Median Values of β for different PEEP for all patients
PEEP [cm H2O] 0 5 7 10 12 15
PA
TI
EN
T
1 4.67 7.14 11.79
2 6.1 7.96 11.09
3 4.96 6.75 9.12 12.23
4 2.07 3.58 6.79 8.98
5 4.49 6.51 9.5 11.49
6 3.15 5.67 10.28
7 10.13 12.44 15.17
8 4.73 7.23 9.75 11.94
9 3.85 5.95 8.86
10 2.43 6.88 12.43
11 0.48 5.31 10.48
12 2.96 5.25 8
Median 0.48 4.49 6.51 9.31 11.79 13.8
IQR [3.06, 4.85] [5.67, 7.14] [8.22,10.04] [10.89,12.09] [13.12,14.49]
Table 4.2 shows the percentage error between the clinically measured dFRC and the dFRC
estimated with the model-based method and population constant β value. Figure 4.6 shows
the general trend of clinical dFRC vs predicted dFRC for a PEEP of 5 cmH2O across all
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patients, yielding R2 = 0.712 (R = 0.845). This relatively low linear trend is attributed to
the limited number and range of data points at this one particular PEEP level.
Table 4.2 - Percentage Error of actual dFRC and predicted dFRC for all patients at all PEEP levels
PEEP [cm H2O] 0 5 7 10 12 15
PA
TI
EN
T
1 3.93 8.86 0.01
2 26.44 18.19 16.02
3 9.5 3.54 2.13 3.62
4 116.52 81.97 37.14 31.24
5 0.02 0 2 2.58
6 42.65 14.75 14.7
7 8.1 5.19 9.02
8 5.11 9.98 4.53 1.24
9 16.69 9.42 5.07
10 84.95 35.27 11.04
11 0.52 15.41 11.19
12 51.55 24.06 16.4
Median 0.52 16.69 9.98 9.64 3.62 10.03
IQR N/A [7.31, 47.10] [8.86, 18.19] [4.66, 16.30] [1.91, 9.94] [9.52, 10.54]
Figure 4.6 - Plot of Clinical dFRC vs Predicted dFRC for all patients with a PEEP of 5 cmH2O
Figure 4.7, which shows the predicted dFRC versus the measured dFRC across all patients
at all PEEP levels shows greater linearity over all PEEP values with R2 = 0.947 (R =
0.973). The relatively lower R2 value in Figure 4.6 could thus also be attributed to the
relatively low range of dFRC values compared to Figure 4.7. Hence, the linear trend in
PA
TI
EN
T
PA
TI
EN
T
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clinical vs predicted dFRC is sustained over all PEEP values and a very wide range of
dFRC.
Figure 4.7 - Plot of Clinical dFRC vs Predicted dFRC for all patients for all PEEP values
To show the range of errors for the predicted dFRC, Figure 4.8 shows a Bland Altman plot
with a 90% confidence. Although a few points exist outside the interval, the majority of the
points are within a 90% confidence interval of the mean indicating that the maximum
deviation from measured dFRC is around 200 ml.
Figure 4.8 - Bland Altman plot of predicted dFRC and measured dFRC. Solid red line is the mean difference and
dashed lines represent the 90% confidence interval
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The summary statistic and results in the cross validation test are shown in Figure 4.9 and
Table 4.3. Figure 4.9 shows the median β across all patients and PEEP levels and clearly
shows a linear relationship with PEEP. At a PEEP = 0 cmH2O, the dynamic FRC value
should be zero, and hence the linear relationship between β and PEEP is described as:
Figure 4.9 - Plot of median beta vs PEEP taken across all data points
Table 4.3 - Median, IQR and 90% Confidence Interval of R2 correlation coefficient, mβ and β at every level of
PEEP
Median IQR 90% CI
R2 Coefficient 0.944 [0.933, 0.952] [0.910, 0.960]
Beta Gradient (mβ) 0.953 [0.877, 1.046] [0.804, 1.164]
Beta at PEEP = 5 cmH2O 4.065 [3.695, 4.458] [3.057, 5.020]
Beta at PEEP = 7 cmH2O 6.257 [5.823, 6.680] [5.122, 7.233]
Beta at PEEP = 10 cmH2O 9.074 [8.628, 9.520] [7.883, 10.190]
Beta at PEEP = 12 cmH2O 11.371 [10.873, 11.887] [10.235, 12.230]
Beta at PEEP = 15 cmH2O 13.8 [12.512, 15.170] [12.430, 15.170]
Table 4.3 shows the statistical results for the R2 correlation coefficient between the
estimated and actual dFRC. It also shows the value of mβ across all PEEP values as per
Figure 4.9 and the β for each PEEP level. As shown, a 90% confidence interval still
produces a very high correlation coefficient. The low variability in mβ and β indicates the
= (4.11)
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potential to label them as global population parameters that can be used to describe any
patient at a given level of PEEP.
4.4.1 FRC PREDICTION
Equation (4.9) shows that β incorporates dFRC, FRC, ELspec and α. One of the potential
outcomes of this equation is the ability to calculate FRC. Rearranging Equation (4.9) yields
a new equation with FRC as a function of β, dFRC, ELspec and α, and shown below:
Equation (4.12) provides a new method of estimating FRC provided all other parameters
are known. In the model presented in this chapter, β was assumed to be a constant
population value for a given PEEP, which provided a value dFRC at that PEEP level. In
addition, Chiumello et al reported that ARDS patients have an FRC value of 1013 ± 593
ml, where α = 0.7 ± 0.15 and ELspec = 13.6 ± 4.1 cmH2O [Chiumello et al., 2008].
For Patient 1, when α = 0.7 and ELspec = 13.6 cmH2O, the estimated FRC was calculated to
be 1833 ml. Chiumello reported that ARDS patients had FRC of 1013 ± 593 ml
[Chiumello et al., 2008]. Although the estimated FRC for Patient 1 is slightly higher than
the one standard deviation value reported by literature, this could be attributed to the
values of α and ELspec chosen. In addition, 1833 ml is 1.38 standard deviations above the
mean, implying that is approximately the 92nd percentile value and within the two standard
deviation range of a Bland-Altman plot. Hence, it is an outlying, but not unexpected value.
It must also be noted that the values reported by Chiumello et al are more likely to
resemble a log normal distribution. More specifically, the values of 1013 ± 593 ml were
reported as the mean and one standard deviation. This would imply that the range of
possible FRC values when using two standard deviations, which represents 95% of all the
data, would be between -119 and 2199 ml. Because lung volumes cannot take on negative
values, the use of a normal distribution is not justified, and the true distribution is more
likely to be log normal skewed with a multiplicative standard deviation.
= × (4.12)
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To convert an assumed normal distribution to log normal, the normal mean (µ’) and
standard deviation (σ’) need to be logtransformed to lognormal mean (µ) and standard
deviation (σ) using Equations (4.13) and (4.14).
When the FRC values of Chuimello et al are transformed (µ’ = 1013 ml, σ’ = 593 ml), then
µ = 874 ml and σ = 1.72. Thus, using a lognormal distribution, the expected range of FRC
values within one standard deviation is between 508 and 1504 ml.
Figure 4.10 - FRC as a function of varying α for Patient 1. Thick dotted line indicates estimated FRC when mean
ELspec is used. (A) Normal distribution range - Thin lines show the +/- 1 and 2 SD from mean as reported byChiumello et al [Chiumello et al., 2008]. (B) Lognormal distribution range - Thin dotted lines show the +/- 2 SD
using lognormal distribution
Figure 4.10(A) and (B) show the effect of varying α and ELspec on the estimated FRC using
a normal and lognormal distribution. Although using the mean values of α and ELspec
yielded an FRC of 1833 ml, Figure 4.10 shows the sensitivity of FRC estimations to the
initial estimates of α and ELspec. For Patient 1, Figure 4.10 indicates that there are a range of
values where the estimated FRC fall within the reported range in literature. Thus, the
μ = exp ln(μ ) − 12 ln 1 + σ′μ′ (4.13)
= ln 1 + σ′μ′ (4.14)
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estimation of FRC is sensitive to the estimate of α and ELspec. Table 4.4 shows the
estimated FRC for all patients when the mean values of α and ELspec are used, and also
shows the number of standard deviations away from the normal and log normal mean.
Plots of estimated FRC when α and ELspec are varied are shown in Appendix A.
Table 4.4 - Estimated FRC for all patients when α = 0.7 and ELspec = 13.6 cmH2O, and the number of standarddeviations using a normal and log normal distribution.
Number of SD's away from Mean
Estimated FRC
[mls]
Mean = 1013
ml (Normal)
Mean = 874 ml
(Lognormal)
PA
TI
EN
T
1 1833 1.38 1.37
2 1141 0.22 0.49
3 989 -0.04 0.23
4 1426 0.70 0.90
5 3193 3.68 2.39
6 2470 2.46 1.92
7 1923 1.53 1.45
8 1811 1.35 1.34
9 2520 2.54 1.95
10 931 -0.14 0.12
11 2010 1.68 1.54
12 1591 0.97 1.10
Median 1822 1.36 1.35
4.5 MODEL DISCUSSION
The ability to use lung stress and strain as a proxy produces a reasonable estimate of
dFRC. For the clinical data set used, the results indicated that β increased linearly as a
function of PEEP. Chiumello et al [Chiumello et al., 2008] indicated that the ratio of lung
elastance to total respiratory elastance (α) varied between 0.33 and 0.95 over various PEEP
settings. Gattinoni et al showed that the respiratory mechanics may vary significantly in
patients depending on whether the ARDS originated from pulmonary or extrapulmonary
disease [Gattinoni et al., 1998]. They concluded that, depending on the origin of ARDS,
the total respiratory elastance could increase or decrease as a function of increasing PEEP.
However, interestingly, no significant changes for β occurred in this study, as in
[Chiumello et al., 2008], implying that ELspec and α are interdependent on each other, but
constant in that ratio.
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In this analysis, β incorporates the dFRC, FRC, ELspec and α according to Equation (4.10).
Hence, as β increases, the value of dFRC also increases linearly, which means that β can
be used as a potential metric to track dFRC. Another implication of this model is the
potential ability to estimate true FRC. According to Equation (4.12), FRC is related to the
value of β, α, ELspec and dFRC at a given PEEP. When the mean of α = 0.7 and ELspec =
13.6 cmH2O are used to estimate FRC, the median value across all patients is 1822 ml.
Although this was slightly higher than what is reported in the literature, it is still within
two standard deviations.
In reality, the value of α and ELspec vary and FRC can thus also take on a range of values.
This was shown for Patient 1 in Figure 4.10, and highlighted the sensitivity of the
estimated FRC with regard to α and ELspec. Although the estimations of FRC may not be
accurate, measuring the change in FRC can still yield useful information. In particular, by
tracking estimated FRC daily, or more frequently, the clinician can use the changes in FRC
as an indicator of when to begin weaning a patient from ventilation.
Chiumello defined the specific lung elastance as the transpulmonary pressure at which
FRC doubles [Chiumello et al., 2008] and measured ELspec using the supersyringe
technique and inflating the lungs with an additional volume equal to FRC. Using the dFRC
estimation model, when dFRC equals FRC, the volume of the lung has essentially doubled
(total lung volume equalling FRC plus dFRC), and this results in a β value of 19.4 cmH2O
(using average values for α = 0.7, ELspec = 13.6 cmH2O). Using the median value for mβ
shown in Table 4.3 and Equation (4.11), the PEEP that produces this β value is calculated
to be 20.4 cmH2O. According to Equation (4.2), this corresponds to an equivalent
transpulmonary pressure of 14.3 cmH2O. In this study, the value of ELspec is therefore
evaluated to be 12.9 cmH2O which falls within the limits found by [Chiumello et al.,
2008], as a form of further validation.
Although this is not the exact value, the difference in specific lung elastance values could
arise from the fact that different data sets were used. This study used data from Bersten
[Bersten, 1998] with patients who had severe ARDS. In Chiumello’s study, the specific
lung elastance in ARDS patients had a range from 9.5 to 17.7 cmH2O. The value obtained
in this study falls within this reported range for ARDS patients. Secondly, Bersten reported
PaO2/FiO2 values as low as 66. However, the ranges reported by Chiumello for ARDS
patients had a minimum value of 83. This difference could also cause the specific lung
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elastance to be slightly higher, as the more significant the ARDS, the more applied
pressure required for doubling the FRC.
4.6 MODEL LIMITATIONS
Although the method predicts dFRC, there are some significant limitations to its predictive
capability. At lower PEEP, the error for predicted dFRC was shown to be as high as 120%,
as shown on Table 4.2. As PEEP increased, the percentage error dropped, but some
patients still exhibit a difference of about 200 ml between measured and predicted dFRC.
At lower PEEP, a difference of 200 ml and can cause the predicted dFRC to be very
different than true dFRC. Despite a high R2 value shown in Figure 4.7, the predicted value
either over states or understates the amount of potential lung volume that is being
recruited. In the case of the lower PEEP settings, a large prediction error therefore can
limit the potential estimator method. However, even though an estimate of dFRC can have
an error of up to 120%, the model still more accurately identifies the relative changes on
dFRC due to PEEP. With respect, to Table 4.1, Patient 6 yielded the highest error in
estimated dFRC. Examining Figure 4.11, both the estimated and measured dFRC for this
patient respond in the same way to PEEP, implying that although absolute volume
measurements are inaccurate, the trends are still evaluated.
Another limitation with this model is the assumption ELspec and α being constant. This
assumption only holds during the linear portion of the static PV curve. The linear portion
of the static PV curve is where most of the data points occur on any measured dynamic PV
loop. The PV curves obtained from Bersten [Bersten, 1998] indicated that over 90% of the
data points occurred in the linear portion of the static PV curve. The non-linear portions at
PEEP and PIP are actually high flow regions and thus do not account for or include the
majority of the data. This point is further highlighted by assuming that ΔdFRC/ΔPEEP,
effectively the compliance, does not change as a function of PEEP. An estimate of the
static PV curve was plotted using the points of zero flow from each of the PV loops, and is
shown in Figure 4.12. A linear line of best fit was plotted and the R2 coefficient was
computed to show if the estimated static PV curve was linear or non linear showing there,
and in Table 4.5, that the linear assumptions and data points used hold almost exclusively.
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Figure 4.11 - Measured and estimated dFRC for Patient 6. Although the percentage error is high, the estimated
dFRC can still pick up the trend due to PEEP application
Table 4.5 - Linearity of static PV curve for each patient
Patient R2 Patient R2
1 0.9977 7 1
2 0.9998 8 0.9971
3 0.9995 9 0.9978
4 0.9981 10 0.9972
5 0.9885 11 0.9998
6 0.9975 12 0.998
Figure 4.12 - Estimate of the static PV curve for patient 1 using points of zero flow
Finally, the data used in this study is idealised. In each case, the PEEP is held for 30
minutes before any sampling was done. In a clinical setting, holding two or three PEEP
71
settings for 30 minutes to measure ΔdFRC/ΔPEEP is not practical. Thus, the model may be
limited in clinical use Therefore, for clinical application, the ΔdFRC/ΔPEEP would have to
be estimated without the 30 minute hold on PEEP, and can be achieved if a recruitment
manoeuvre is used.
4.7 SUMMARY
The model uses 2 parameters to estimate the dFRC for a given PEEP. The parameters are β
and mβ, where mβ is the gradient of the line of β vs PEEP. Cross correlation and validation
showed very tight ranges for each value of R2 over PEEP. This result implies that β and mβ
can be used as universal population parameters across all PEEP levels to estimate the
dFRC and its change for a given PEEP, as well as for any ARDS patient.
However, the limited number of datasets used in this validation implies further validation
is required to justify β and mβ as population constants. To ensure that the parameters are
true population constants, a larger dataset is required. In addition, the potential for the
model to predict FRC must also be similarly further investigated. Thus, there is a
requirement for further clinical trials to investigate this model. The following chapters
examine the study design for a series of clinical trials and will examine the clinical
viability of the recruitment model and the dFRC model.
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Chapter 5 - Study Design
Prior to any intervention within the ICU, ethics approval is required to ensure that the
protocols used in clinical trials are safe. To develop adequate protocols, the objectives of
the clinical trials need to be fully clarified. The purpose of the trials was to validate the
models of lung mechanics developed and presented in this thesis. More specifically, the
trials aim to examine the clinical viability of the recruitment and dFRC estimation models.
5.1 TRIAL OBJECTIVES
The general objective of the trials was to use clinical data to validate mathematical models.
However, to ensure that the trials were effective, a more specific set of objectives were
required. The goal was to ensure that any protocol developed was optimised to provide the
most clinical information possible.
5.1.1 RECRUITMENT MODEL
The recruitment model discussed in Chapter 3 highlighted the importance of PEEP as a
clinical parameter to optimise. In particular, the problem of how much PEEP is the primary
motivation to develop these model-based approaches. The recruitment model requires PV
curves as inputs to determine the recruitability of the patient.
The preliminary validation performed using data obtained from Bersten [Bersten, 1998]
used PV loops from PEEP values ranging from 5 to 15 cmH2O. At most, a patient did not
have more than four PV curves to fit in the model. In addition, the study did not use a
recruitment manoeuvre to obtain PV curves. Rather, 30 minutes of sustained PEEP was
applied with the resulting PV data obtained at each level.
The first objective of these clinical trials was to examine how individual patient’s
responded to a given level of PEEP in a clinically realistic setting. In addition, the effect of
different PEEP values on a patient’s recruitability, or ability to recruit with PEEP, was
required to examine how a patient-specific response could be determined. These criteria
led to the development of the first part of the study. It was decided that the first part of the
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study would use a recruitment manoeuvre to obtain PV curves at various levels of PEEP.
The use of the recruitment manoeuvre would ensure that the process of obtaining PV loops
could be done in a more clinically realistic and shorter timeframe than Bersten [Bersten,
1998]. Simultaneously, multiple PV loops could be recorded to allow the model to evaluate
the effect of recruitment at different PEEP values.
The initial model validation performed in Chapter 3 indicated that the recruitment model
has the ability to predict and quantify alveolar recruitment. Because the model captures the
total lung capacity (TLC) for a patient, the effect of PEEP on alveolar recruitment can be
quantified. In effect, the model calculates the total number of alveolar units recruited with
respect to the TLC.
Various studies have shown that recruitment can be accurately measured using CT scans
[Gattinoni et al., 2001, Lu et al., 2006, Malbouisson et al., 2001, Rouby et al., 2003]. Thus,
a second objective is to correlate the recruitment measured from CT scans with the model
output if possible. In particular, CT scans at various PEEP levels will be required to
correlate the recruitment at different PEEP, where patient consent and ethical
considerations do not prohibit them.
5.1.2 DYNAMIC FRC (DFRC) MODEL
The dFRC estimation model introduced in Chapter 4 examined the effect of PEEP on
pulmonary volume. In particular, the model used a population constant, the PEEP stress
parameter (β), and used an estimate of static linear compliance to estimate dFRC for a
given patient at a set level of PEEP. As discussed previously, the data used in the initial
validation only ranged from 5 to 15 cmH2O. Although the model showed high linearity
between β and PEEP, two major problems need to be addressed. First, for β to be a true
population constant, a larger dataset is required for validation. Second, the low levels of
PEEP in the validation do not indicate how β behaves at higher levels of PEEP.
The third objective is to examine the effect of higher PEEP on dFRC and increase the size
of the population on which β is based on. Thus, to provide further validation of the dFRC
model, the recruitment manoeuvre needs to include true dFRC measurements and also
include higher PEEP values. Finally, the dFRC model was also shown to have the ability to
potentially predict FRC non-invasively. Because FRC can be measured using CT scans
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[Gattinoni et al., 2001, Malbouisson et al., 2001, Gattinoni et al., 1995], the CT scans
obtained will also be used to validate the FRC prediction, where possible.
The four objectives discussed form the basis of the study and provide a platform to design
a set of clinical trials. Essentially, the trial consists of two parts; (1) a specialised
recruitment manoeuvre, and (2) CT scanning with a recruitment manoeuvre occurring
simultaneously. The trial objectives are outlined in Table 5.1. It is important to note that
ethical considerations limit CT scans in some patients, so the CT scan correlation will not
occur for all patients.
Table 5.1 - Study objectives and corresponding clinical trial required
Study Objective Trial Required
1 - Examine patient recruitability using the lung mechanics model Recruitment Manoeuvre
2 - Correlate alveolar recruitment between recruitment model and CT scans CT Scan Correlation
3 - Validate dFRC model and increase dataset for population constant Recruitment Manoeuvre
4 - Correlate predicted FRC with measured FRC CT Scan Correlation
5.2 PROTOCOL DEVELOPMENT
While meeting the objectives for the study, the clinical trial protocols must also be safe.
All protocols developed must be approved by the New Zealand Upper South Island A or B
Regional Ethics Committee. The following section discusses the evolution of the protocols
developed both for the recruitment manoeuvre and the CT scanning parts of the study, and
the ethics considerations encountered.
5.2.1 RECRUITMENT MANOEUVRES
For patients involved in the study, it was decided that a recruitment manoeuvre would be
required. This would allow clinicians to recruit an already ill patient, while simultaneously
acquiring data for the study. The primary objective of a recruitment manoeuvre is to re-
inflate collapsed alveoli. This outcome is achieved by using periodic higher pressure
manoeuvres with moderate levels of PEEP to change the visco-elastic strain state of ARDS
affected alveoli so they will subsequently open at lower pressures, aiding recruitment
[Gattinoni et al., 2006, Lapinsky and Mehta, 2005, Moran et al., 2003]. The overall,
clinical result of this additional recruitment is a beneficial effect on oxygenation with the
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presence of adequate PEEP, as well as preventing the de-recruitment of existing lung units
[Lapinsky and Mehta, 2005].
Various forms of recruitment manoeuvres exist [Lapinsky and Mehta, 2005]. A common
method of recruiting patients is by using sustained high pressure inflation with airway
pressures between 35 and 50 cmH2O for a duration of 20 to 40 seconds [Amato et al.,
1998]. However, this method does not apply incremental PEEP during the manoeuvre and
may not result in beneficial outcomes.
The intermittent sigh method is also used as a method to recruit patients [Pelosi et al.,
2003]. A sigh is a breath with higher tidal volume than conventional breaths. In practice,
the method uses 3 intermittent sighs, which produces sufficient pressure to recruit alveoli.
However, any beneficial effect on oxygenation was shown to be short term [Pelosi et al.,
2003]. In addition, the sigh method does not reflect PEEP changes.
Finally, intermittent increases in PEEP can be used as a recruitment manoeuvre with peak
airway pressures of up to 45 cmH2O [Gattinoni et al., 2006]. In this method, PEEP is
increased for a few breaths and peak airway pressure is increased. Because this method
involves the direct application of PEEP, this type of manoeuvre is appropriate for this
study.
Conventional PEEP recruitment manoeuvres use a single intermittent PEEP value. The
primary data required for this study comprises of PV data at different PEEP levels. Thus,
the recruitment manoeuvre was modified to allow an incremental PEEP trial that would
allow multiple PV curves to be obtained at different levels of PEEP.
5.2.2 CT SCANS
The use of CT scans in quantifying alveolar recruitment and measuring FRC have been
shown to be an important research tool. Several studies have used CT scans with success
[Gattinoni et al., 2001, Gattinoni et al., 1995, Lu et al., 2006, Malbouisson et al., 2001,
Rouby et al., 2003]. More importantly, they have successfully correlated alveolar
recruitment to CT scans, as well as providing the ability to measure FRC.
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FRC MEASUREMENT
The analysis of CT scans utilises the attenuation of individual pixels, as discussed in
Chapter 1. Each pixel is assigned a particular attenuation or Hounsfield Unit (HU) [Vieria
et al., 1999]. Performing an analysis on a scan and interpreting the HU attenuation can
yield information on the level of gas in the lung. To measure the FRC of a lung, a full lung
CT scan is required starting from the apex to the diaphragm at ZEEP [Gattinoni et al.,
2001, Malbouisson et al., 2001]. Typically, a high resolution spiral CT scanner is used to
obtain a full lung CT, which is both highly invasive, radiation intensive, and time and
resource intensive.
In a full lung CT, the entire image is made up of several slices of CT scans of known
thickness. Each slice is made up of voxels, a unit of volume measurement. Because
individual voxels have different HU attenuation, it is possible to determine if the voxel
contains gas or lung tissue. In a given slice, the total number of voxels can be calculated,
and then multiplied by the slice thickness to determine the volume of gas in a slice. This
process is then repeated across all the CT slices, and the total gas volume is summed to
determine the FRC [Gattinoni et al., 2001, Malbouisson et al., 2001]. Hence, using enough
slices, a highly accurate assessment of FRC and recruitment can be made, even for a highly
heterogeneous ARDS lung.
ALVEOLAR RECRUITMENT
The analysis of voxel attenuation can also be used to determine the level of PEEP induced
alveolar recruitment. Currently, two different approaches are used to quantify recruitment
using CT scans [Gattinoni et al., 2006, Malbouisson et al., 2001]. The method by
Malbouisson et al [Malbouisson et al., 2001] uses a similar approach as the FRC
measurement. A full spiral CT is obtained at PEEP conditions and the resulting gas volume
is compared to FRC to evaluate the PEEP induced recruitment.
In contrast, alveolar recruitment can also be evaluated using single slice scans. The study
by Gattinoni et al used a single slice CT located 1 cm above the diaphragm [Gattinoni et
al., 2001]. The change in non-aerated lung volume between PEEP and ZEEP conditions for
a given slice is then used to evaluate alveolar recruitment.
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The single slice method and the full lung CT method each have unique advantages and
disadvantages. Obtaining a high resolution full lung CT scan can provide a more accurate
estimation of alveolar recruitment [Malbouisson et al., 2001], and also provide a
measurement of FRC. However, the high resolution scanner may expose patients to
unnecessarily high radiation doses. In addition, such scans are also very time and resource
intensive.
In comparison, a single slice need not be high resolution and provides a less intensive dose
of radiation. However, the single slice method cannot measure FRC. In addition, it is by
nature less accurate, particularly in a heterogeneous lung, and thus can underestimate or
overestimate the level of recruitment. These issues are fundamentally due to the fact that
the single slice does not consider recruitment across an entire, heterogeneous ARDS lung.
The specific research objectives of a study decide what CT course should be used. For this
research, the use of an appropriate CT protocol depends on the following criteria:
 Measurements required for validation (Performance Factor)
 Resolution of measurements required (Performance Factor)
 Acceptable level of radiation exposure for patient (Safety Factor)
These three metrics thus balance the performance required from the measurement, and
patient safety or risk. To satisfy the three criteria for patients receiving a CT scan, it was
decided that a full lung CT scan would be obtained at ZEEP, followed by three single slice
scans at various PEEP values. This approach would allow the measurement of FRC that
was required, while also allowing the scans to assess PEEP induced recruitment. With
respect to patient safety, avoiding four full high resolution lung CT scans, the radiation
dose delivered to the patient is minimised, while still being able to achieve the objectives
of the study outlined in Table 5.1.
5.2.3 ETHICAL CONSIDERATIONS
The study was submitted for consideration by the New Zealand Upper South Island A
Regional Ethics Committee. Although the study was split into two sections, the ethics
committee was satisfied with the safety and recruitment manoeuvre, as they are well
documented in the literature [Amato et al., 1998, Lapinsky and Mehta, 2005, Moran et al.,
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2003, Pelosi et al., 2003]. The primary concern from the ethics committee was with regard
to the radiation dose and risks associated with the proposed CT scans.
The main objection from the ethics committee revolved around a study published by
Brenner and Hall [Brenner and Hall, 2007]. The study examined the effects of radiation
doses from CT scans on the future of public health in the United States. In particular, the
study compared the radiation dose delivered from CT scans compared to conventional x-
rays and concluded that although the individual risks are minimal, the aggregate effect on
the population will cause a public health problem in the future. The study also argued that
due to the increased risk of cancer, clinicians should avoid unnecessary CT scans whenever
possible.
Because the research study presented in this thesis was the first of its kind in New Zealand,
and only a few have been done elsewhere [Gattinoni et al., 2001, Malbouisson et al.,
2001], there was no set standard for the ethics committee to determine how much radiation
is too much. The committee thus requested the following information:
 A comprehensive analysis on the science of radiation dosage from CT scan systems
 An experimental method to limit the exposure from radiation to patients
THE SCIENCE OF RADIATION
A common measure of effective radiation dose is the millisieverts (mSv). This measure of
radiation is used when the distribution of radiation is not homogeneous, as the case with
CT scans. The effective dose allows for a rough comparison between different CT
scenarios, but provides only an approximate estimate of the true risk.
The effective dose from the four CT scans proposed in this study, as estimated by the
Medical Physics & Bioengineering Department at Christchurch Hospital, was calculated as
10.2 mSv. The International Commission on Radiological Protection (ICRP), an advisory
board providing recommendations and guidance on radiation protection, approximates that
the increase in fatal risk of cancer is 5% per 1000 mSv [ICRP, 2008]. Thus, the doses
delivered in this study would, linearly analysed, attribute to a 0.05% increase in cancer
risk.
The main problem with the methods of examining risk through radiation is the ongoing
debate between the uses of the linear no threshold model (LNT) [NCRP, 2002, Preston,
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2003] and radiation hormesis model [NCRP, 2002, Feinendegen, 2005, Feinendegen and
Pollycove, 2001, Tubiana, 2005]. The two models are different ways of approximating the
damage caused by ionising radiation. The LNT model suggests that the damage by ionising
radiation is linear and directly proportional to the dose. In contrast, the radiation hormesis
model suggests that below a certain threshold, radiation exposure can be beneficial or have
no harm [Cohen, 2008, Feinendegen, 2005, Tubiana, 2005], which is a non-linear, dose
dependent approach. More specifically, low dose radiation may cause positive genetic
traits to develop and protect against cancer [Feinendegen and Pollycove, 2001], while
extremely higher doses could cause harm. This model is shown schematically in Figure
5.1.
Figure 5.1 - Risk of Cancer vs Radiation Dose for LNT (blue) and Radiation Hormesis model (red). Radiation
hormesis shows beneficial impact of low dose radiation
These conflicting models are a result of a lack of data with respect to radiation damage.
The majority of evidence comes from studies looking at the effects of Hiroshima and
Nagasaki bomb survivors, from patients who have received large doses for medical
purposes, and miners exposed to high levels of radiation [Preston, 2003]. These studies
support the LNT model but are, importantly, limited to high dose cases where the 2 models
might well be similar in prognosis. Crucially, studies examining the effects of low dose
radiation at a cellular level [Feinendegen and Pollycove, 2001] support the hormesis
model.
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IMPACT ON STUDY DESIGN
Although the LNT model is widely accepted, there is still a strong push in the field to
adopt the radiation hormesis model [Cohen, 2008]. Because of the conflicting evidence
from the two models, the ethics committee approved the CT study, with the following
restrictions:
 Only patients who were scheduled for a CT scan for other clinical reasons were
eligible for the CT part of the overall study
 Patients who had a cumulative radiation exposure greater than 20 mSv per annum
(for the current year) or 100 mSv over 5 years prior to the study were excluded.
The value of 20 mSv per annum was defined to be the upper limit of exposure that a
patient could receive. This is the value recommended by the ICRP [ICRP, 2008], and
adopted by the New Zealand Ministry of Health [NRL, 2009], on the maximum allowable
dose for occupational radiologists and medical radiation technologists (MRT).
Because no similar study using CT had been previously performed in New Zealand, this
application and resulting limit on radiation exposure was the first to set a standard on
radiation dose. The Upper South Island A Regional Ethics Committee approved this study
with these amendments.
5.3 METHODOLOGY & PROTOCOLS
The goal of this research was to recruit up to 10 MV patients receiving treatment in the
Christchurch Hospital ICU. All patients enrolled in the study underwent a recruitment
manoeuvre over different levels of PEEP. If eligible, patients were then transported to the
CT scanner for four lung CT’s. The following sections discuss the inclusion and exclusion
criteria for patients, and specific protocols used to adjust PEEP.
5.3.1 PATIENT SELECTION CRITERIA
INCLUSION CRITERIA
1. Patients on MV therapy.
2. All recruited patients were to be over the age of 16.
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3. Patients were included in trial if PF ratio was between 150 and 300 mmHg on the
day of consent. Patients who have a PF ratio, partial pressure of arterial oxygen
(PaO2) divided by the fraction of inspired oxygen (FiO2), between 200 – 300 mmHg
are defined as ALI. PF ratios below 200 mmHg are defined as ARDS. Patients with
a PF ratio less than 150 mmHg were deemed too unwell for inclusion.
EXCLUSION CRITERIA
1. Patients who were likely to be discontinued from MV therapy in 24 hours.
2. Patients who were moribund and/or not expected to survive for greater than 72
hours
3. Patients who were not disorientated in time, place or person. These patients were
excluded as they would have required additional sedation, which may have
prolonged their length of stay.
4. Patients with asthma were excluded.
5. Patients who had significant brain injury. The application of high airway pressures
can increase blood pressure in the brain that could have proved harmful.
6. Women less than 45 years were excluded for the CT part of the study to mitigate
any added risk of breast cancer
7. Patients who had already received 20 mSv through medical radiation in the last
twelve months or would receive a cumulative radiation dose of ≥ 20 mSv (over a
12 month period) as a result of the additional study scans, were excluded from the
CT section of the study.
8. Patients who had already received 100 mSv through medical radiation in the last
five years or would receive a cumulative radiation dose of ≥ 100 mSv (over a 5
year period) as a result of the additional study scans, were excluded from the CT
section of the study.
5.3.2 TRIAL SETUP
Because patients were sedated, consent was obtained on behalf of the patient by immediate
family members only. If patients recovered later, then they would provide final consent on
the use of the data. Consented patients were sedated, or sedated and paralysed using
muscle relaxants, to prevent spontaneous respiratory efforts. The patient’s initial ventilator
82
settings, plateau pressure at end expiration, tidal volume, and initial PEEP setting were all
recorded.
All patients were ventilated using volume controlled mode, synchronised intermittent
mandatory ventilation (SIMV) while the study was conducted. SIMV sets the tidal volume,
with the airway pressure dependent on the patient’s condition. The tidal volume was
selected by the clinician treating the patient and was not changed for the duration of the
measurements. However, if the patient was already on a volume controlled mode, then
tidal volume was not directly set by the clinician. If a patient was on pressure controlled
ventilation, they were switched to SIMV. The measured tidal volume of the pressure
controlled mode was then used to set the mandatory tidal volume of the SIMV mode.
Patients who were spontaneously breathing were put on SIMV mode and given additional
sedation to synchronise their respiratory efforts with the ventilator. In addition, muscle
relaxants were used if the patient was unaware of their surroundings. Patients were sedated
with propofol and rocuronium bromide (ROC) was the preferred relaxant.
All patients in the study underwent a protocolised recruitment manoeuvre with the airway
pressure and the volume data collected. Heart rate, blood pressure and body temperature
were also recorded. Before the recruitment manoeuvre and 30 minutes post manoeuvre, an
arterial blood gas was taken to measure the PF ratio. This measurement was used to
evaluate any changes on blood oxygenation.
Patients were ventilated using a Puritan Bennett PB840 ventilator (Covidien, Boulder, CO,
USA) in the Department of Intensive Care, Christchurch Hospital, New Zealand. A
Hamilton Medical flow sensor (Hamilton Medical, Switzerland) was attached to the y-
piece of the tubing and connected to a calibrated pneumotachometer. The
pneumotachometer was used to obtain the pressure and flow measurements, and could
capture the volume changes due to PEEP. A standard Dell™ (Dell, Austin, TX, USA)
laptop was used in conjunction with the software Labview Signal Express (National
Instruments, Austin, TX, USA) to obtain the raw measurements and store it in a text file.
Raw data was then processed with the aid of Matlab 2009 (The Mathworks, Natick,
Massachusetts, USA) for use with the model.
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5.3.3 STUDY PROTOCOLS
The protocol used in this study was based on the work by Gattinoni et al [Gattinoni et al.,
2006], but was modified to satisfy the objectives of this study. The protocol involved a
PEEP trial, with PEEP incremented in steps of 5 cmH2O and peak airway pressure limited
to 45 cmH2O. Two individual protocols were developed for the recruitment manoeuvre
without and with the added CT scans. In addition, an expiratory and inspiratory hold was
performed to measured auto-PEEP and inspiratory resistance respectively. Once the
maximum PEEP was achieved, PEEP was decremented in steps of 5 cmH2O until PEEP
was back to the initial setting.
PROTOCOL 1 – RECRUITMENT MANOEUVRE ONLY
In this protocol, once all the equipment was connected to the patient’s breathing circuit, the
clinician deflated the patient to ZEEP. Next PEEP was incremented by steps of 5 cmH2O
and PV curves obtained. Once maximum PEEP (PEEPmax) was achieved, such that airway
pressure was equal to 45 cmH2O, the clinician then decremented PEEP in steps of 5
cmH2O until the ventilation settings was restored back to the patient’s initial settings.
Table 5.2 summarises this protocol.
Table 5.2 - Recruitment manoeuvre protocol
Process
1 - Pneumotachometer is attached to the ‘Y’ connector of the patient’s ventilation circuit.System is tested
2 - Deflate to ZEEP, and then carry out 5 more PV loops.
3 - Hold ventilation in end expiration for 20 seconds to determine Auto-PEEP for the finalbreathe
4 - Hold ventilation in end inspiration for 20 seconds to determine circuit resistance for thefinal breathe
5 -
Apply 5 cmH2O PEEP and carry out 5 PV loops with tidal volume of 500ml (or set to thepatient’s previous setting, whichever is the lesser). This data will be captured. This tidal
volume will remain constant for the duration of the study.
6 - Apply an additional 5 cmH2O PEEP to the last PEEP value used and carry out 5 PV loops.
7 - Repeat step 6 until peak airway pressures reach 45 cmH2O and PEEPmax is thus found
8 - Decrement PEEP in steps of 5 cmH2O until initial PEEP setting is achieved
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PROTOCOL 2 – RECRUITMENT MANOEUVRE WITH CT SCAN
This part of the study included a set of CT scans, while simultaneously performing a
recruitment manoeuvre. Thus, at least three and a maximum of four, CT scans were to be
obtained. Because each patient exhibited a different PEEPmax, the level of PEEP where CT
scans could be obtained was different for each patient. Thus, a patient who has a PEEPmax
of 15 cmH2O may have CT scans at different levels of PEEP compared to a patient who
has a PEEPmax of 35 cmH2O. Depending on the value of PEEPmax, the PEEP where CT
scans were obtained would vary. Table 5.3 shows the PEEP levels where CT scans are to
be obtained depending on the PEEPmax.
The PEEP values where CT scans needed to be obtained had to be determined before the
patient was transported to the radiology department, ensuring no time was wasted while in
the CT scanner. Prior to moving the patient, the clinician would determine PEEPmax by
increasing PEEP until peak airway pressure was 45 cmH2O. For example, if the clinician
determined that PEEPmaxwas 18 cmH2O, then CT scans would be obtained at PEEP values
of 0, 5, 10 and 18 cmH2O according to Table 5.3.
Table 5.3 - PEEP level where CT scans are obtained depending on PEEPmax
PEEPmax PEEP level of CT scan
6 to 10 0 5 10 or PEEPmax
11 to 15 0 5 10 15 or PEEPmax
16 to 20 0 5 10 20 or PEEPmax
21 to 25 0 10 15 25 or PEEPmax
26 to 30 0 10 20 30 or PEEPmax
31 to 35 0 15 25 35 or PEEPmax
36 to 40 0 20 30 40 or PEEPmax
Once PEEPmax was determined, the patient was transported to radiology, positioned in the
scanner, and the protocol outlined in Table 5.2 was performed. The only modification was
when the patient was deflated to ZEEP, during the expiratory hold, a full lung CT would be
performed from the apex to the diaphragm. Additionally, single CT scans would be
85
obtained at the predetermined PEEP levels. At the completion of all scans, the patient was
then transported back to the ICU for regular care.
5.4 SUMMARY
This chapter discussed the evolution of the study design and related ethical considerations.
In particular, until now, no formal benchmarking has occurred when subjecting patients to
additional CT scans. However, the research presented in this chapter indicated that the
current theories regarding radiation risk are divergent and far from conclusive. This result
has lead to the first formal benchmark dose that patients are allowed to receive in New
Zealand. This formal upper limit is a step in making CT and other radiation related studies
a more standardised practice in New Zealand.
The recruitment manoeuvres and protocols described provide a platform to analyse PV
curves and validate the models structure and its clinical function as well. The recruitment
manoeuvres used were based on prior, well regarded studies of lung function. These study
protocols were modified only to optimise this study to validate the model-based methods
presented.
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Chapter 6 - Recruitment Model Validation
Ten patients were recruited to take part in this study, of which two patients underwent
multiple clinical trials on different days. This chapter examines the results of the clinical
trials and discusses the clinical implications of model-based approaches to help select
patient-specific ventilation settings. In specific, the recruitment model was tested on
patient data and a process of optimal PEEP selection is discussed.
Although the initial validation performed in Chapter 3 showed the behaviour of threshold
opening pressure (TOP) and threshold closing pressure (TCP) as a function of PEEP, that
study did not specifically address how these metrics can be used to select optimal PEEP. It
was seen that the shape of the mean shifts can give an indication as to which level of PEEP
to use in ventilation therapy. In essence, the TOP and TCP mean shifts can yield
information on patient recruitability and how patients respond to PEEP. However, no
specific approaches were put forward on that data.
In addition, the study in Chapter 3 was highly linear. TOP and TCP showed strong linear
trends with respect to PEEP. However, the linear trend could be attributed to the small
range of PEEP used. To completely validate the recruitment model, and create a robust
means of determining PEEP, a larger range of PEEP is required to be tested.
6.1 METRICS
6.1.1 METRICS FOR PEEP DECISION SUPPORT
TOP
To optimise PEEP, the clinician must have the ability to assess how recruitable a patient is
with respect to PEEP. The slope of the TOP mean shift yields information on the patient-
specific level of alveolar recruitability. If the TOP mean shift is flat with little or no change
in TOP with PEEP, then the application of PEEP does not yield recruitment. However, if
an increase PEEP yields a large decrease in mean TOP, it implies that additional PEEP
produces additional recruitment of new alveoli units. Based on this change, the TOP can be
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used as a metric for PEEP selection. Thus, PEEP can be selected on the basis of how TOP
changes with PEEP.
In particular, following this idea, if TOP decreases, then the clinician should continue to
increase PEEP. If no change in TOP is observed, implying no recruitment, then no
additional PEEP is should be applied. A third case, which is counter intuitive, occurs when
TOP can increase with PEEP. This result can occur when there are leaks in the circuit or
the lung compliance suddenly increases for some reason. In this situation, applying
additional PEEP is sub-optimal.
TCP
The clinician must also consider the de-recruitment behaviour of the patient. In this
situation, the TCP mean shift can be used to titrate PEEP. Similar to the way TOP behaves,
TCP can either increase as a function of PEEP or remain constant. If TCP increases, then
the application of PEEP continues to prevent de-recruitment of unstable units. In contrast,
if TCP remains constant, then added PEEP yields no positive benefit to monitoring the
recruitment status or recruited alveoli units of the lung. Thus, if TCP increases, then the
clinician should continue to increase PEEP to prevent de-recruitment maintaining recruited
alveoli. If little or no change in TCP is observed, PEEP should not be increased.
As discussed in Chapter 2, the application of PEEP can risk inducing VILI [Ricard et al.,
2003, Carney et al., 2005, Gajic et al., 2004, Adams et al., 2003]. Although in some cases
TCP could continue to increase with PEEP, the risk of VILI can be mitigated by setting a
benchmark PEEP value. When the mean TCP is greater than PEEP, then more than 50% of
alveoli will de-recruit during expiration. Thus, the point where PEEP and TCP mean are
equal represents the PEEP at which no more than 50% of alveoli de-recruit. This value
represents a somewhat arbitrary trade-off. Although a higher PEEP could prevent further
de-recruitment, it could increase the risk VILI. Hence, it represents a turning point in the
return on increased PEEP, and thus, this PEEP setting should be used when the objective is
to prevent de-recruitment.
TOP and TCP shifts with PEEP could take on the four possible cases shown in Figure 6.1.
In the best case, the mean shifts would exhibit the combination shown in Figure 6.1(A),
where TOP decreases and TCP increases (with high slope). This combination indicates that
more recruitment occurs as PEEP is increased, while a larger proportion of alveoli also
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remain recruited during expiration. Figure 6.1(B) shows the case where the patient is not
highly recruitable, but the application of PEEP prevents de-recruitment. In contrast, Figure
6.1(C) shows a patient who exhibits high recruitability, but struggles to keep alveoli
recruited during expiration. The worst clinical situation for an ARDS affected lung is
shown in Figure 6.1(D). In this case, the patient exhibits limited alveoli recruitability as
shown by the flat TOP curve, and also does not retain recruited alveoli during expiration.
This scenario would be associated with almost zero net recruitment with increasing PEEP
and thus with increased risk of VILI, regardless of PEEP, due to repetitive opening and
closing of alveoli [Carney et al., 2005, Ricard et al., 2003]. This situation is also most
reflective of a health patient. As a patient’s condition improves, the TOP and TCP
gradients should become flatter.
Figure 6.1 - Combinations of TOP and TCP mean shift
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NET RECRUITMENT
Although TOP and TCP can be used individually to evaluate optimal PEEP, it is possible
to evaluate the net effect of recruitment and de-recruitment together. Because the primary
objective of MV is to maximise recruitment and minimise de-recruitment, a third metric
may be used to choose PEEP by examining the difference between the amounts of alveoli
recruited at certain PEEP during inspiration and the amount remaining at the end of
expiration.
Figure 6.2 shows a static PV curve with total lung capacity (TLC). When an airway
pressure of Pcrit is applied, the volume during inflation is represented by the volume Vinf.
However, during the deflationary portion of the static curve, the lung experiences a level of
hysteresis and results in much higher lung volume for a given pressure, Vdef. The
percentage of lung recruited at a given pressure is the lung volume divided by the TLC.
Thus, during inflation for a given pressure, the percentage recruited volume is Vinf divided
by the TLC. Simultaneously, during deflation, the percentage alveoli remaining recruited at
expiration is the Vdef divided by TLC. The difference between the percent of alveoli
remaining recruited at expiration and percent recruited during inflation is the net level of
recruitment and varies as a function of pressure.
Figure 6.2 - Static PV curve during inflation and deflation. Hysteresis is shown, with the volume at inflation, Vinf,much lower than volume during deflation, Vdef, for a given pressure, Pcrit
Though the mechanism of hysteresis is still not fully understood, studies have shown that
the larger the hysteresis, the higher the recruitability of the lung [Bernard et al., 1994,
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Henzler et al., 2005, Hickling, 1998, Hickling, 2002]. Thus, the airway pressures should be
increased to provide additional recruitment. However, as airway pressure increases, a point
of maximum net recruitment occurs at a pressure Pcrit, shown in Figure 6.3. At pressures
below Pcrit, the alveoli de-recruit faster than new alveoli recruit. As recruitment begins, the
net recruitment increases until it reaches a maximum. At pressures above Pcrit, recruitment
and de-recruitment begin to slow, causing net recruitment to drop. Thus, this metric
provides the clinician with the pressure required where to keep the process of recruitment
and de-recruitment in balance, and provide the best trade off with respect to PEEP.
Figure 6.3 - Net recruitment as a function of pressure. Pcrit indicates pressure where net recruitment is maximised.At pressures below Pcrit, the rate of de-recruitment increases, while pressures above Pcrit, the rate of recruitmentdecreases.
This net recruitment parameter is only valid when TOP is decreasing. If TOP increases
with PEEP, then additional PEEP causes alveoli overstretching and a TCP metric would be
more useful. In particular, although net recruitment may increase mathematically in this
situation, it is not due to true recruitment. Hence, net recruitment should only be used if the
TOP continues to decrease with PEEP.
CHOICE OF METRIC
The choice of metric depends on the particular requirements of the patient. Although all
the metrics will be used in the clinical validation, the use of a given metric in the clinic
should be rated on performance versus clinical expectation. Thus, the three metrics used
are:
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 TOP mean
 TCP mean
 Net rate of recruitment
The level of accuracy in selecting PEEP is dependent on the range of values predicted by
the three metrics. However, the three metrics provide multiple means of selecting patient-
specific PEEP.
Each parameter provides useful information to the clinician. If the primary objective is to
maximise alveolar recruitment, then the TOP provides information on how PEEP affects
recruitability. In contrast, if the objective is to ensure PEEP maintains recruitment, or
prevent de-recruitment, then the TCP should be used to guide PEEP selection. Finally, the
net recruitment is useful when examining the combined effects of recruitment and de-
recruitment.
6.1.2 DISEASE STATE METRICS
In addition to PEEP selection metrics, four other parameters are introduced to illustrate
how the ARDS disease state varies and can be assessed with time. The primary outputs of
the model are the TOP / TCP mean and SD. While the level of recruitability is described
by the TOP and TCP mean, the level of compliance is described by the SD. Although SD
and compliance reflect the ARDS condition and the TOP mean represents the
recruitability, they are both not unrelated.
MEAN – TIME METRIC
The first metric to evaluate the evolution of disease state uses the TOP mean shift. As a
patient’s condition changes, the magnitude of the TOP for a given PEEP also changes.
Monitoring how the TOP varies with time can give an indication as to how stiff the lung is.
If the TOP increases, it indicates that alveoli have de-recruited over time or become less
recruitable at a given pressure, and a higher pressure is required to re-recruit them.
Similarly, a decrease in TOP implies that overall, more, new lung units are available at a
given pressure, and the lung has become less stiff. The trend of TOP can take on three
possible scenarios as shown in Figure 6.4, and tracking this metric on a regular basis can
indicate whether new alveoli have recruited. In specific, this implies a worsening, static or
improving disease state in the lung.
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Figure 6.4 - Change in TOP as a function of time. Metric provides information with a  change in lung condition
and stiffness, and also provides information to the overall disease state
COMPLIANCE – TIME METRIC
The second metric uses the SD to assess how the compliance of the lung changes with
time. The change in SD could give information as to how the condition of the lung has
changed, as shown in Figure 6.5. As the study by Schiller et al [Schiller et al., 2003]
showed, alveoli with various levels of injury appear in the same region of the lung, and
even in the same microscopic field, because the ARDS lung is highly heterogeneous
[Ashbaugh et al., 1967, Bernard, 2005, Gattinoni et al., 1998, Hudson and Steinberg, 1999,
Maggiore et al., 2003, Ware and Matthay, 2000, Zilberberg and Epstein, 1998]. However,
injured units recruit at higher pressures, while healthier units recruit at lower pressures.
Therefore, changes in SD could evaluate how healthy and damaged units are distributed as
their relative percentages and compliance change.
In particular, over time, an increase in SD could be interpreted as more injured lung units
being present in the lung. Similarly, a decrease in SD could be attributed to a reduction and
a corresponding improvement in disease state. More specifically, the increase or decrease
of ARDS as in Figure 6.5 implies an increase or decrease in heterogeneity seen in the
model by SD.
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Figure 6.5 – Model standard deviation as a function of time.
TOP GRADIENT METRIC
A third metric to evaluate the evolution of disease state uses the gradient of the TOP mean
shift. As a patient’s condition changes, the gradient of the TOP curve also changes. The
gradient of TOP represents the patient’s recruitment response to PEEP. More specifically,
if the TOP curve is steep, the patient is highly recruitable. In contrast, if the TOP gradient
is shallow, then the patient is non-responsive to PEEP, and will not experience additional
PEEP induced recruitment.
When evaluated over time, the gradient examines how the recruitability response varies.
An increase in magnitude of the TOP gradient implies that the patient is becoming more
responsive to PEEP. Similarly, a decrease in the magnitude of the  TOP gradient suggests
that that patient is becoming less responsive to PEEP.
TCP GRADIENT METRIC
The fourth metric examines the gradient of the TCP mean shift as a function of time.
Similar to the TOP gradient, the TCP gradient assesses how PEEP affects the de-
recruitment behaviour of alveoli. A steep TCP curve suggests that additional PEEP can
prevent de-recruitment. Alternatively, a flat TCP suggests that applying additional PEEP
does not prevent more de-recruitment.
By evaluating the gradient of TCP over time, it is possible to see how de-recruitment status
of alveoli vary. An increase in the gradient over time suggests that fewer alveoli are de-
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recruiting as a function of PEEP. In contrast, if the gradient of TCP drops, then the
application of PEEP does not prevent de-recruitment. Patients who are healthy will have all
available alveoli recruited. Thus, these healthy patients will exhibit flat TOP and TCP
gradients. However, this analysis only considers mechanically ventilation of very ill
patients where the TOP and TCP gradient can vary significantly.
6.1.3 METRIC SUMMARY
Seven metrics have been developed that will be used in the validation process. Three
metrics have been developed as a means to guide PEEP selection, with the remaining four
used as a metric to track disease state over time. The model was fitted using PV loops
above the auto-PEEP, with the results presented in the following section. The latter four
metrics are tracked only in patients undergoing multiple trials.
6.2 CLINICAL RESULTS
The trial protocols developed in Chapter 5 described the process of acquiring PV curves
from patients in this study. Although PV curves were obtained from ZEEP to a maximum
PEEP, an expiratory hold was performed to measure auto-PEEP. Auto-PEEP is a common
phenomenon in patients who are mechanically ventilated, and represents the pressure that
is already in the lung without any external ventilation.
When auto-PEEP is present, an obstruction or collapsed airway causes gas to be trapped
within alveoli [Fernández et al., 1990, Mughal et al., 2005], as shown in Figure 6.6(A). As
the pressure in the airway is increased during inflation or with increased PEEP, the airway
opens up and the compliance suddenly increases. This is due to the sudden added volume
from these pre-recruited alveoli due to the presence of auto-PEEP, shown in Figure 6.6(B).
The presence of auto-PEEP can also be detected by examining the PV curves for different
PEEP levels and noting that they have the same peak airway pressures, shown in Figure
6.7. Because the presence of auto-PEEP does not accurately reflect the underlying
ARDS/ALI disease state or overall recruitability and compliance of the lung, the model
was re-fitted in these cases without including PV loops below auto-PEEP.
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Figure 6.6 - Schematic highlighting concept of Auto-PEEP. Figure (A) shows the presence of a collapsed airway,
with recruited alveoli causing a level of auto-PEEP. Figure (B) shows the collapsed airway opening up when
additional PEEP is applied
Figure 6.7 - PV curves for Patient 1 at PEEP below auto-PEEP. Auto-PEEP was equal to 7 cmH2O
6.2.1 MODEL-BASED OPTIMAL PEEP
The model was able to fit the clinical data well. Ten patients were enrolled in the study,
with the cause of their lung injury highlighted in Table 6.1. As expected, the standard
deviation and the mean were significantly higher for the TOP distribution than the TCP
distribution across all patients. All the data showed a linear increase in TCP, and a
decrease in TOP as a function of PEEP. Table 6.2 summarises the best fit threshold
pressure distribution parameters and the average fitting errors for Patient 1 and excludes
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PV curves with PEEP levels below the auto-PEEP. Tables of fitting errors for all patients
are shown in Appendix B and summarised in Table 6.3. In all cases, the model was
unmodified from what was presented in Chapter 3, with patient-specific standard deviation
held constant for each patient across all PEEP values in a given trial. The fitting errors are
presented as average absolute volume fitting errors and as percentage errors.
Table 6.1 - Characteristics of trial patients
Sex
Age
[years]
Cause of lung
injury
Patient 1 Femle 61 Peritonitis
Patient 2 Male 22 Trauma
Patient 3 Male 55 Aspiration
Patient 4 Male 88 Pneumonia
Patient 5 Male 59 Pneumonia
Patient 6 Male 69 Trauma
Patient 7 Male 56 Legionnaires
Patient 8 Female 45 Aspiration
Patient 9 Male H1N1
Patient 10 Male Legionnaires
Table 6.2 - Model fitting error for Patient 1
PATIENT 1
Number of Units 144000
Inflation SD 15
Deflation SD 7
Auto-PEEP [cmH2O] 10
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
10 30.97 22.17 7.86 15.57 15.48 4.61
15 28.07 22.50 4.44 17.68 5.61 1.02
20 27.12 22.27 3.11 19.88 5.72 0.63
25 26.41 21.71 2.05 22.43 7.47 0.68
27 26.18 15.11 1.34 23.39 2.73 0.24
Table 6.3 - Summary of fitting errors for all patients
Inflation Deflation
Error [ml] Error [%] Error [ml] Error [%]
Median 19.47 2.50 6.96 0.82
IQR [12.36 – 22.79] [1.56 – 4.62] [4.51 - 13.22] [0.54 - 2.34]
Range [1.73 - 55.09] [0.63 - 151.80] [1.39 - 58.17] [0.11 - 116.89]
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Figure 6.8 - Main plot shows TOP and TCP as a function of PEEP for Patient 1. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table 6.4 – Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient 1
Method OptimumPEEP [cm H2O] Reason
TOP 27 Recruitment maximised - but could pose risk of VILI
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net Recruitment 20
Lower PEEP does not maximise recruitment, while higher PEEP
does not minimise de-recruitment
Clinical Setting 10 Clinician selected
Figure 6.8 illustrates the TOP and TCP curves for Patient 1. In addition, the model fit and
net recruitment curves are also shown. The main plot shows the effect of PEEP on mean
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TOP and TCP. Patient specific optimal PEEP was determined by using the three metrics
described in Section 6.1.1 . Finally, the optimal patient-specific PEEP depending on the
TOP, TCP and net recruitment are also evaluated and compared to the clinical PEEP
setting on Table 6.4. TOP and TCP curves for all patients are shown in Appendix C.
The results of the model-based approach are summarised in Table 6.5, as well as the auto-
PEEP each patient experienced. The clinical PEEP setting is also shown for comparison.
Table 6.5 – Summary of auto-PEEP and model-based PEEP selection metrics for all patients.
Auto-
PEEP
[cmH2O]
Clinically
Selected PEEP
[cmH2O]
Inflation SD
Model-Based PEEP Selection
[cmH2O]
TOP TCP NetRecruitment
Patient 1 10 10 15 27 20 20
Patient 2 2 12 11 15 15 15
Patient 3 0 10 12 10 15 20
Patient 4 9 10 25 20 20 30
Patient 5 - Trial 1 13 12 16 20 25 25
Patient 5 - Trial 2 8 12 15 20 25 20
Patient 6 - Trial 1 10 11 11 15 20 20
Patient 6 - Trial 2 3 13 14 15 15 20
Patient 6 - Trial 3 2 10 14 10 20 15
Patient 7 2 7.5 10 5 10 10
Patient 8 0 12 15 15 20 30
Patient 9 12 10 15 25 20 29
Patient 10 3 10 16 15 20 15
6.2.2 MONITORING DISEASE EVOLUTION
Patients 5 and 6 had multiple trials and recruitment manoeuvres on different days. The
purpose of these cases was to examine if the model could track the evolution of the disease
state with time. Patient 5 had two trials, with the second performed three days after the
first. Patient 6 had three trials, with the subsequent two manoeuvres performed 7 and 14
days later. The variations of TOP, SD, TOP gradient and TCP gradient are shown in Figure
6.9 for Patient 5 and Figure 6.10 for Patient 6.
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PATIENT 5
The average TOP for patient 5 was calculated using the modelled TOP values at PEEP
values of 15, 20 and 25 cmH2O from Table B.1. Figure 6.9(A) shows the average TOP and
SD over time for Patient 5, and shows that a significant drop in average TOP, and a
negligible drop in SD. This result implies that Patient 5 has indeed recruited. However, the
state of the ARDS affected lung has only slightly improved.
Figure 6.9(B) shows the variance of the TOP and TCP gradient over time. The TOP
gradient shows no change over time, suggesting that the recruitment response to PEEP has
not changed. In contrast, the TCP gradient shows a slight increase over time. This result
implies that the effectiveness of PEEP to prevent de-recruitment has improved over time
resulting in an improved condition overall.
Figure 6.9 – (A) Average TOP and SD over time for Patient 5 and (B) TOP and TCP gradient over time
PATIENT 6
Figure 6.10 shows the state of the disease for Patient 6, with average TOP calculated using
PEEP values of 10, 15 and 20 cmH2O. Similar to Patient 5, Patient 6 exhibits a decrease in
average TOP, indicating recruitment has occurred with time over the three trials. However,
Figure 6.10(A) also indicates that between the first and second trial, SD has increased. This
increase would imply that there is an increase in unhealthy alveoli and a loss of
compliance. Prior to the trial, the clinician hypothesised that this patient had severe ARDS.
Hence, the distribution of healthy to unhealthy alveoli was extremely heterogeneous and
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there were potentially large numbers of affected alveoli. The increased level of recruitment
could be attributed to marginally unhealthy units being recruited after sustained level of
pressure. However, the increase in SD suggests that the condition of unhealthy alveoli was
getting worse or that more alveoli were becoming ARDS affected. This patient later died
due to severe respiratory failure, which supports this conclusion.
Figure 6.10(B) shows the gradient of TOP and TCP. Between the first and second trial, the
magnitude of the TOP gradient seems to decrease, or become flatter, suggesting that the
patient is becoming less responsive to PEEP induced recruitment. This lack of response
becomes even more pronounced between the second and third trial. In particular, the TOP
gradient begins to become positive indicating that the levels of PEEP used are sub-optimal.
The TCP gradient shows a slight increase with time. This would imply, similar to Patient 5,
that the effectiveness of PEEP to prevent de-recruitment has improved somewhat.
Figure 6.10 - (A) Average TOP and SD over time for Patient 6 and (B) TOP and TCP gradient over time
It is also interesting to note the difference in magnitude between TOP and TCP gradients
between both patients. During the first trial, Patient 6 exhibited a much higher negative
TOP gradient than Patient 5. This would suggest that Patient 6 was more responsive to
PEEP than Patient 5. However, with time, Patient 6 become much less responsive, as
shown in Figure 6.10(B) compared to Patient 5. Similarly, the magnitude of TCP gradient
also indicates that PEEP was much more effective at preventing de-recruitment in Patient
5. This result can be inferred by examining Figure 6.9(B) and noting that the gradient of
TOP is much steeper when compared to Patient 6.
101
Tracking the evolution of the disease provides useful information into how the patient is
reacting to ventilation therapy overall, as well as how they are progressing in the ICU. The
use of four metrics allows insight into the different objectives of ventilation. In particular,
the metrics potentially allow the clinician to examine whether the patient recruited, the
state of the ARDS affected alveoli, the response on recruitment through PEEP and the
response to prevent de-recruitment through PEEP.
6.3 DISCUSSIONS & LIMITATIONS
6.3.1 PEEP SELECTION
Based on the results of these clinical trials, the model highlighted aspects of MV that are
clinically important in determining optimal PEEP. First, the model evaluates waveforms to
assess recruitment and de-recruitment, thus determining the recruitability of the patient’s
lungs. By examining how recruitable a patient is with respect to TOP, TCP, and net rate of
recruitment, the model evaluates the point where additional PEEP does not cause
additional recruitment or retention of alveoli.
The model uses the TOP to assess the impact on recruitability using PEEP. The clinical
data suggested that Patients 1, 3 and 4 were highly recruitable. These patients showed a
significant drop in TOP as PEEP increased. In contrast, Patients 2, 6, 7 and 8 showed
negligible or no change in TOP as PEEP increased, with PEEP resulting in minimally
additional or no recruitment. Patient 5 underwent two trials, and in trial 1, was not very
recruitable due to the minimal changes seen in TOP. However, during the second trial,
Patient 5 had a much stronger recruitment response to PEEP, with the TOP dropping much
more rapidly as PEEP was applied.
The model also uses TCP to evaluate optimal PEEP. Rather than aiming to maximise
recruitment, using TCP as a metric, the aim is to prevent de-recruitment or maintain
recruited alveoli. All ten patients showed an increase in TCP as PEEP increased. This
suggests that continual increases in PEEP will at least minimise de-recruitment, and PEEP
should be maximised. However, because high PEEP can result in VILI [Adams et al.,
2003, Carney et al., 1999, Gajic et al., 2004, Ricard et al., 2003], the PEEP where no more
than 50% of alveoli de-recruit was chosen as the optimal PEEP in this analysis. Although
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this is an arbitrary value, it represents a trade off between patient safety and ventilation
efficacy.
Finally, the model also used the net recruitment as a metric to select PEEP. This metric is
only valid when the TOP decreases. Patients 2, 5 (trial 2), 6 (trials 1 and 3) and 7 showed
an increase in TOP at high levels of PEEP, as shown in Figure 6.11(A) and Appendix C.
Based on alveolar recruitability, an increase in TOP would imply that high PEEP results in
volume lost. Physiologically, this outcome would imply that there are more alveoli being
destroyed (due to over inflation) than being recruited. However, this sudden change of
patient condition is highly unlikely due to the relatively low pressures that were used in
this trial.
Figure 6.11 - (A) TOP and TCP vs PEEP for Patient 5, Trial 2. (B) Net recruitment for Patient 5, Trial 2
indicating sub-optimal ventilation beyond 20 cmH2O.
The clinical data showed this increase in TOP occurred when the compliance of the
dynamic PV curve decreased markedly. When the compliance of the lung decreases, the
pressure required to deliver a given volume of air increases. This result can occur when
alveoli are maximally recruited and begin to over-inflate [Schiller et al., 2003]. Thus, an
increase in PEEP results in alveolar over-inflation rather than additional recruitment, and
ventilating at higher PEEP is similar to ventilating above the upper inflection point (UIP).
Therefore, the increase in TOP is an indication of alveolar over-inflation thus justifying the
conclusion that it results in sub-optimal ventilation, as can be seen in Figure 6.11(B).
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6.3.2 COMPLIANCE CHANGES
The model used a constant SD across PEEP and within a given trial to reflect the disease
state of a patient, as fitted to the largely linear portion of the dynamic PV curve. When the
model was applied to the clinical data, it was evident that the standard deviation is not
necessarily constant across all PEEP values considered in this study. At low and high
PEEP, the compliance is significantly different compared to PEEP in the linear portion of
the static PV curve [Harris, 2005]. The variation in compliance is shown in Table 6.6 for
the patients in this study. The unusually high compliance values could be attributed to the
presence of auto-PEEP in patients. Regardless of this limitation, it still reflects the
recruitment response to PEEP indicating the robustness of the model.
Table 6.6 - Variation in compliance across all patients
Compliance [ml/cmH2O]
Patient 1 [34.92 - 60.47]
Patient 2 [58.34 - 103.91]
Patient 3 [25.70 - 107.96]
Patient 4 [21.82 - 75.19]
Patient 5 - Trial 1 [24.40 - 55.57]
Patient 5 - Trial 2 [26.94 - 62.21]
Patient 6 - Trial 1 [17.02 - 58.69]
Patient 6 - Trial 2 [33.70 - 63.12]
Patient 6 - Trial 3 [23.64 - 77.45]
Patient 7 [5.76 - 23.48]
Patient 8 [32.14 - 72.48]
Patient 9 [36.70 - 61.23]
Patient 10 [26.74 - 44.68]
The preliminary validation performed in Chapter 3 used PV curves obtained during 30
minutes of sustained pressure [Bersten, 1998] and showed similar compliance across the
different PEEP. Recruitment manoeuvres applying sustained pressure for relatively long
periods of time have been shown to improve recruitability [Lapinsky and Mehta, 2005].
This approach may have resulted in the very constant compliance in the data used in the
initial validation on the Bersten data [Bersten, 1998]. The model required multiple PV
loops to assess the recruitability of the patient. From a practical perspective, if multiple PV
loops are required, it is not feasible to hold the PEEP for 30 minutes as part of a clinical
protocol for everyday use. Thus, in this situation, a short recruitment manoeuvre would be
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more appropriate clinically, as used in these clinical trials. However, it may result in
slightly different compliances across various PEEP levels.
Figure 6.12(A) shows PV curves from the Bersten dataset and Figure 6.12(B) from the
clinical dataset. Figure 6.12(A) shows the linear compliance not varying significantly in
the three curves. In contrast, Figure 6.12(B) shows compliance varying at extreme PEEP,
but remaining relatively constant in the linear region. Thus, although 30 minutes of
sustained PEEP is not performed for the clinical dataset, the relatively constant compliance
within the linear region is still obtained, which still incorporates the clinically acceptable
PEEP ranges. In addition, the data from Bertsen used a maximum PEEP of 15 cmH2O, and
did not push PEEP to higher values compared to the trials used in this study. Thus, the
relatively constant compliance seen by Bersten could have also been attributed to the fact
that PEEP was not tested at extreme values.
Figure 6.12 - (A) PV curves for a dataset from Bersten et al showing similar linear compliance. (B) PV curves
from clinical data. Similar compliance is exhibited in the linear portion, but compliance significantly varies at low
and high PEEP.
6.3.3 SD & COMPLIANCE
Compliance in the linear portion of the static PV curve has been reported to be between 20
and 61 ml/cmH2O for patients with ALI and ARDS [Amato et al., 1998, Brower et al.,
2004, Gattinoni et al., 2006, Gattinoni et al., 1998, Jonson and Svantesson, 1999]. Table
6.7 summarises the inflation SD and the corresponding compliance of the linear portion of
the static PV curve, with the results plotted in Figure 6.13. The aim of this analysis was to
examine the strength of the correlation between SD and compliance.
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Table 6.7 - SD and linear compliance for each clinical patient. Compliance was normalised to allow correction for
varying TLC.
Inflation
SD
Linear
Compliance
[ml/cmH2O]
TLC [mls]
Normalised Linear
Compliance
[ml/cmH2O]
TLC [mls]
Patient 1 15 37.79 1440 26.25 1000
Patient 2 11 60.52 1710 35.40 1000
Patient 3 12 71.66 2200 32.48 1000
Patient 4 25 34.94 2200 15.88 1000
Patient 5 - Trial 1 16 48.80 1980 24.61 1000
Patient 5 - Trial 2 15 42.26 1610 26.25 1000
Patient 6 - Trial 1 11 33.92 960 35.36 1000
Patient 6 - Trial 2 14 47.97 1710 28.02 1000
Patient 6 - Trial 3 14 43.21 1540 28.04 1000
Patient 7 10 25.11 650 38.57 1000
Patient 8 15 46.20 1760 26.23 1000
Patient 9 15 49.58 1890 26.23 1000
Patient 10 16 36.17 1470 24.60 1000
Figure 6.13 - SD vs linear compliance for all patients
Figure 6.13 suggests that there is no strong correlation between inflation SD and the linear
compliance. However, this result could be attributed to the fact that the TLC varies
significantly between patients. For example, Patient 1 and Patient 8 exhibit the same SD,
but the linear compliance is different, as shown in Figure 6.14.
Figure 6.14 shows the quasi-static inflation PV curve for Patient 1 and 8. Although both
patients have the same SD, the linear compliance is different due to the difference in TLC.
To correct for the varying lung capacity, the compliance was normalised, such that all
patients exhibit a TLC of 1 L. This normalization effectively scales the static PV curve,
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and thus, modifies the compliance. The normalised compliance values are shown in Table
6.7, and plotted in Figure 6.15.
Figure 6.14 - Static PV curve for Patient 1 and Patient 8. Red solid lines show the linear compliance for both
patients. SD is identical for both patients, but TLC is different, causing linear compliance to vary.
Figure 6.15 - SD vs normalised linear compliance for all patients
Figure 6.15 shows the normalised compliance as a function of SD and a very strong
exponential relationship. In essence, the SD captures the effect of compliance. Although
numerically, SD may not accurately represent true linear compliance, these results show
that SD can be effectively used as an indicator of the diseased state. More specifically, SD
can be used to determine the normalised linear compliance, which accounts for varying
TLC between patients.
107
6.3.4 MECHANICAL FAILURE
Patient 2 showed an increase in TOP when PEEP was set above 15 cmH2O, seen on Figure
6.16(A). In this particular case, the increase in TOP could also be attributed to a leak in the
circuit. To prevent leaks from the circuit, an endotracheal cuff is used to seal the tube.
When a patient is ventilated and intubated, the cuff is set by filling it with air and inflating
it within the trachea. This causes a pressure build up in the cuff and ensures it is less
susceptible to leaks.  The cuff pressure generally set in the Christchurch Hospital ICU was
between 30 and 40 cmH2O. For this patient, the cuff was set to 30 cmH2O.
Figure 6.16 - (A) TOP and TCP vs PEEP for Patient 2. (B) Net recruitment for Patient 2 indicating sub-optimal
ventilation beyond 15 cmH2O.
The increase in TOP begins to occur at a PEEP of 15 cmH2O where the peak airway
pressure approaches 30 cmH2O, as shown on Figure 6.16(A). As the airway pressure
approaches and exceeds the cuff pressure, the cuff begins to slip and cause a slight leak.
The leak was detected after the trial was completed when the cuff pressure was shown to
have dropped, implying that a leak did in fact occur.
In this case, the application of higher PEEP is indicative of the leak resulting in sub-
optimal ventilation. Thus, the increase in TOP could potentially also be used as a method
to determine mechanical failures in the circuit which could lead to sub-optimal ventilation.
If an increase in TOP is observed, then the clinician could check the cuff to ensure no leaks
are present. If the TOP continues to increase, then this could be attributed solely due to
over-inflation resulting in applied PEEP being reduced.
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6.3.5 EFFECT OF INSPIRATORY RESISTANCE
The effect of endotracheal tube resistance was evaluated by performing an inspiratory hold
during the deflation to ZEEP and measuring plateau pressure. The difference in peak
pressure and plateau pressure was attributed to the pressure loss of the tube. Patients 1 - 4
did not have this measurement taken as this was a modification to the original study
approved. Because a known decelerating flow waveform was used, the inspiratory
resistance could be calculated. By correcting for resistive pressure, the PV curves takes on
a narrower shape, as shown in Figure 6.17.
Figure 6.17 - PV curve takes on a narrower shape when corrected for resistive pressure
The model was re-fitted with the corrected PV curves, and the resulting TOP and TCP
calculated. Figure 6.18 shows the TOP and TCP plot for Patient 5, trial 1. As shown in the
plot, the overall magnitude of the TOP drops, while the TCP increases. This result is as
expected, as the pressure to overcome resistance has been compensated for. In particular,
the pressure required to recruit alveoli is lower. Similarly, the pressure required to de-
recruit alveoli is higher. It must be noted that in both cases, the overall trend of the TOP
and TCP is still similar, and thus, the results, which are based on trends are unchanged.
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Figure 6.18 - TOP and TCP magnitude change when model is fitted to PV loops with resistive pressure removed
for Patient 5, Trial 1
The inspiratory hold is an additional step when obtaining the PV curves. Although the
magnitude of TOP and TCP changes when corrected for resistive pressure, the trend is
similar, and still produces the same patient-specific PEEP response. Thus, from a practical
perspective, not measuring the flow resistive component still yields similar responses. By
avoiding this measurement, an additional measurement step can be avoided when obtaining
the PV loops.
6.3.6 AIRWAY OBSTRUCTIONS
One of the major limitations of this model is the reliance on the quality of the PV curve. In
particular, the model does not work when patients exhibit severe airway obstructions, was
the case with Patient 4. Patient 4 exhibited very high auto-PEEP of 9 cmH2O and, as a
result, the model was only fitted to PV curves with PEEP above 10 cmH2O.
Figure 6.19 shows the flow and pressure waveforms. The waveforms highlight an
interesting scenario where airway pressure begins to decrease even though the ventilator is
still delivering positive flow. More specifically, the volume of the lung continues to
increase even though there is a pressure drop.
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Figure 6.19 - Raw Flow vs Time and Pressure vs Time for Patient 4
In patients with ARDS and ALI, the lung is very heterogeneous. Some areas of the lung are
compliant and healthy; while other portions of the lung can be extremely stiff [Gattinoni et
al., 2005]. In addition to a heterogeneous distribution of alveoli, an ARDS lung can exhibit
significant airway resistance due to the presence of fluid secretions within the airway. The
drop in pressure can be explained when one considers this heterogeneous nature of the
ARDS lung.
When the ventilator delivers air to the lungs, the pressure in the airway increases. As more
air flows into lungs, the airflow takes the path of least resistance and begins to fill the
highly compliant and healthy alveoli, A, as shown in Figure 6.20. However, the volume of
alveoli A is limited by its compliance and the size cannot expand any further. The
continual flows delivered by the ventilator means that there is still a pressure build up in
the airways. As this pressure increases at point 1, the flow then overcomes the resistance
blocking alveoli B and causes more volume to be opened up.
In this trial, the flow waveform used was a decelerating flow pattern. When the pressure
difference at point 1 overcomes the resistance, flow begins to enter alveoli B. However,
because the flow is decelerating, the newly available volume is not being filled fast enough
by the decelerating airflow. Thus, although lung volume is still increasing, the pressure
drops due to the lack of flow.
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Figure 6.20 - Schematic highlighting the decreasing pressure phenomena
This pressure drop could also be indicative of the severity of the disease state. Patient 4
was the only one who exhibited this drop in pressure. This point implies that this patient
has severe airway restrictions, similar to what a COPD patient experiences. The pressure
drop indicates that there are severe resistances to the airflow and highlight that the lung
may be heterogeneous to the point of being critically ill. Patient 4 later died due to
advanced respiratory failure further highlighting that a drop in pressure could be attributed
to the level of critical illness of ARDS.
Although Patient 4 showed such a pressure drop, the true compliance for this patient is
when the pressure and volume increase (ie – when alveoli A is filling). Hence, the model is
fitted to the regions of PV loops where pressure and volume are increasing. However, the
problem with fitting to this region is that there are not many data points available. Hence,
although the model can still fit to the PV curves, it may not give an accurate representation
of patient recruitability.
6.3.7 H1N1
Patient 9 was admitted to the ICU with the H1N1 virus. Patient 9 was in the ICU for six
days before consent was obtained and the patient was included in the trial. The patient
exhibited similar compliance to other ARDS affected patients, with optimal PEEP selected
as 25, 20 and 29 cmH2O through TOP, TCP and net recruitment respectively. The use of
high PEEP in H1N1 patients has proven to be beneficial [Ramsey et al., 2010, Peris et al.,
2010], and the model-based optimal PEEP correlates well with current observations.
112
However, the metrics calculated using this model may not highlight the true mechanics
observed in H1N1 patients as the patient was under ventilation for several days before the
trial began. During this time, the H1N1 became less acute and more ARDS-like as patient
condition improved in response to therapy.
6.4 SUMMARY
The clinical trials have highlighted the potential for clinical use for the recruitment model.
Although the model was not modified from what was described in Chapter 3, this chapter
introduced the three metrics used to select an optimal patient-specific PEEP. Although the
TOP, TCP and net recruitment provide three difference methods to evaluate the PEEP,
they provide a set of values that can be used in the clinic as a guideline.
This chapter also introduced four additional metrics to help with assessing how the disease
state evolves with time. Tracking the TOP with time yields information on the
recruitability of the patient, and how this changes with time. In addition, tracking the SD
provides information on how compliant the patient is and the state of the disease with time.
Finally, tracking the gradient of TOP or TCP with time, provides information on how the
patient’s response to PEEP has changed.
The model has shown to be limited when patients experience severe airway obstructions.
This may limit the use of the model when trying to ventilate COPD patients and patients
with airway obstructions. In addition, the model is also limited by the assumption of
constant SD across all PEEP. The clinical data shows that there is significant compliance
change at different PEEP. However, even when assuming constant SD, the model still
gives a reasonable estimation of recruitability. In particular, the model shows an increase
in TOP at high PEEP, when compliance decreases, indicating the beginning of sub-optimal
ventilation.
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Chapter 7 - dFRC Estimation Validation
Chapter 4 introduced a model to estimate dynamic FRC (dFRC) as a function of PEEP. In
particular, the model introduced the PEEP Stress parameter (ß) as a means to estimate
dFRC, given that the compliance of the patient is known. The initial validation, as per
chapter 4, was performed with data from 12 patients where each patient had an associated
dFRC measurement. The results suggested that ß was a function of PEEP, and could be
assumed constant across all patients. In essence, ß was assumed to represent a population
stress constant as a function of PEEP, which a surprising result for a diverse patient group.
The purpose of this chapter is to further validate the use of ß as a population constant. The
clinical data obtained, from the trials performed per Chapter 5, had dFRC measurements
for ten additional patients. In addition, the data also included measurements at much higher
PEEP levels than were used compared to the first dataset from Bersten [Bersten, 1998].
7.1 CLINICAL RESULTS
During the recruitment manoeuvre performed on the clinical group, the deflation to ZEEP
ensured that dFRC could be measured. During ZEEP, the volume of the lung is recorded as
zero. Because the pneumatachometer measures changes in volume due to pressure, when
PEEP is applied, dFRC can be measured. Thus, dFRC at a given PEEP is defined as the
change in volume between ZEEP and PEEP. All ten patients were deflated to ZEEP, with
the only exception being Patient 6, Trial 1. Figure 7.1 shows a plot of PEEP vs clinically
measured dFRC for Patient 1, which effectively represents the static PV curve. Static PV
curves for all patients are shown in Appendix D.
The estimation of dFRC for the clinical data was performed via two methods using
Equation 4.9. The initial estimation of dFRC was performed using the median ß from the
initial validation in Table 4.1, Chapter 4. A second estimation was performed by evaluating
the median ß for all twenty patients, comprising of 12 patients from the initial validation of
Chapter 4 (Group 1) and the ten clinical patients from the new trials of Chapter 5 (Group
2). Because Equation 4.9 requires a compliance term to estimate dFRC, compliance was
evaluated in the linear portion of the static PV curve shown in Figure 7.1 by the solid line.
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Figure 7.1 - PEEP vs dFRC for Patient 1. Red thicker solid line indicates the linear portion of the static PV curve
Table 7.1 shows the median ß for Group 1, as reported from Chapter 4. Although Group 1
only contained PEEP values of 5, 7, 10, 12 and 15 cmH2O, linear extrapolation was used to
calculate median ß at higher PEEP values. The median ß from Group 1 was used to
evaluate dFRC on Group 2, with the percentage error between calculated and measured
dFRC shown in Table 7.2. Table 7.3 shows the median ß when Group 1 and 2 are
combined. It thus includes the median ß from the 12 patients from Group 1 ([Bersten,
1998]), as well as from the ten clinical patients in Group 2. Table 7.4 shows the percentage
error between the measured and calculated dFRC of Group 2 using the values from Table
7.3.
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Table 7.1 - Median ß from initial validation using data from Group 1 [Bersten, 1998], as per Chapter 4
PEEP [cmH2O] 5 7 10 12 15
Median ß 4.49 6.51 9.31 11.79 13.8
Table 7.2 -Percentage Error of actual dFRC and predicted dFRC for all patients in Group 2 at all PEEP levels using median ß from Table 7.1
PEEP [cmH2O] 5 10 15 16 20 22 25 27 28 29 30
PA
TI
EN
T
1 263.01 91.04 43.32 26.73 17.11 16.79
2 38.63 11.28 5.10 2.55 4.45
3 36.36 12.25 4.02 2.95 5.74 7.86
4 986.83 329.40 105.22 55.06 41.37 35.35
5 - Trial 1 280.45 341.36 174.46 55.81 13.26
5 - Trial 2 2399.16 343.20 114.33 55.93 34.81 32.54
6 - Trial 2 35.84 21.79 11.65 6.76 13.47
6 - Trial 3 0.20 11.79 11.91 8.40
7 23.23 25.75 11.72 9.05
8 47.91 27.12 15.29 8.74 2.48 1.27
9 95.49 196.54 77.84 43.54 26.57 27.61 22.10
10 96.16 47.98 28.74 15.66 12.49 11.66
Median 72 38 22 9 16 20 13 14 8 30 22
IQR
[36.23,
267.37]
[19.41,
229.76]
[11.70,
84.68] N/A
[7.58,
49.30]
[12.04,
27.22]
[10.76,
19.47]
[12.89,
15.51] N/A
[28.84,
31.31]
[11.69,
28.73]
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Table 7.3 - Median ß from all patients, comprising of data from Group 1 [Bersten, 1998] and data from Group 2
PEEP [cmH2O] 5 7 10 12 15 16 20 22 25 27 28 29 30
Median ß 3.33 6.85 8.38 11.79 12.34 16.58 16.33 19.91 20.84 22.38 25.90 21.12 23.27
Table 7.4 - Percentage Error of actual dFRC and predicted dFRC for all patients in Group 2 at all PEEP levels using median ß from Table 7.3
PEEP [cmH2O] 5 10 15 16 20 22 25 27 28 29 30
PA
TI
EN
T
1 192.71 83.24 37.69 23.62 19.32 11.80
2 11.79 6.74 0.96 0.03 3.17
3 9.96 7.66 0.07 0.42 7.74 10.37
4 776.37 311.86 97.15 51.25 44.05 39.56
5 - Trial 1 206.78 323.33 163.66 51.98 15.40
5 - Trial 2 1915.20 325.09 105.90 52.10 37.36 23.25
6 - Trial 2 9.53 16.82 7.26 4.13 15.62
6 - Trial 3 19.53 15.39 15.37 10.66
7 38.10 28.78 15.19 2.68
8 19.27 21.93 10.76 6.07 4.42 4.42
9 57.63 184.43 70.84 40.01 28.96 18.66 25.90
10 58.18 41.94 23.67 12.82 14.62 6.89
Median 48 35 20 3 13 20 16 9 10 21 26
IQR
[17.40,
95.33]
[16.46,
216.29]
[9.88,
77.42] N/A
[5.10,
45.63]
[11.72,
28.81]
[12.90,
18.96]
[8.12,
8,73] N/A
[19.81,
22.10]
[15.16,
29.31]
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Figure 7.2 - Plot of Measured vs Predicted dFRC for all datasets. Red crosses indicate data points from Group 1
and blue dots indicate data points from Group 2. Dashed line is regression line for Group 1, dotted line for Group
2 and solid line for combined data set.
Figure 7.2 shows the predicted dFRC versus the measured dFRC for both Group 1 and 2.
The plot shows strong linearity across all PEEP for Group 2 with an R2 value of 0.909 (R =
0.9534). This linear relationship agrees with the results from Chapter 4, where Group 1
showed an R2 value of 0.947. In addition, by combining the both Group 1 and 2, R2
remained high with a value of 0.912.
Figure 7.3 - Bland Altman plot of predicted dFRC and measured dFRC for clinical patients. Solid red line is the
mean difference and dashed lines represent the 90% confidence interval
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Figure 7.3 shows the Bland Altman plot with a 90% confidence. Compared with the results
of Figure 4.8, Chapter 4, the 90% interval for the clinical data suggests much higher
differences between predicted and measured dFRC. In addition, the mean difference is also
much higher. However, this large difference can be attributed to some limitations of the
model.
One of the implicit assumptions of the model is that the specific lung elastance (ELspec) and
α are constant, where α represents the static lung elastance and represents the ratio of the
lung elastance (EL) to the chest wall elastance (ECW). The assumption of α being constant is
only valid during the linear portion of the static PV curve. Therefore, as discussed in
Chapter 4, the dFRC estimation model may not accurately predict dFRC when there are
significant changes in compliance. Figure 7.4 shows the static PV curves for Patient 4 and
5, which include these significant changes occurring at very low and very high PEEP.
Figure 7.4 - PEEP vs dFRC for (A) Patient 4, (B) Patient 5, Trial 1, (C) Patient 5, Trial 2 and (D) Patient 9. Plots
show very low compliance at low PEEP highlighting a limitation to the dFRC estimation model across wide PEEP
ranges. However, this variation in compliance occurs at PEEP outside clinically reasonable range
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As shown in the plots, there is a significant change in compliance across the range of
PEEP. In particular, compared to other patients, Patients 4, 5 and 9 showed extremely low
compliance at low PEEP. Patients 4, 5 and 9 showed extremely high errors when
comparing predicted and measured dFRC, shown in Table 7.4. This result implies that the
model may not be valid in regions where large compliance changes occur. When Patients
4, 5 and 9 are removed from the dataset, the Bland-Altman plot is modified and is shown
in Figure 7.5.
Figure 7.5 - Bland Altman plot of predicted dFRC and measured dFRC for clinical patients without Patients 4, 5
and 9. Solid red line is the mean difference and dashed lines represent the 90% confidence interval
When Patients 4, 5 and 9 are excluded from the analysis, the mean and 90% confidence
interval changes significantly. Figure 7.5 indicates that maximum deviation, within 90%
confidence, from measured dFRC is between 100 and 200 ml. These values correspond
well with the values obtained during the preliminary analysis of Chapter 4, where the 90%
interval was between 120 and 200 ml, shown on Figure 4.8.
Table 7.5 shows the percentage and absolute errors between predicted and measured dFRC
for all datasets for PEEP values of 5, 10 and 15 cmH2O. This includes the datasets from the
initial validation of Chapter 4 (Group 1), along with the clinical data obtained during the
new trials presented (Group 2). Although the inter quartile range (IQR) for a PEEP of 5
cmH2O reaches as high as 45%, the low median percentage error may suggest that β is, in
fact, a useful population constant.
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Table 7.5 - Percentage error between predicted and measured dFRC across all data sets using median ß. Absolute
error in brackets
PEEP [cmH2O] 5 10 15
GR
OU
P 1
-B
ER
ST
EN
 DA
TA
SE
T 1 3.93 (17.41)2 26.44 (94.81) 16.02 (104.38)
3 9.5 (24.06) 2.13 (9.80)
4 116.52 (177.30) 37.14 (184.92)
5 0.02 (0.00) 2 (31.62)
6 42.65 (170.55)
7 8.1 (81.36) 9.02 (134.62)
8 5.11 (22.62) 4.53 (41.32)
9 16.69 (83.17) 5.07 (58.03)
10 84.95 (98.80) 35.27 (116.25) 11.04 (65.68)
11 15.41 (84.71) 11.19 (121.53)
12 51.55 (124.97) 16.4 (107.23)
GR
OU
P 2
-C
LI
NI
CA
L
DA
TA
SE
T
1 192.71 (117.38) 83.24 (195.77) 37.69 (178.16)
2 11.79 (23.18) 6.74 (33.55) 0.96 (7.66)
3 9.96 (24.47) 7.66 (48.40) 0.07 (0.77)
6 - Trial 2 9.53 (19.19) 18.82 (76.73) 7.26 (54.46)
6 - Trial 3 19.53 (44.65) 15.39 (80.95) 15.37 (122.06)
7 38.10 (52.28) 28.78 (83.00) 15.19 (55.57)
8 19.27 (25.78) 21.93 (69.38) 10.76 (56.59)
10 58.18 (51.99) 41.94 (100.96) 23.67 (98.79)
Median 19 (52) 16 (81) 11 (61)
IQR
[9.64 (23.62) ,
47.10 (96.81)]
[6.97 (50.81),
27.07 (106.51)]
[7.70 (54.74),
15.33 (116.24)]
7.2 DISCUSSION & LIMITATIONS
7.2.1 COMPLIANCE CHANGES
One of the major limitations that the clinical trials have highlighted is the effect of large
compliance changes. As discussed in Section 7.1 and Chapter 4, the model assumes that
the static lung elastance, α, remains constant across the range of PEEP. This assumption is
only valid in effectively the linear portion of the static PV curve. At low and high PEEP
levels, the lung and chest elastance can vary significantly, and this variation can contribute
to significant compliance changes.
Patients 4 and 5 exhibited very large compliance changes as PEEP varied. More
specifically, an increase from ZEEP to 5 cmH2O PEEP yielded almost no volume change,
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indicating very low compliance. However, a further increase in PEEP resulted in larger
volume changes. For both patients, this variable compliance change implies that elastance
is not constant across PEEP. Hence, the large errors between predicted and measured
dFRC for some estimates based on these patients can be attributed to this variable
compliance, highlighting a significant limitation with the model. In contrast, patients who
exhibited largely linear compliance across all measured PEEP seemed to show small errors
between measured and predicted dFRC.
It must be noted that the regions where there is significant compliance change occur
outside the clinically useful range of PEEP. More specifically, compliance is very low at
extremely low and high PEEP, which is generally not used when attempting to recruit
patients. Thus, although some patients did not exhibit constant compliance, compliance
remained linear in the clinically applicable segment of the static PV curve. In addition,
although there may be large errors between measured and estimated dFRC, the relative
changes of dFRC in the linear portion still show similar trends. Thus, although these errors
are large, general trends remain the same.
This sudden compliance change is also attributed to the large percentage error for Patient 2
when PEEP was 5 cmH2O, as shown on Table 7.2 and Table 7.4. The extremely low
compliance meant that the true measured volume was close to zero. Thus, when calculating
the percentage error, the denominator approaches zero yielding an extremely large
percentage error, for an absolute change in volume that is not necessarily clinically
significant.
7.2.2 COMBINED DATASET
To ensure that ß is truly a population constant, the size of the dataset was increased. Data
from Group 1 (12 datasets – 39 data points) was added to Group 2 (ten datasets – 54 data
points) and the median ß was calculated. The median ß calculated across the combined
dataset, shown in Table 7.3, still showed a linear trend as seen in Figure 7.6. In addition,
extending the data set also indicates that ß remains linear even at high PEEP.
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Figure 7.6 - Median β across combined dataset compared with the median β of Group 1
The difference between the median ß for the initial validation on Group 1 and the
combined dataset (Group 1 & Group 2) shows a small difference, as shown in Figure 7.6.
However, this difference is assumed to occur due to the limited size of the dataset of Group
1. Hence, there is a strong indication of a global population constant. As the size of the
dataset increases, ß should also change. More specifically, as the number of data points
increase, the assumption of ß representing a population constant will become more valid.
7.2.3 DFRC & RECRUITMENT MODELS
To accurately apply the recruitment model, the patient requires a deflation to ZEEP so that
dFRC can be measured. In reality, the deflation to ZEEP can prove to be harmful to
patients who are severely ARDS affected, as it may cause sudden de-recruitment. During
the clinical trials, all patients were deflated to ZEEP with the exception of the first trial for
Patient 6. For this trial, the lowest PEEP was set at 10 cmH2O, with PEEP being
incremented to 15, 20 and 25 cmH2O, shown in Figure 7.7.
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Figure 7.7 - PV curves for Patient 6, Trial 1. No measurements of dFRC were taken as patient was not deflated to
ZEEP
Although the recruitment model can be fitted to these PV loops, the model works best
when dFRC measurements are known. If the deflation to ZEEP is deemed unsafe for the
patient, then estimating dFRC could be used as an alternative to actual measurements.
Figure 7.8 shows dFRC being estimated and the corresponding PV curves being shifted for
Patient 6, Trial 1. The re-calculated PV curves can be fitted to the recruitment models to
evaluate new threshold opening (TOP) and threshold closing pressure (TCP) parameters,
which are shown in Figure 7.9. This process is only valid when β is a population constant,
which is a function of PEEP.
Figure 7.8 - PV curves for Patient 6, Trial 1. dFRC is estimated using the linear compliance for Patient 6, Trial 1.
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Figure 7.9 - Comparison of TOP and TCP when dFRC is estimated for Patient 6, Trial 1
Figure 7.9 shows the TOP and TCP when dFRC is estimated in this way for that patient.
Although there is a decrease in absolute values of TOP and TCP, the trend of both seems to
remain relatively constant. In addition, when dFRC is not measured, TCP predicts
optimum PEEP at 20 cmH2O. In contrast, when dFRC is estimated, TCP selected PEEP is
15 cmH2O.
7.3 SUMMARY
The results discussed in this chapter further highlight the potential for β to be used as a
global population constant (as a function of PEEP) for estimating dFRC. The preliminary
validation performed in Chapter 4 provided evidence on the variation in β when PEEP was
varied between 5 and 15 cmH2O, and showed a linear relationship between PEEP and β.
By increasing the dataset, the linear relationship was also shown to hold at higher PEEP
values up to 30 cmH2O.
The increased dataset has also highlighted a limitation to the dFRC estimation model. For a
given patient, when compliance changes significantly with PEEP, the model fails to
accurately estimate true dFRC. Thus, the model is primarily valid when compliance is
constant across all PEEP for a given patient. For patients where compliance did vary
significantly at low and high PEEP, this limitation may not necessarily pose a major
problem as these PEEP values are outside the clinically useful range. In addition, although
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predicted and measured dFRC may show high percentage errors, within the linear region,
the trends are still the same.
The dFRC model can be used in conjunction with the recruitment model when dFRC
measurements are not available. When the deflation to ZEEP is deemed to hazardous to the
patient, estimating dFRC provides a means to improve the results of the recruitment model
and provide a more accurate set of PEEP results and potentially improved decision support.
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Chapter 8 - Cardiac Output Estimation
Hitherto, the models presented in this thesis use lumped parameter models as a means to
optimise ventilation therapy. More specifically, the models presented are classified as
recruitment models, where recruitment is the primary objective for mechanical ventilation.
The models introduced in Chapters 3 and 4 examine the effect of PEEP on lung
recruitment and lung volume. However, as discussed in Chapter 2, gas exchange models
are an alternative lumped parameter model which can be used to help select PEEP based
on oxygenation.
This chapter introduces a third mathematical model that combines the effect of recruitment
and gas exchange. The combination of these two principles leads to additional information
being available to the clinician. More specifically, by combining gas exchange and
recruitment models, it is possible to examine the effects of PEEP on thoracic cavity
pressures, and thus on the cardiovascular system and circulation, which are also very
important clinical variables in the ICU.
8.1 INTRODUCTION
Patients diagnosed with ARDS often experience pulmonary shunt or gas exchange
abnormalities due to lack of recruited alveoli. Shunt also occurs when there is an increased
thoracic pressure that restricts blood flow, thus reducing gas exchange in the lung. The
primary objective of MV is to improve the condition of the patient by increasing alveoli
recruitment and thus also improving or optimising gas exchange.
As discussed in previous chapters, the application of sub-optimal PEEP can cause
repetitive opening and closing of alveoli. In addition, the application of PEEP can also
decrease cardiac output (CO) [Cournand et al., 1947, King et al., 1973]. The decrease in
CO from high PEEP is due to the reduction in stroke volume of the heart. As PEEP
increases, the intrathoracic pressure increases, which increases cardiac afterload and thus
restricts the venous flow into the thorax resulting in a lowered CO. Any decrease in CO
lowers oxygen consumption, as determined by Fick’s law, and describes the inability of the
heart to pump enough blood to meet the metabolic requirements of the body. Reduced CO
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can also have an impact on circulation management and therapeutics used. Hence, the
application of PEEP to improve recruitment may have unintended negative impacts on the
cardiovascular system.
Current methods to measure CO, such as thermodilution and pulse pressure methods, are
clinically invasive, requiring the use of catheters [Forrester et al., 1972, Leibowitz and
Oropello, 2007]. These catheters carry some added risks of infection [Lorente et al., 2004],
and are thus used only in an increasingly limited subset of critically ill patients receiving
MV. More specifically, for critically ill patients, the benefits from CO measurements may
not offset the dangers associated with invasive tools. In addition, these methods take time
and effort, are not performed regularly and cannot be monitored in clinical real time.
Hence, significant motivation exists to develop non-invasive, real-time tools to track CO,
independent of the need to monitor and manage MV
MV patients treated for ARDS may not have CO measurements readily available.
However, the changes in CO due to changes in applied PEEP are important as it may also
help indicate an optimal level of PEEP. In particular, if a change in PEEP causes a large
drop in CO, it may more than offset its benefit on recruitment. Alternatively, if the drop in
CO is minimal, then the benefits of PEEP induced recruitment may offset the detrimental
effects of an insignificant drop in CO. Hence, the ability to model changes in CO due to
PEEP may also prove beneficial for optimizing the setting of PEEP, which can itself be
controversial [Levy, 2002].
This chapter aims to combine the effects of two individual models to estimate changes in
CO due to PEEP. The recruitment model, developed in Chapter 3, is combined with the
oxygen diffusion model of Andreassen et al [Andreassen et al., 1996]. The diffusion model
estimates pulmonary shunt and oxygen diffusion resistance by measuring variations in
fraction of inspired oxygen (FiO2) and arterial oxygen saturation (SpO2). The diffusion
model takes inputs of cardiac output, FiO2 and other ventilation data, and estimates
pulmonary shunt and diffusion resistance as outputs.
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8.2 DIFFUSION MODEL
A detailed explanation of the recruitment model is presented in Chapter 3. The following
section introduces the diffusion resistance model developed by Andreassen et al
[Andreassen et al., 1996] and the mathematics behind it.
Current methods of describing gas exchange abnormalities, such as arterial oxygen
saturation, alveolar arterial oxygen pressure gradient or venous admixture [Wandrup, 1992,
Wandrup, 1995] are insufficient. In particular, these parameters lump the effects of oxygen
diffusion and true pulmonary shunt into a single parameter. This single parameter is
typically inadequate as it is difficult to interpret which mechanism causes the gas exchange
abnormality.
Pulmonary shunt occurs when the alveoli in the lung are perfused with blood, as desired,
but not adequately ventilated. In patients with ARDS, alveoli collapse occurs as a result of
fluid build up, which results in the ARDS lung not being ventilated. Thus, as ARDS
severity increases, pulmonary shunt also increases. Even if alveoli are recruited or do not
collapse, if gas exchange does not occur it is considered to be part of the shunt volume.
Similar abnormality or failure of gas exchange can occur when CO and minute ventilation
are mismatched [Karbing et al., 2007].
In patients who are mechanically ventilated, the application of PEEP can increase alveolar
recruitment. As more alveoli are recruited, there is an increase in alveolar ventilation and
as a result, pulmonary shunt decreases. Using standard data, such as SpO2 and arterial
oxygen pressure (PaO2), curves of SpO2 can be generated as a function FiO2. These curves
can then be used to estimate the pulmonary shunt and diffusion resistance [King et al.,
1974, Andreassen et al., 1999].
The model developed by Andreassen et al [Andreassen et al., 1996] uses a compartmental
oxygen status model as shown in Figure 8.1. The net oxygen consumption by the alveoli
(VO2) is calculated by using known values of FiO2, fraction of expired oxygen (FeO2),
respiratory frequency (f) and tidal volume (Vt), and where dead space (Vd) is the amount of
air in the lungs that does not reach the alveoli, and thus is does not contribute to any gas
exchange.
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Figure 8.1 - Diffusion Model reproduced from Rees & Andreassen et al [Rees et al., 2002, Andreassen et al., 1996]
= ( − )( − ) (8.1)
Once the inspired gas reaches the alveolar compartments, oxygen begins the diffusion
process across the alveolar membrane to the capillaries. The partial pressure of oxygen in
the capillary (PcO2) is a function of the partial pressure in the alveoli minus the drop in
partial pressure due to diffusion resistance (R), where Pb is the atmospheric pressure.
Ventilator Settings:
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Alveolar Ventilation:
Alveolar gas exchange:
Shunt Equation:
3)
2)
1) VO2 = f(VT - VD)(FIO2 - FEO2)
PcO2 = FEO2 (PB - PH2O) – Rdiff x VO2
CaO2 = CcO2 – fs(CcO2 – CvO2)
Blood Parameters:
4)
5)
6)
O2Cap = Hb – HbMet - HbCO
SO2 = ODC(PO2,pH,DPG,T,PcO2)
CaO2 = (PaO2 x αO2) + (SaO2 x O2Cap)
FEO2, VO2, VD
130
= ( × ) − ( × ) (8.2)
After the oxygen has diffused through the alveolar wall, oxygen from the capillaries with
high concentration (CcO2) mixes with venous blood, which has low concentration (CvO2).
Depending on the level of pulmonary shunt (fs), the arterial oxygen concentration can be
evaluated (CaO2).
= − ( − ) (8.3)
The oxygen carrying capacity of haemoglobin (O2Cap) can be defined as a function of blood
parameters such as haemoglobin (cHb), methaemoglobin (cMetHb) and
carboxyhaemoglobin (cCOHb).
= − − (8.4)
The oxygen saturation curve (ScO2) can then be calculated based on the oxygen
dissociation curve (ODC).
= ( × ( ) × ( ) × ( ) × ) (8.5)
Finally, CcO2 can then be defined:
= × + ( × ) (8.6)
The net difference between the arterial concentration and the drop in oxygen consumption
by the tissues then gives CvO2.
= − (8.7)
Table 8.1 shows the different parameters that are measured, estimated and calculated in
this diffusion resistance model. First, the model requires a gas exchange analyser to
measure the FiO2 and FeO2 values along with a pulse oximeter to measure the SpO2.
Respiratory frequency and tidal volume are measured with a ventilator, while the
haemoglobin concentrations are measured by taking a blood sample.
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In the model developed by Andreassen et al [Andreassen et al., 1996], CO was estimated.
However, it can also be measured using thermodilution techniques, although it is not
clinically feasible in regular, repetitive fashion. Using all these measurements, and an
estimate of dead space, it is then possible to calculate shunt and diffusion resistance by
solving Equations (8.1) - (8.7).
Table 8.1 - Measured, estimate and calculated parameters in the diffusion resistance model
Directly Measured Parameters Estimated Parameters Calculated Parameters
Respiratory Frequency (f) Dead Space (Vd) Shunt (fs)
Inspired Oxygen Content (FiO2) Diffusion Resistance (R)
Expired Oxygen Content (FeO2)
Tidal Volume (Vt)
Atmospheric Pressure (PB)
Pulse or Arterial Oxygen Saturation (SpO2)
Cardiac Output (CO)
Haemoglobin (cHb)
Methaemoglobin (cMetHb)
Carboxyhaemoglobin (cCOHb)
8.3 COMBINED MODEL DEVELOPMENT
8.3.1 DIFFUSION MODEL PARAMETERS
The diffusion model by Andreassen et al [Andreassen et al., 1996] was used to simulate
responses to variations in the model parameters. In particular, the study examined how
shunt and oxygen diffusion resistance varied under different FiO2. The simulations used the
input parameters shown in Table 8.2.
Figure 8.2 shows the SpO2 varying as a function of FiO2 depending on the level of shunt
with a diffusion resistance of zero. When no shunt exists, the SpO2 curve is identical to the
oxygen dissociation curve. However, as shunt increases, then for a given FiO2, the level of
oxygen saturation decreases.
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Table 8.2 - Diffusion model parameters from Andreassen et al [Andreassen et al., 1996]
Respiratory frequency f 14 min-1
Tidal volume Vt 0.5 L
Dead space volume Vd 0.15 L
Cardiac output CO 5 L/min
Oxygen consumption VO2 11.5 mmol/min
Haemoglobin cHb 9 mmol/L
Methaemoglobin cMetHb 0 mmol/L
Carboxyhaemoglobin cCOHb 0 mmol/L
Oxygen solubility coefficient AO2 0.0102 mmol/(L kPa)
Arterial pH status pHa 7.4
Capillary pH status pHc 7.4
Arterial base excess BEa 0 mmol/L
Capillary base excess BEc 1 mmol/L
Arterial blood temperature Ta 37 C
Capillary blood temperature Tc 37 C
Barometric pressure PB 101.3 kPa
Figure 8.2 - Oxygen saturation curves changing as a function of FiO2 and various levels of shunt
Figure 8.3 shows the effect of varying the diffusion resistance instead of shunt. Similar to
shunt, an increase in oxygen resistance also causes incomplete oxygenation. It is assumed
that shunt is zero for all the curves in this figure.
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Figure 8.3 - Oxygen saturation curves at various levels of diffusion resistance and shunt = 0
Theoretically, if two different FiO2 measurements were taken and the corresponding SpO2
values measured and plotted, it is possible to evaluate the shunt and diffusion resistance by
plotting the best fit SpO2 curve. However, in Figure 8.2 and Figure 8.3, the cardiac output
is held at a constant value of 5 L/min. Unless measured, the value of CO is assumed to be
5.0 L/min in this analysis [Rees et al., 2002, Andreassen et al., 1996]. However, in patients
with ARDS where PEEP is titrated based on clinical choice, the assumption of using a
constant CO is not valid. In addition, as a result of MV therapy and other aspects of their
condition, CO is much more variable, with a typical range of 2-8 L/min [Hoeper et al.,
1999, Luecke and Pelosi, 2005, Vidal Melo, 1998].
Figure 8.4 - Oxygen saturation curve varying as a function of cardiac output
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While such changes in CO were not modelled by Andreassen et al, they are easily
incorporated into this model. Figure 8.4 shows the effect of varying cardiac output given a
shunt value of 10% and a diffusion resistance of 0 kPa/L/min. As shown in Figure 8.4, an
increase in cardiac output causes a more complete oxygenation of the blood. Overall, it
adds a third unknown variable, CO, to the shunt and diffusion resistance noted previously.
In Figure 8.2 – Figure 8.4, the lines of constant shunt, diffusion resistance and cardiac
output are analogous to principles in thermodynamics, such as isotherms (lines of constant
temperature), isobars (lines of constant pressure) and isochors (lines of constant volume).
In particular, if two states are known, then it is possible to determine the third state of a gas
as all variables are interrelated. Similarly, the lines of constant shunt, diffusion resistance
and cardiac output are all interrelated.
8.3.2 ESTIMATING SHUNT CHANGES DUE TO PEEP – LINKING
THE TWO MODELS
Because the current diffusion models use CO as an input, it is possible to estimate the
shunt and diffusion resistance if a few measurements such SpO2 and FiO2 are taken.
However, as PEEP increases, the level of alveoli recruitment also increases at the cost of
decreased CO. Thus, unless the patient has a continuous measurement of CO, then an
alternative method must be developed to generate the SpO2 curves and predict shunt.
The principle hypothesis behind the linked model is that any increase in PEEP directly
causes a decrease in shunt. In ARDS affected lungs, collapsed alveoli do not contribute to
the ventilation process. Although the capillaries around collapsed alveoli may be properly
perfused they contribute to pulmonary shunt because they do not contribute to gas
exchange and ventilation. As PEEP is applied, more alveoli are recruited, which means
there is more aerated surface area for gas exchange, which causes a decrease in shunt
[Acosta et al., 2007, Michelet et al., 2005]. Thus, if it is possible to estimate changes in
shunt, theoretically, it should be possible to estimate CO, as all other parameters are
assumed known.
If shunt decreases with increased recruitment, then it is possible to estimate shunt changes
using the recruitment model from Chapter 3. Because the recruitment model has the ability
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to estimate changes in recruitment, it is hypothesised here that the increase in recruited
volume due to PEEP is directly related to the decrease in shunt. More specifically, changes
in recruited volume are assumed equal to the corresponding reductions in shunt.
This novel method of linking up recruitment and gas exchange models provides a new
insight into lung mechanics. In particular, using recruitment models to estimate shunt, and
combining with gas exchange models provides a new method to track CO changes.
Figure 8.5 - Model fitting using measured PV loops - Dataset 1 from Bersten [Bersten, 1998]. dFRC is measured
and then all PV loops fitted to maximum theoretical TLC
Figure 8.5 shows the PV curves for Dataset 1, from Bersten [Bersten, 1998], fitted to the
recruitment model. If an initial shunt value is known or estimated, then to estimate a
percentage change in shunt, the changes in dFRC can be examined with reference to the
maximum theoretical TLC. Thus, using the stated hypothesis, the percentage change in
shunt (∆fs) for a given change in PEEP can be evaluated using Equation (8.8).
∆ = −− (8.8)
Although the recruitment model cannot predict absolute shunt fractions, it does have the
ability to predict changes in shunt volume, which is the clinically critical aspect. Thus, for
the first PEEP setting, a shunt fraction is measured using the diffusion model using a
known or estimated CO. Once an initial shunt measurement is obtained, changes in PEEP
induced recruitment can be used to estimate the shunt at a new level of PEEP by
136
calculating the percentage change in shunt from that initial value, using the stated
hypothesis.
Given that result, subsequent measurements of FiO2 and SpO2 at the new PEEP, and fitting
an SpO2 curve constrained by the new level of shunt allows the level of CO to be estimated
working backwards to find the CO value that yields this curve. This overall process of
evaluating the CO is summarised in Figure 8.6.
Figure 8.6 - Flow chart determining the process of estimating cardiac output at a higher PEEP level
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In particular, Figure 8.6 shows the need for an initial measurement of CO. Once an initial
measurement or a reasonable estimate is obtained, it is then possible to track changes in
CO with changes to PEEP. As noted, such an initial or daily measurement is readily
available via thermodilution if necessary catheters are not in place. Thus, over a given time
period, the changes in CO are calibrated to the initial or regular CO measurements
obtained through thermodilution, or if available, invasive catheters. Finally, large predicted
changes in CO with this method could generate a new, confirmatory thermodilution
measurement.
8.4 MODEL VALIDATION & ANALYSIS
8.4.1 PROOF OF CONCEPT
To test the concept of tracking changes in CO, a proof of concept (POC) model has been
evaluated based on a mixture of simulated parameters and clinical data. The data used in
the study uses one set of data containing PV loops obtained from Bersten [Bersten, 1998]
and arterial blood gas measurements from Andreassen et al [Andreassen et al., 1996].
Although these measurements do not correspond to the same data set, the aim is to evaluate
the utility of the POC model presented and the robustness of its underlying assumptions
prior to further clinical validation.
Three PV loops were obtained from Bersten [Bersten, 1998] with the associated deflation
to dFRC for dataset 1. The TOP and TCP were modelled using the recruitment model
described in Chapter 3, with the PV loops shown in Figure 8.5 and in Table 8.3. Using
Equation (8.8), it is then possible to evaluate the percentage change in shunt as PEEP
increases.
Table 8.3 - Measured PV data for Patient 1 from Bersten [Bersten, 1998] fitted with the recruitment model
PEEP [cmH2O] dFRC [L] TLC [L] ∆fs
5 0.441
1.98
7 0.674 -0.15
12 1.1125 -0.34
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Because there is no initial measurement of shunt at the first PEEP level, it is not possible to
estimate the shunt at higher levels of PEEP. The PV data from Bersten did not include any
blood gas measurements. To simulate the POC model, the blood gas data from Andreassen
[Andreassen et al., 1996] was used and is shown in Table 8.4. To fit the SpO2 curve, two
measurements of FiO2 were required. These initial FiO2 and SpO2 measurements at t1 and t2
were assumed to occur at the initial PEEP setting of 5 cmH2O. It was also assumed that the
CO at the first PEEP was 5 L/min. These overall values and assumptions, while not from
the same dataset, are clinically realistic. Measuring SpO2 at two different FiO2 values for a
given PEEP is also readily achieved.
Table 8.4 - Measured values of varying FiO2 and SpO2 from Andreassen et al. These values are assumed to occurat the initial PEEP level
Time t1 Time t2
FiO2 [%] 25 35
SpO2 [%] 90.9 95.1
Fitting the diffusion model to the data in Table 8.4 yields a shunt of 17% and a diffusion
resistance of 36 kPa/L/min. For the purpose of this POC model, it is assumed that this is
the true shunt at the initial PEEP. The raw data points and the best fit SpO2 curve are
shown in Figure 8.7.
Figure 8.7 - Best fit oxygen saturation curve assumed to occur at the first PEEP. Shunt = 17% and diffusion
resistance = 36 kPa/L/min with CO = 5 L/min
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After evaluating the shunt at the initial PEEP level, it is then possible to evaluate the shunt
at higher PEEP settings using the percentage change in shunt from the results in Table 8.3.
For the higher PEEP values, the measured SpO2 is fit to an oxygen saturation curve by
constraining the predicted shunt and thus, evaluating the new CO, which is shown in
Figure 8.8.
Table 8.5 - Modified shunt and cardiac output as a function of PEEP. * indicates measured or known input values.
+ indicates estimated values
PEEP [cmH2O] FiO2 [%] SpO2 [%] Shunt [%] R [kPa/L/min] CO [L/min]
5 [25 35]* [0.909 0.951]* 17* 36 5*
7 [25 35]* [0.91 0.96]* 14.5+ 36 4.7+
12 [25 35]* [0.91 0.97]* 9.5+ 36 4.3+
The shunt, CO and diffusion resistance for this POC model example are summarised in
Table 8.5 along with the values of FiO2 and SpO2.
Figure 8.8 - Improved oxygenation as shown by the increase in oxygen saturation with the application of PEEP
8.4.2 OPTIMISATION OF PEEP & PATIENT CARE
In the POC model, the cardiac output was shown to drop from 5 to 4.3 L/min as PEEP
increased from 5 to 12 cmH2O. This drop agrees with current data showing that CO drops
with increased PEEP [Cournand et al., 1947, King et al., 1973]. The POC model showed
that the application of PEEP improved oxygenation. However, Figure 8.4 shows that any
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decrease in CO should reduce oxygenation with all else equal and shunt at a constant
value.
The results of the POC model thus confirm the trade off between the amounts of decreased
shunt versus the decrease in cardiac output. To test this theory, the CO was set to drop
from 5 to 1.5 L/min (corresponding to a drop of 0.5 L/min/cmH2O) as PEEP increased, for
the same shunt values shown in Table 8.5. The resulting oxygen saturation curves are
shown in Figure 8.9 and it is evident that if the drop in cardiac output is too high, then the
application of PEEP and resulting increased volume for gas exchange does not improve
oxygenation, as seen by the minimal gap between curves in Figure 8.8 vs Figure 8.9. In
addition, SpO2 curves in Figure 8.9 actually drop as PEEP is increased and the drop in CO
is too high. Such a situation clinically would thus require increased FiO2, with its own risks
[Register et al., 1987], to improve SpO2.
Figure 8.9 - Decrease/ negligible effect on oxygenation due to PEEP indicating that there is a tradeoffs between
decreased shunt and decreased CO when PEEP is applied
Figure 8.9 shows that if the drop in CO is too high, it can have a detrimental effect on
oxygenation even with decreased shunt. The decrease in CO offsets the positive effects of
PEEP application and recruitment and causes decreased oxygenation, which is
contradictory to the overall intention of applying PEEP. More importantly, the ability to
capture this effect in this analysis suggests that this model can be used to evaluate
oxygenation based on changes in cardiac output due to PEEP.
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Figure 8.10 shows the effect on oxygenation depending on the magnitude of the cardiac
output drop as PEEP is applied. The dashed curve represents the oxygenation change when
PEEP is 7 cmH2O and the shunt is estimated at 14%, while the dotted curve is for PEEP of
12 cmH2O and shunt at 9%. The curves give an indication of the maximum allowable drop
in CO for a given shunt that will not offset the benefit of increasing PEEP. Three distinct
points are shown; labelled A, B and C in this figure.
Figure 8.10 - Effect of drop in cardiac output on oxygenation
Point A represents the maximum allowable drop in cardiac output (approximately 0.43
L/min/cmH2O) at which application of PEEP 7 cmH2O will still yield beneficial
oxygenation. However, at point A, if the PEEP is then raised to 12 cmH2O, the
oxygenation is worse. Thus, point B is the maximum allowable CO drop if a PEEP of 12
cmH2O is to be applied (approximately 0.33 L/min/cmH2O). Between points B and C, an
applied PEEP of 12 cmH2O will provide better oxygenation than the initial PEEP, but still
not as good as provided by PEEP of 7 cmH2O. Only if the drop in CO is less than 0.3
L/min/cmH2O (Point C), then a PEEP of 12 cmH2O is more beneficial than 7 cmH2O.
Thus, based on the drop in CO as a function of PEEP, this model-based approach provides
a means of optimising the PEEP setting in ventilation with respect to CO and oxygenation.
In the case shown in Figure 8.10, the ideal PEEP levels are determined by the drop in CO
and summarised in Table 8.6. Hence, during an initial recruitment manoeuvre, if the drop
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in cardiac output can be estimated, then based on the rate of change of CO due to PEEP, an
optimal PEEP can be selected. More importantly, the entire process requires only an initial
estimate of CO or a minimum single invasive thermodilution measurement. From that
point, it can noninvasively track changes in CO as required, although the need to
recalibrate is not yet known and will require clinical verification.
Table 8.6 - Optimum level of PEEP depending on rate of cardiac output change
PEEP [cmH2O] Drop in cardiac output [L/min/cmH2O]
5 > 0.43
7 > 0.29 and < 0.43
12 < 0.29
8.4.3 ROBUSTNESS TESTING
In clinical practice, the need to initially measure the CO may not be viable due to the
severity of the patient’s condition, and an estimate for the CO at the base PEEP may be
required. To test the validity of the initial CO estimate, a robustness test was conducted.
Cardiac output differs between patients and is typically reported to range from 2-8 L/min
[Hoeper et al., 1999, Luecke and Pelosi, 2005, Vidal Melo, 1998]. For the initial PEEP
level of 5 cmH2O in Figure 8.8, the CO was varied between 2 and 8 L/min in steps of 0.5
L/min. Using the linear least squares method, a line of best fit was then plotted to fit
through the ‘measured’ data points at a PEEP of 7 and 12 cmH2O. The results of the
robustness test are shown in Table 8.7, where the initial estimate of CO at PEEP = 5
cmH2O is shown in the grey cells. The drop in CO and percentage drops in CO are shown
for the different initial estimates on Figure 8.11 and Figure 8.12.
Figure 8.11 shows the effect of different initial estimates of CO on the absolute drop in CO
at higher PEEP values. The graph illustrates the absolute drop on CO to be highly
dependent on the initial estimate of CO. As the initial estimate of CO increases towards 8
L/min, the drop in CO also increases, and shows significant differences from the median
CO drop.
However, from a percentage drop perspective, Figure 8.12 indicates that the percentage
drop does not vary too much. The percentage drop of CO with the application of PEEP is
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approximately constant and does not drop by more than 15%. It is also clear that all points
are within close proximity to the median. Thus, given an arbitrary initial estimate between
2 and 8 L/min, it is possible to track percentage changes as a function of PEEP application,
which is the clinically more important aspect when monitoring patients.
Table 8.7 - Initial estimate of CO at PEEP = 5 cmH2O (grey cells). Drop in CO and percentage drop in CO shownfor the different initial estimates
PEEP [cmH2O] Drop in CO [L/Min] Percentage Drop in CO [%]
5 7 12 PEEP 5 & 7 PEEP 7 & 12 PEEP 5 & 7 PEEP 7 & 12
Ca
rdi
ac 
Ou
tpu
t [L
/m
in]
2 1.8 1.7 0.2 0.1 10 6
2.5 2.4 2.2 0.1 0.2 4 8
3 2.7 2.5 0.3 0.2 10 7
3.5 3.3 3 0.2 0.3 6 9
4 3.6 3.3 0.4 0.3 10 8
4.5 4.2 3.8 0.3 0.4 7 10
5 4.7 4.3 0.3 0.4 6 9
5.5 5.1 4.6 0.4 0.5 7 10
6 5.3 4.9 0.7 0.4 12 8
6.5 6.1 5.5 0.4 0.6 6 10
7 6.3 5.8 0.7 0.5 10 8
7.5 6.8 6.1 0.7 0.7 9 10
8 7.2 6.3 0.8 0.9 10 13
Median 0.4 0.4 9.3 8.5
Max 0.8 0.9 11.7 12.5
Minimum 0.1 0.1 4.0 5.6
Figure 8.11- Scatter plot of drop in CO for different initial estimates of CO relative to median drop. (A) Drop
from changing PEEP from 5 to 7 cmH2O, (B) drop from changing PEEP from 7 to 12 cmH2O
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Figure 8.12 - Scatter plot of percentage drop in CO for different initial estimates of CO relative to median
percentage drop. (A) Drop from 5 to 7 cmH2O, (B) drop from 7 to 12 cmH2O
8.4.4 SENSITIVITY TO LUNG MECHANICS
The estimation of percentage change in shunt is calculated using Equation (8.8), and is
dependent on the maximum theoretical lung capacity, as determined by the recruitment
model. However, the theoretical lung capacity is a value derived from the model fit and is
not necessarily the exact value of true lung capacity. Thus, the estimation of shunt changes
according to Equation (8.8) may have some error.
To test how the change in shunt is affected by different values of theoretical lung capacity,
a sensitivity test was performed. By varying the theoretical lung capacity by 10%, the
effect on the shunt at a PEEP of 7 cmH2O and the percentage decrease in shunt between 5
and 7 cmH2O was modelled to measure the sensitivity of these two parameters.
As shown in Figure 8.13, a 10% change in the theoretical lung capacity causes the
percentage drop on shunt between PEEP of 5 and 7 cmH2O to be between 10 and 15%.
Although this is still within what is clinically tolerable, it indicates that the percentage drop
is reasonably sensitive to the lung capacity.
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Figure 8.13 - Effect on the percentage drop in shunt from 5 to 7 cmH2O as the theoretical lung capacity is varied
by 10%
However, if the absolute value of shunt is examined, then there is very minimal difference
when the lung capacity is varied. Figure 8.14 shows that for a 10% change in lung
capacity, the shunt evaluated at a PEEP of 7 cmH2O only varies by a maximum of 3%.
This apparent lack of sensitivity illustrates that even though the recruitment model does not
estimate the true lung capacity, one can be relatively confident that the shunt at higher
PEEP levels is reasonably accurate given the initial shunt measurement is known, or well
estimated using the thermodilution delivered CO measurement.
Figure 8.14 - Effect on shunt at PEEP 7 cmH2O as the theoretical lung capacity is varied by 10%
146
8.5 MODEL LIMITATIONS & DISCUSSIONS
The model this chapter presents has some limitations that must also be discussed. The first
major limitation is the lack of complete clinical data in validating this model. Although the
aim of this chapter was only to describe the proof of concept, the combination of two
different data sets does not give an accurate representation of true lung mechanics. For this
model to be properly validated, a full set of clinical trials is required. These trials must
capture both lung mechanics and gas exchange parameters, in addition to cardiovascular
measurements, which was not possible with the originally designed trials of Chapter 5.
When evaluating the changes in shunt due to PEEP application, the CO model assumes
that diffusion resistance does not change for the purpose of simplicity. It also considers and
treats shunt as being homogeneous and responsive to PEEP, which is not always the case
[Gattinoni et al., 1998]. These assumptions may or may not be accurate and will need to be
tested with further clinical data.
The estimations of shunt changes according to Equation (8.8) are dependent on the total
lung capacity as modelled by the recruitment model. In reality, this theoretical lung
capacity could take on any value and thus, the estimation of shunt changes may not be
entirely accurate. However, the data from the recruitment trials required a wide range of
PEEP values. When higher PEEP PV curves are incorporated into the recruitment model,
the accuracy of estimating maximum lung capacity increases.
Finally, the initial measurement of shunt requires a known value of cardiac output. In this
study, the initial cardiac output for the PEEP of 5 cmH2O was assumed to be 5 L/min. This
measurement may require some invasive measurement that may not be ideal for all MV
patients. Furthermore, without the use of clinical data, it is difficult to see how frequently
the CO needs to be re-calibrated to the initial measurement from thermodilution. However,
even if the initial cardiac output is estimated, the changes in CO are still tracked, which is
the more important parameter. Thus, the initial measurement of the initial CO can be
avoided if the changes in CO is all that is needed, provided that a reasonably accurate
estimate is available.
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8.6 SUMMARY
The combination of recruitment and gas exchange models presented in this chapter provide
a tool that can be used in two applications. First, it can be used to monitor CO and assess
the impact of changes in PEEP on the resulting CO. Hence, it can, secondly, potentially be
used to optimise PEEP with respect to gas exchange and oxygenation, as well as its impact
on circulation and its management.
More specifically, two models are presented and linked through a hypothesis that a change
in shunt can be reasonably approximated by a change in lung volumes due to PEEP
changes. It should be noted that this approximation is necessary as there is still no accurate
measurement of shunt, including CT, available. A proof of concept case study based on
clinical data is used to show the model’s capability and validity. Finally, a sensitivity
analysis is performed to illustrate the models potential robustness to its underlying
assumptions.
Such linked physiological models offer the opportunity to move beyond simple clinical,
model-based decision support to more complex cases including physiological interactions
between systems. In particular, the ability to combine the pulmonary system to the
cardiovascular system would allow a more complete and holistic picture of how different
interactions occur within the body. Although the model is presented using a proof of
concept, further clinical validation is required.
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Chapter 9 - Conclusions
9.1 OVERVIEW
The use of mechanical ventilation for ICU patients has major implications for mortality
and length of stay in the hospitals. The current approach to choosing ventilation settings
does not provide patient-specific therapies and can often result in sub-optimal treatment,
increasing length of MV, length of stay and mortality. Models of recruitment and lung
stress are produced and tested in the clinic using readily available PV data to provide
patient-specific information. The models provide clinically useful information to evaluate
lung status, and show significant potential to be used at the bedside as a diagnostic tool. A
third model is developed to highlight the link between the cardio and pulmonary system,
enabling further potential model-based monitoring and diagnostic applications, as well as a
more holistic approach to modelling.
9.2 SPECIFIC OUTCOMES & IMPLICATIONS
Mechanical ventilation is widely utilised in the ICU, but the costs for treatments can be
high. Patients experiencing breathing difficulties are subjected to MV therapy to help assist
breathing. In particular, when patients are diagnosed with ARDS and ALI, the resulting
collapse of lung units can result in an effectively smaller lung volume, which interferes
with the process of gas exchange. This outcome can be exacerbated when ventilation is
sub-optimal resulting in increased lung damage, length of MV, length of stay, cost and
mortality. The problem is worsened by the limited data available to clinicians at the
bedside with respect to lung recruitment and status. Thus, there is significant motivation to
develop more optimal ventilation therapies.
Although several studies have shown low tidal volumes to be an effective ventilation
strategy, the selection of optimal PEEP is still debated. Conventional methods that examine
the PV curve inflection points (LIP and UIP) provide a guide to select PEEP. However, the
LIP and UIP can take on a range of values and do not offer one unique setting. The
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introduction of model-based approaches provides an alternative method for selecting
PEEP.
Model-based approaches use readily available clinical data to capture dynamics. Although
models can be classified as finite element models and lumped parameter models, only
lumped parameter models are clinically viable at the bedside for patient-specific therapy
optimisation. The two main lumped parameter modelling approaches describe gas
exchange and recruitment. In the past, clinical models using gas exchange have been
developed, but in patients with ARDS, recruitment is the primary and dominant concern.
However, current recruitment models lack the power to guide therapy, and have only been
created as research tools. Thus, there is strong motivation to create models that fill this gap
and capture recruitment in a manner that can be directly used in a clinical setting.
The recruitment model presented in this thesis is based on physiologically relevant and
mechanically accurate components. It utilises newly hypothesised and clinically observed
lung mechanics. It is the first clinically focused lung model to base its mechanics on the
primary mechanism of recruitment and de-recruitment. Patient-specific and physiologically
relevant model parameters are thus able to be directly identified using readily available
clinical PV data. Hence, it can provide the necessary patient-specific identification of lung
status and condition. The model was initially validated using retrospective clinical data
consisting of 12 patients with various PEEP levels and the associated dFRC’s. The initial
results suggested a high level of clinical relevance, while capturing the recruitment effect
through PEEP.
A second model was developed that described the effect of PEEP on dFRC using lung
stress and strain as a proxy. The dFRC model developed and validated a generic population
PEEP stress parameter, β, to estimate changes in dFRC at various levels of PEEP. The
dFRC model was initially validated with the retrospective clinical data, the results of which
suggested that β could be attributed as a population constant function of PEEP, a unique
finding.
To validate the clinical viability of the recruitment and dFRC models, a series of ethics
approved clinical trials was required. The study was to be split into two components. The
first part of the study was to perform a specialised recruitment manoeuvre on ventilated
patients and record PV data at various levels of PEEP. The second part of the study
150
involved the use of CT scans. By correlating the images from CT scans with the model
output, it was hoped to provide further validation of the model output. Concerns that
patients would be exposed to unnecessary doses of radiation were addressed by limiting
the effective exposed dose to 20 mSv. Ethics was approved by the New Zealand Upper
South Island A Regional Ethics Committee.
Real time clinical data was used to validate the recruitment model. Outputs of the model
were the TOP and TCP mean as well as the net recruitment. These three metrics provided a
means to select optimal PEEP depending on the selection criteria. If the aim was to
maximise recruitment, then TOP was used to choose PEEP. In contrast, if the objective
was to minimise de-recruitment, then the TOP would be used to guide therapy. Finally, the
net recruitment was used when the combined effect of recruitment and de-recruitment was
required. Although the TOP, TCP and net recruitment provided three different methods to
evaluate optimal PEEP, they provided a set of values that could be used in the clinic as a
guideline. These physiologically relevant parameters uniquely capture lung status from
standard PV loops. They are the first such clinically used model parameters to guide
ventilation therapy based on patient recruitability.
In addition to these physiologically based PEEP selection metrics, four additional metrics
were developed to assess how disease state varies with time. More specifically, if a patient
undergoes multiple trials on different days, then the model can track the TOP, SD, TOP
gradient and TCP gradient which yield important information on the disease state of the
patient. Tracking these metrics provide a clearer physiological picture of how the disease
condition is changing using model-based parameters. The parameters represent a unique
model-based approach to track disease state only using basic, non-invasive, real time
clinical data.
The dFRC model was also validated with the same real time clinical data. This secondary
validation indicated that β remained linear and a population constant, even with high PEEP
values. This result strengthened the argument of the linear relationship between PEEP and
β. However, the increased dataset also highlighted some limitations of the model. When
patients exhibit very large changes in compliance, the errors between measured and
estimated dFRC are large. However, this limitation may not pose a major problem, as the
PEEP levels where compliances changes are large are generally well outside of the
clinically acceptable range of PEEP. In addition, although predicted and measured dFRC
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may show high percentage errors, within the linear region, the trends are still the same. The
dFRC model can thus be used in conjunction with the recruitment model when dFRC
measurements are not available providing valuable added insight. In particular, deflation to
ZEEP is likely to often be deemed hazardous to the patient. Thus, model-based estimates
of dFRC, even with some error, provide a means to improve the results of the recruitment
model and provide a more accurate set of PEEP values, resulting in potentially improved
decision support and added clinical insight that was not previously available.
Finally, the combination of lumped parameter models can yield additional information,
rather than if each model was used by itself. By combining recruitment and gas exchange
models, a third novel model is developed that yields information on the cardiovascular
system. The models are linked on the hypothesis that a change in shunt can reasonably be
approximated by a change in lung volume due to PEEP. The CO model can be used to
monitor CO and assess the impact of changes in PEEP on the resulting CO. Hence, it can,
secondly, potentially be used to optimise PEEP with respect to gas exchange and
oxygenation, as well as its impact on circulation and its management. A proof of concept
in silico analysis based on clinical data showed this models capability and a sensitivity
analysis was performed to illustrate its robustness to its founding assumptions.
Overall, the models developed and tested in this research are based on fundamental
physiology and lung mechanics of the ventilated patient. The models fit a variety of
clinical datasets and showed the potential for clinical use at the bedside. Preliminary
validation on retrospective data warranted full scale clinical trials. Although no CT data
was obtained, the results of the clinical trials suggest that the models can potentially be
used to assist therapies and guide clinicians as a diagnostic decision support tool and a
continuous patient monitoring tool in critical care.
The models developed and tested in this research provide rapid parameter identification
while retaining important physiological information and is obtained by using PV data more
effectively. This research represents the first in such clinical trials where recruitment
models are used to derive diagnostic information. In addition, the development of a dFRC
stress model provides a unique population constant, β. The modelling approaches used in
this research provide a novel way of guiding therapy and setting mechanical ventilation
parameters.
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Chapter 10 - Future Work
The models developed in this thesis combined with the clinical validation presented
provide a platform to deliver optimised ventilation therapy. The models have shown good
clinical viability and the results give an indication of the potential pathways of work that
could be conducted in the future to further this research.
10.1 CLINICAL PATHWAY
The acquisition of additional datasets would require a more clinical focus. In particular, the
development of new clinical trials would benefit new research objectives and allow the
concept of model-based methods to progress.
10.1.1 CT SCANNING
The major limitation to this study was the lack of CT data. A limit of 20 mSv was set on
patients who were asked to participate in the CT study. The total dose from the proposed
CT scans was evaluated to be 10.2 mSv which was below the acceptable limit. However,
patients coming into the ICU often require urgent CT scans, for other clinical reasons,
upon admission. This initial scan, not related to the study, causes the total effective dose on
a patient to be high. Thus, any additional scan from this study would exceed the limit of 20
mSv. Another way of incorporating CT scans into the study may be to use animal data. In
particular, trials could be set up to induce lung damage in pigs or goats to mimic ARDS.
These trials could then incorporate a set of recruitment manoeuvres in conjunction with CT
scans. By using animal data, the dose limitations of CT scans for humans may not pose a
major problem when used on animals.
10.1.2 N × N TRIALS
To evaluate the impact of the recruitment model on mortality and length of stay, an NxN
trial would be required. During this sort of trial, two cohorts of N patients would be
selected. One, non-interventional, cohort would be ventilated using conventional methods.
In contrast, the second cohort would undergo a daily or regular recruitment manoeuvre and
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be ventilated according to the recruitment model output. The mortality rates, length of
mechanical ventilation and length of stay will be recorded to evaluate the utility of model-
based recruitment models. Inflammatory markers associated with ARDS and ALI could
also be measured to assess the impact of the therapy on patient condition.
10.1.3 NON-INTERVENTIONAL TRIALS
The recruitment model showed the ability to use model metrics to track the state of the
disease and resulting lung condition as a function of time. However, the results in this
thesis were limited to two patients. To test the efficacy of the tracking parameters, a larger
cohort is required. Thus, a set of non-interventional trials could focus on acquiring PV data
for each patient over time. By collecting data multiple times at regular intervals over
several patients, and correlating disease state metrics with mortality, this trial could
provide a validation to the usefulness of these new metrics.
10.1.4 CARDIAC OUTPUT MONITORING
The CO model introduced in Chapter 8 used a proof of concept to show the potential of
such a model in the clinic. To thoroughly validate this model, a proper clinical trial is
required with cardiovascular measurements occurring simultaneously with ventilation
measurements. More specifically, the trial will need an intervention from the clinician to
vary PEEP and inspired oxygen fraction while also recording continuous cardiovascular
data. This will allow the CO model to be fully validated, and if successful, will allow a
future pathway of non-invasive CO tracking with PEEP changes.
10.1.5 VARIATION IN VENTILATION MODE
In the clinical trials performed in this research, PV curves were obtained under constant
volume conditions to ensure repeatability among different patients. However, obtaining PV
loops under different ventilation modes would evaluate the robustness of the recruitment
model. In particular, obtaining PV curves using pressure controlled ventilation or different
flow waveforms would allow for more potential use. Because clinicians use different
settings for various patients, by testing the model on other settings, the models use can be
expanded.
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10.1.6 SPONTANEOUSLY BREATHING PATIENTS
One disadvantage with the current recruitment model presented is that it does not account
for spontaneously breathing patients. In this study, patients were sedated to prevent
spontaneous breathing. Because a proportion of ventilated patients still breathe
spontaneously, sedating all patients is not practical. Given current trends in providing MV,
this proportion is likely to increase. Thus, the model should account for patients
spontaneously breathing.
The primary difficulty when examining spontaneously breathing patients occurs when a
measurement of transpulmonary pressure is required. For patients who are fully sedated,
transpulmonary pressure should reflect airway pressure when an inspiratory hold is
performed, as in these trials. However, for patients who spontaneously breathe, any sudden
change in diaphragmatic movement can cause sudden changes in transpulmonary pressure.
To measure transpulmonary pressure, the oesophageal pressure is required in conjunction
with airway pressure. The difficulty arises when trying to measure oesophageal pressure
with an oesophageal balloon, which is a very intrusive measurement and not feasible for
regular clinical use. Thus, a means of circumventing this difficulty is required.
One possible set of clinical trials could focus on obtaining oesophageal pressure
measurements simultaneously with airway pressure measurements in spontaneously
breathing patients. During these trials, examining correlations between oesophageal and
airway pressures could yield information as to the interaction between the two values in
spontaneously breathing patients. Furthermore, if a useful physiological or empirical
relationship exists between oesophageal pressure and airway pressure, it then may be
possible to make estimates of transpulmonary pressure and account for spontaneously
breathing patients without invasive manoeuvres, enabling model-based approaches for
these patients.
10.1.7 DATASET SIZE
To further validate the use of β as a population parameter, a larger dataset is required.
During all the potential types of trials described previously, an invasive measurement of
dFRC may also be performed at various PEEP. Ultimately, for β to be used as a population
constant in the clinic, the size of the tested dataset must be large enough to warrant it as a
155
population constant. Although the research presented here suggests it is a population
constant, further trials must be carried on to confirm this.
Finally, the research showed variations in β across different patients. Although this
variation was minimal across the majority of patients studied herein, some patient’s β
values varied significantly. Because β is a function of chest and lung elastance, another set
of trials could focus on examining the elastance characteristics of different patients and
correlating with β.
10.2 MODELLING PATHWAY
Although additional datasets may open the possibility of developing new research
objectives, the acquisition of the clinical data in this research may open up the possibility
of alternative models. In addition, the use of the recruitment model is currently limited to
analysing the data after the trials. Thus, from an engineering perspective, there is potential
for creating a real-time automated model.
10.2.1 ARDS DISTRIBUTION MODELLING
The current recruitment model assumes that alveoli are either recruited or de-recruited. The
model does not consider the effect over-stretching. Although models have been developed
that account for different type of alveoli, these are clinically impractical due to the
excessive computational time. To overcome this limitation, a new modelling approach may
be required.
Various works have shown the individual compliance curves of healthy and unhealthy
alveoli. Using the individual compliance curves, it may be possible to estimate a
distribution of healthy and unhealthy alveoli. More specifically, when the recruitment
model is fitted to PV curves, an estimate of the total lung capacity (TLC) is given. Using
an estimate of TLC, for a given pressure and unit compliance, the sum of the individual
alveoli could then give the volume at that given pressure. This modelling approach may
give a rapid indication as to the heterogeneity of the lung and could be correlated with lung
CT scans to validate it.
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10.2.2 INCREMENTAL STRESS STRAIN APPROACH
For a given increment in pressure, the lung experiences a combination of increased strain
and alveolar recruitment. Increased strain is seen on alveoli that have already previously
recruited, while collapsed alveoli begin to newly recruit. Theoretically, if there was an
increase in volume for no increase in pressure, this would imply that all the volume change
is attributed to increased recruitment and zero additional strain on existing alveoli (infinite
lung compliance). Thus, this hypothetical situation would represent the zero strain case. In
contrast, if the change in volume produced a disproportionately large change in pressure,
then the level of additional recruitment is overshadowed by the increase in strain of
existing recruited alveoli.
When PEEP is applied, every increment of PEEP produces a certain amount of stretch on
already recruited lung units. Thus, although applying additional PEEP may cause
additional recruitment, it may significantly overstretch existing alveoli which may cause
more harm. Another potential modelling approach is to expand on this concept and
examine how incremental strain of individual alveoli corresponds with the compliance of
the PV curve.
More specifically, based on the compliance curves of individual alveoli, it may be possible
to evaluate the strain on each alveoli. By comparing the alveolar strain with the compliance
of the entire PV curve, it may be possible to develop a new metric that highlights the risks
between applying PEEP and the stretch on previously recruited healthy alveoli.
10.2.3 COPD
The research presented in this thesis fitted the steady portion of the dynamic PV curve to
get estimates of the patient recruitment behaviour. One of the limitations of such an
approach is it discards the dynamic portion of the PV curve. In patients suffering from
COPD, the initial dynamic deflationary portion can give an indication to the severity of the
COPD. More specifically, COPD patients have a much faster initial passive deflation.
In reality, most patients will have some level of obstruction present. Thus, depending on
the shape of the deflation PV curve, the recruitment model may be extended to quantify the
level of the obstruction for each patient. This may prove useful when trying to ventilate
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patients, as clinicians could quantify the severity of COPD and recognise that a new
ventilation strategy is required.
10.2.4 AUTOMATION
The analysis of the data in this research occurred after the trials had been completed. To be
viable in the clinical scenario, the model requires a full or semi automated system which
would incorporate data acquisition, processing and analysis. In addition, the process must
be easy to use for the intensive care staff, and should incorporate all the processes that
were highlighted in the recruitment manoeuvre and have the option of correcting for
endotracheal tube resistance. Finally, the data must be easy to read and implement if
necessary.
158
159
Appendix A – FRC Sensitivity Plots
Figure A. 1 - FRC as a function of varying α for Patient 1. Thick dotted line indicates estimated FRC when mean
ELspec is used. (A) Normal distribution range - Thin lines show the +/- 1 and 2 SD from mean as reported byChiumello et al [Chiumello et al., 2008]. (B) Lognormal distribution range Thin dotted lines show the +/- 2 SD
using lognormal distribution
Figure A. 2 - FRC as a function of varying α for Patient 2
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Figure A. 3 - FRC as a function of varying α for Patient 3
Figure A. 4 - FRC as a function of varying α for Patient 4
Figure A. 5 - FRC as a function of varying α for Patient 5
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Figure A. 6 - FRC as a function of varying α for Patient 6
Figure A. 7 - FRC as a function of varying α for Patient 7
Figure A. 8 - FRC as a function of varying α for Patient 8
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Figure A. 9 - FRC as a function of varying α for Patient 9
Figure A. 10 - FRC as a function of varying α for Patient 10
Figure A. 11 - FRC as a function of varying α for Patient 11
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Figure A. 12 - FRC as a function of varying α for Patient 12
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Appendix B – Model Fitting Errors
Table B. 1 - Model fitting errors for all patients
PATIENT 1
Number of Units 144000
Inflation SD 15
Deflation SD 7
Auto-PEEP [cmH2O] 10
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
10 30.97 22.17 7.86 15.57 15.48 4.61
15 28.07 22.50 4.44 17.68 5.61 1.02
20 27.12 22.27 3.11 19.88 5.72 0.63
25 26.41 21.71 2.05 22.43 7.47 0.68
27 26.18 15.11 1.34 23.39 2.73 0.24
PATIENT 2
Number of Units 171000
Inflation SD 11
Deflation SD 7
Auto-PEEP [cmH2O] 2
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
5 22.15 50.26 16.50 12.40 23.68 8.98
10 21.53 37.78 6.14 13.86 7.08 1.28
15 21.53 41.85 4.78 16.10 7.47 0.78
20 22.69 35.41 3.15 18.24 4.82 0.41
22 23.60 33.79 2.76 19.48 7.65 0.60
PATIENT 3
Number of Units 220000
Inflation SD 12
Deflation SD 8
Auto-PEEP [cmH2O] 0
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
0 26.07 51.08 151.80 14.38 45.59 116.89
5 22.54 55.09 16.17 13.97 40.19 11.08
10 21.25 12.79 1.97 14.57 18.31 2.76
15 21.25 25.68 2.43 16.34 20.53 1.92
20 21.25 36.99 2.49 18.11 23.34 1.58
25 21.25 48.72 2.65 19.98 13.26 0.76
28 22.37 32.58 1.69 21.86 12.88 0.69
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PATIENT 4
Number of Units 220000
Inflation SD 25
Deflation SD 10
Auto-PEEP [cmH2O] 9
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
10 55.56 9.37 5.52 20.04 4.28 1.16
15 44.45 32.86 7.02 21.10 8.24 1.31
20 37.09 35.19 4.47 21.58 1.95 0.19
25 33.18 39.34 3.52 23.13 1.39 0.11
30 30.77 24.31 1.77 24.75 5.10 0.32
PATIENT 5 - TRIAL 1
Number of Units 198000
Inflation SD 16
Deflation SD 10
Auto-PEEP [cmH2O] 13
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
15 44.89 25.88 12.31 27.83 14.49 6.04
20 43.26 9.93 2.73 29.83 10.80 2.31
25 43.26 53.48 7.86 31.61 20.67 3.12
PATIENT 5 - TRIAL 2
Number of Units 161000
Inflation SD 15
Deflation SD 8
Auto-PEEP [cmH2O] 8
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
10 36.99 31.51 19.71 19.30 15.86 7.52
15 33.05 16.44 4.16 21.09 10.88 2.75
20 31.11 15.75 2.39 22.72 2.85 0.45
25 32.42 21.27 2.52 25.73 13.99 1.55
29 32.42 30.72 2.85 26.91 10.75 1.03
PATIENT 6 - TRIAL 1
Number of Units 96000
Inflation SD 11
Deflation SD 7
Auto-PEEP [cmH2O] 10
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
10 28.72 41.45 49.57 17.42 35.78 27.75
15 25.57 18.04 4.02 17.76 11.07 2.87
20 26.75 9.68 1.88 19.40 5.20 0.91
25 28.44 7.69 1.05 21.20 6.31 0.76
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PATIENT 6 - TRIAL 2
Number of Units 171000
Inflation SD 14
Deflation SD 8
Auto-PEEP [cmH2O] 3
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
5 23.58 27.97 7.98 12.41 11.54 3.46
10 21.89 7.07 1.17 14.09 7.25 1.28
15 20.83 9.70 1.11 15.66 2.70 0.32
20 20.83 18.99 1.56 16.49 17.35 1.37
25 20.83 20.73 1.41 18.60 2.91 0.19
PATIENT 6 - TRIAL 3
Number of Units 154000
Inflation SD 14
Deflation SD 9
Auto-PEEP [cmH2O] 2
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
5 19.88 43.11 11.66 12.33 17.91 5.31
10 17.76 17.00 2.37 12.38 3.81 0.58
15 17.76 9.18 0.95 13.57 6.14 0.61
20 18.85 8.43 0.76 14.94 2.71 0.22
PATIENT 7
Number of Units 65000
Inflation SD 10
Deflation SD 5
Auto-PEEP [cmH2O] 2
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
5 15.89 1.73 0.63 8.70 4.51 1.93
10 15.89 17.74 3.77 11.29 3.28 0.66
15 19.09 11.95 2.16 14.39 3.09 0.56
16 19.50 19.96 3.37 14.79 4.86 0.83
PATIENT 8
Number of Units 176000
Inflation SD 15
Deflation SD 10
Auto-PEEP [cmH2O] 0
Inflation Deflation
PEEP [cmH2O] Mean Error [ml] Error [%] Mean Error [ml] Error [%]
0 33.03 36.08 81.81 13.11 58.17 34.11
5 28.67 34.56 13.37 15.51 12.30 4.29
10 27.41 12.36 3.18 17.32 10.47 2.36
15 26.58 14.82 2.44 18.87 2.03 0.31
20 26.58 15.54 1.72 20.62 3.48 0.38
25 26.58 21.82 1.90 22.21 4.63 0.38
30 26.58 14.11 1.02 22.93 2.12 0.15
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PATIENT 9
Number of Units 189000
Inflation SD 15
Deflation SD 9
Auto-PEEP 12
Inflation Deflation
PEEP Mean Error [ml] Error [%] Mean Error [ml] Error [%]
15 29.53 13.22 2.04 20.37 5.27 0.84
20 29.14 12.09 1.45 21.97 3.88 0.44
25 28.61 17.32 1.56 23.36 8.29 0.66
29 28.60 15.40 1.17 24.41 2.12 0.15
30 28.49 11.20 0.79 25.00 6.85 0.47
PATIENT 10
Number of Units 147000
Inflation SD 16
Deflation SD 9
Auto-PEEP 3
Inflation Deflation
PEEP Mean Error [ml] Error [%] Mean Error [ml] Error [%]
5 30.54 33.80 17.27 16.50 20.39 9.43
10 28.76 13.10 3.04 17.62 6.33 1.69
15 27.99 6.73 1.04 19.16 13.18 2.11
20 27.99 11.97 1.56 21.94 5.15 0.59
25 27.99 10.75 1.08 24.01 5.48 0.54
27 27.99 8.70 0.80 24.94 6.02 0.59
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Appendix C – Recruitment Model Results
Figure C. 1 - Main plot shows TOP and TCP as a function of PEEP for Patient 1. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 1 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
1
Method Optimum PEEP[cm H2O] Reason
TOP 27 Recruitment maximised - but could pose risk of VILI
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 20
Lower PEEP does not maximise recruitment, while higher PEEP does
not minimise de-recruitment
Clinical
Setting 10 Clinician selected
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Figure C. 2 - Main plot shows TOP and TCP as a function of PEEP for Patient 2. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 2 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
2
Method Optimum PEEP[cm H2O] Reason
TOP 15 Recruitment maximised - Higher PEEP resulted in circuit leak
TCP 15 Higher PEEP results in less de-recruitment
Net
Recruitment 15
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal
Clinical
Setting 12 Clinician selected
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Figure C. 3 - Main plot shows TOP and TCP as a function of PEEP for Patient 3. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 3 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
3
Method Optimum PEEP[cm H2O] Reason
TOP 10
Recruitment maximised - Additional PEEP does not cause additional
recruitment
TCP 15 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 20
Lower PEEP does not maximise recruitment, while higher PEEP does
not minimise de-recruitment
Clinical
Setting 10 Clinician selected
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Figure C. 4 - Main plot shows TOP and TCP as a function of PEEP for Patient 4. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 4 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
4
Method Optimum PEEP[cm H2O] Reason
TOP 30 Recruitment maximised - but could pose risk of VILI
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 30 Lower PEEP does not maximise recruitment
Clinical
Setting 10 Clinician selected
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Figure C. 5 - Main plot shows TOP and TCP as a function of PEEP for Patient 5, Trial 1. Bottom left plot is the
model fit. Bottom right indicates net recruitment
Table C. 5 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
5, Trial 1
Method Optimum PEEP[cm H2O] Reason
TOP 20
Recruitment maximised - Additional PEEP does not cause additional
recruitment
TCP 25 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 25 Lower PEEP does not maximise recruitment
Clinical
Setting 12 Clinician selected
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Figure C. 6 - Main plot shows TOP and TCP as a function of PEEP for Patient 5, Trial 2. Bottom left plot is the
model fit. Bottom right indicates net recruitment
Table C. 6 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
5, Trial 2
Method Optimum PEEP[cm H2O] Reason
TOP 20
Recruitment maximised - Additional PEEP is suboptimal and
increases compliance
TCP 25 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 20
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal
Clinical
Setting 12 Clinician selected
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Figure C. 7 - Main plot shows TOP and TCP as a function of PEEP for Patient 6, Trial 1. Bottom left plot is the
model fit. Bottom right indicates net recruitment
Table C. 7 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
6, Trial 1
Method Optimum PEEP[cm H2O] Reason
TOP 15
Recruitment maximised - Additional PEEP is suboptimal and
increases compliance
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 20
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal
Clinical
Setting 11 Clinician selected
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Figure C. 8 - Main plot shows TOP and TCP as a function of PEEP for Patient 6, Trial 2. Bottom left plot is the
model fit. Bottom right indicates net recruitment
Table C. 8 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
6, Trial 2
Method Optimum PEEP[cm H2O] Reason
TOP 15
Recruitment maximised - Additional PEEP does not cause additional
recruitment
TCP 15 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 20
Lower PEEP does not maximise recruitment, while higher PEEP does
not minimise de-recruitment
Clinical
Setting 13 Clinician selected
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Figure C. 9 - Main plot shows TOP and TCP as a function of PEEP for Patient 6, Trial 3. Bottom left plot is the
model fit. Bottom right indicates net recruitment
Table C. 9 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
6, Trial 3
Method Optimum PEEP[cm H2O] Reason
TOP 10
Recruitment maximised - Additional PEEP does not cause
additional recruitment
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net Recruitment 15
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal
Clinical Setting 10 Clinician selected
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Figure C. 10 - Main plot shows TOP and TCP as a function of PEEP for Patient 7. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 10 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
7
Method Optimum PEEP[cm H2O] Reason
TOP 5
Recruitment maximised - Additional PEEP does not cause additional
recruitment
TCP 10 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 10
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal
Clinical
Setting 7.5 Clinician selected
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Figure C. 11 - Main plot shows TOP and TCP as a function of PEEP for Patient 8. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 11 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
8
Method Optimum PEEP[cm H2O] Reason
TOP 15
Recruitment maximised - Additional PEEP does not cause
additional recruitment
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net Recruitment 30
Lower PEEP does not maximise recruitment, while higher PEEP
is sub-optimal. But may risk VILI
Clinical Setting 12 Clinician selected
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Figure C. 12 - Main plot shows TOP and TCP as a function of PEEP for Patient 9. Bottom left plot is the model fit.
Bottom right indicates net recruitment
Table C. 12 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
9
Method Optimum PEEP[cm H2O] Reason
TOP 25
Recruitment maximised - Additional PEEP does not cause additional
recruitment
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 29
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal. But may risk VILI
Clinical
Setting 10 Clinician selected
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Figure C. 13 - Main plot shows TOP and TCP as a function of PEEP for Patient 10. Bottom left plot is the model
fit. Bottom right indicates net recruitment
Table C. 13 - Clinically selected PEEP and Optimal PEEP indicated by TOP, TCP and net recruitment for Patient
10
Method Optimum PEEP[cm H2O] Reason
TOP 15
Recruitment maximised - Additional PEEP does not cause additional
recruitment
TCP 20 Higher PEEP results in less de-recruitment but can risk VILI
Net
Recruitment 15
Lower PEEP does not maximise recruitment, while higher PEEP is
sub-optimal. But may risk VILI
Clinical
Setting 10 Clinician selected
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Appendix D – Measured dFRC Plots
Figure D. 1 - PEEP vs Clinically measured dFRC for Group 2, Patient 1
Figure D. 2 - PEEP vs Clinically measured dFRC for Group 2, Patient 2
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Figure D. 3 - PEEP vs Clinically measured dFRC for Group 2, Patient 3
Figure D. 4 - PEEP vs Clinically measured dFRC for Group 2, Patient 4
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Figure D. 5 - PEEP vs Clinically measured dFRC for Group 2, Patient 5 – Trial 1
Figure D. 6 - PEEP vs Clinically measured dFRC for Group 2, Patient 5 – Trial 2
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Figure D. 7 - PEEP vs Clinically measured dFRC for Group 2, Patient 6 – Trial 2
Figure D. 8 - PEEP vs Clinically measured dFRC for Group 2, Patient 6 – Trial 3
185
Figure D. 9 - PEEP vs Clinically measured dFRC for Group 2, Patient 7
Figure D. 10 - PEEP vs Clinically measured dFRC for Group 2, Patient 8
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Figure D. 11 - PEEP vs Clinically measured dFRC for Group 2, Patient 9
Figure D. 12 - PEEP vs Clinically measured dFRC for Group 2, Patient 10
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